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Chapter 1  
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Proline is a unique amino acid. It has the highest solubility of any amino acid 
reaching a solubility limit of 6.5 M [H20 20 °C] (1). The side chain bonds with the amino 
group, creating a secondary amine rather than a primary amine. This unique side chain 
creates a pyrrolidine ring which is thought to contribute heavily to its diverse functions 
and roles. 
Although proline has never been investigated as a possible cryo-additive for 
macromolecular cryocrystallography, there is extensive literature on its unique properties 
and unusual functions (1-7). Plants, bacteria, invertebrates, protozoa and algae all 
accumulate proline during water stress, including cold acclimation to increase freezing 
tolerance (7). Proline also can increase solubility of some compounds, including proteins 
and be added to guard against denaturation during dehydration (4). Further, cells 
accumulate proline while experiencing water stress, which fits with its known role as an 
effective osmolyte. When cells are under water stress, dehydration, high salt, or low 
temperature, they up regulate proline synthesis and down regulate proline degradation. 
Proline has also been known to increase viability of cells after freezing when added 
exogenously, usually better than other cryoprotectants such as glycerol (6). 
The unique function of proline has led cells to evolve specialized enzymes to 
control proline metabolism. Proline catabolism to glutamate happens in a two-step, four 
electron oxidation catalyzed by two enzymes. First, proline is oxidized to Δ1-pyrroline-5-
carboxylate (P5C) the flavin dependent proline dehydrogenase (PRODH). PRODH uses 
flavin adenine dinucleotide (FAD) as an electron acceptor. Reduction of FAD to FADH2 
disrupts the aromaticity of the isoalloxazine ring and reorganizes the ribityl chain. P5C 
then goes through a non-enzymatic, pH dependent hydrolysis to glutamate γ-
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semialdehyde (GSA) (8). The final two electron oxidation is catalyzed by P5C 
dehydrogenase (P5CDH), which oxidizes GSA to glutamate using NAD
+
 as the electron 
acceptor. 
PRODH and P5CDH are conserved in bacteria and eukaryotes. They are arranged 
into three different domains, or branches, based on sequence analysis of PRODHs (9, 10). 
In branches 1 and 2 the two enzymes are combined into a single polypeptide; a 
bifunctional enzyme known as proline utilization A (PutA) (11). PutA appears to be 
limited to Gram-negative bacteria. Branch 1 houses PutAs from alpha-, beta-, and 
gamma-proteobacteria and ranges in chain length from 999 to about 1400 residues. The 
overall sequence identity within this branch is about 38%. Branch 1 further has a subset 
of trifunctional PutAs that have a DNA-binding domain located in the N-terminus of the 
enzyme. These enzymes tend to be longer, about 1270-1361 residues, and have the third 
function of repressing transcription of the put regulon. High levels of proline in the 
bacterium cause the enzyme to disengage from the regulon and allow transcription of 
PutA. Branch 2 contains only bifunctional enzymes from delta- and epsilon-
proteobacteria as well as cyanobacteria with a chain length of 980-1300 residues. The 
sequence identity within this branch is as low as 23% suggesting a more diverse group, 
even without the presence of trifunctional enzymes (9, 12). 
To date the structures of Bradyrhizobium japonicum PutA (BjPutA) (13, 14) from 
branch 1 and Geobacter sulfurreducens PutA (GsPutA) (15) from branch 2 have been 
determined. BjPutA was the first structure solved and was the only full length structure 
solved for some time. This structure revealed the presence of a large, internal, water-
filled cavity that linked the PRODH domain with the P5CDH domain. This tunnel is 
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about 75 Å in length and implies the channeling of the intermediate P5C/GSA. Steady-
state kinetics and a fluorescence assay also had results indicative of channeling the 
intermediate between active sites. The BjPutA PRODH active site was blocked form the 
main cavity by a universally conserved ion pair between R456 and E197. It was 
hypothesized that this ion pair was a gate that allowed access to the tunnel from the 
PRODH active site. Unfortunately, due to the high concentration of ammonium sulfate, 2 
M, and the presence of sulfate in the active site, no structural information from ligand 
soaking with proline analogs and inhibitors could be perform (13).  
GsPutA revealed a similar cavity with kinetics matching the results expected for 
channeling. GsPutA had the added advantage of being higher resolution (1.8, as 
compared to 2.1 Å) and having a precipitating solution that did not contain ammonium 
sulfate. This gave more in depth structural analysis to be done and saw the 
conformational changes revolved around the breaking of the ion pair and lending strength 
to the idea of this being a gate to the main cavity (15). 
Branch 3 contains Gram-positive (3A) and eukaryotic (3B) enzymes. However, 
these enzymes are monofunctional and encoded on separate and distinct genes (9). There 
is no presence of a large internal cavity linking the two and to date there is no clear 
evidence suggesting that these two monofunctional enzymes interact and channel 
substrate. In eukaryotes, PRODH is found interacting with the inner mitochondrial 
membrane (16, 17), while P5CDH is found as a soluble enzyme in the mitochondrial 
matrix (18, 19). The product of proline catabolism, glutamate, can go through 
deamination and enter the TCA cycle as α-ketogluterate. Ornithine gets converted to 
GSA/P5C by ornithine amino transferase, allowing cross talk between the urea cycle and 
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proline metabolism. Further, P5C produced from PRODH can be transported out of the 
mitochondria to the cytosol where it can be reduced back to proline by P5C reductase and 
transported back into the mitochondria (20). This redox shuttling transfers redox 
equivalents from the pentose phosphate pathway to the electron transport chain and could 
explain eukaryotes desire to uncouple the PRODH and P5CDH activities. 
Further, monofunctional P5CDH is an aldehyde dehydrogenase and belongs to the 
aldehyde dehydrogenase (ALDH) superfamily. The ALDH family is huge with hundreds 
of distinct genes found in all forms of life (21). Specifically, P5CDH is ALDH4A1 and 
has the characteristic Rossman fold found for binding NAD
+ 
(22).  P5CDH has been 
known to have a broad substrate specificity, oxidizing several semialdehydes (23). The 
best example is its ability to oxidize both P5C and hydroxy-P5C (24), however unique 
and distinct PRODH enzymes are needed to oxidize proline and hydroxyproline. Several 
common mutations of the human P5CDH gene have been reported to cause a loss of 
function resulting in the metabolic disorder type II hyperprolinemia (25-27). PRODH and 
P5CDH genes are activated by p53, a known tumor suppressor which indicates proline 
catabolism in apoptosis, stress, and even cancer (28, 29). 
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Summary of Research. 
 My doctorate work has been separated into several parts. First, investigation into 
the channeling found in PutA enzymes. This study involved solving the structure of 
several mutant enzymes of BjPutA including D779Y, Δ1-986, E460A, and E197A. 
Further, soaking of the wild type structure with a high concentration shed light on the 
movement of the proposed ion-pair gate. This soak also spurred on research that 
ultimately found that proline was usable as a cryoprotectant for macromolecular 
crystallography. This study led to crystallization and structure determination of BjPutA, 
several BjPutA mutants, lysozyme, glucose isomerase, histidine acid phosphatase and 
mouse P5CDH. Several studies were done on P5CDH, specifically the mouse P5CDH. 
This study involved ligand soaking with varying sizes and chain lengths of 
semialdehydes to better understand the enzymes substrate selectivity. The result was the 
characterization of a binding loop that played a critical role in anchoring the substrate in 
the correct orientation for catalytic activity. Studies on the yeast P5CDH (Put2) were also 
carried out, but the crystal structure showed an inherent flexibility of this binding loop 
characterized by the mouse studies. Lastly extensive small angle X-ray scattering (SAXS) 
was performed to determine how we can influence oligomeric states.  
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Abstract  
L-Proline is one of Mother Nature’s cryoprotectants. Plants and yeast accumulate proline 
under freeze-induced stress and the use of proline in the cryopreservation of biological 
samples is well established. Here, it is shown that L-proline is also a useful cryoprotectant 
for protein crystallography. Proline was used to prepare crystals of lysozyme, xylose 
isomerase, histidine acid phosphatase and 1-pyrroline-5-carboxylate dehydrogenase for 
low-temperature data collection. The crystallization solutions in these test cases included 
the commonly used precipitants ammonium sulfate, sodium chloride and polyethylene 
glycol and spanned the pH range 4.6–8.5. Thus, proline is compatible with typical 
protein-crystallization formulations. The proline concentration needed for cryoprotection 
of these crystals is in the range 2.0–3.0 M. Complete data sets were collected from the 
proline-protected crystals. Proline performed as well as traditional cryoprotectants based 
on the diffraction resolution and data-quality statistics. The structures were refined to 
assess the binding of proline to these proteins. As observed with traditional 
cryoprotectants such as glycerol and ethylene glycol, the electron-density maps clearly 
showed the presence of proline molecules bound to the protein. In two cases, histidine 
acid phosphatase and 1-pyrroline-5-carboxylate dehydrogenase, proline binds in the 
active site. It is concluded that L-proline is an effective cryoprotectant for protein 
crystallography.  
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2.1. Introduction 
X-ray diffraction data collection at cryogenic temperatures (∼100 K) is nearly 
universal in macromolecular crystallography today. As water occupies a substantial 
fraction (∼0.5) of the volume of macromolecular crystals, crystalline ice typically forms 
upon exposure of the untreated protein crystal to cryogenic temperatures. Crystalline ice 
can degrade diffraction quality, and the intense powder diffraction rings from 
microcrystalline ice compromise the adjacent protein reflections. This problem is 
typically prevented by adding a high concentration of a solute, known as the 
cryoprotectant, to the mother liquor or stabilizing solution (1). Commonly used 
cryoprotectants include glycerol, ethylene glycol, 2-methyl-2,4-pentanediol, low-
molecular-weight polyethylene glycols (PEGs) and sucrose (2-4). Lithium salts and 
sodium malonate can also be used as cryoprotectants in some cases (5, 6). More recently, 
the osmolytes trimethylamine N-oxide, sarcosine and betaine have been used successfully 
as cryoprotective agents for protein crystals (7, 8). 
A motivation for the current study is nature’s use of the amino acid L-proline as a 
cryoprotectant. Plants accumulate proline in response to environmental stresses, 
including freezing temperatures (9-11). For example, early studies on coastal 
bermudagrass shoots showed that drought stress caused an increase of proline from less 
than 0.1 mg per gram of dry weight to over 15 mg per gram (12). Also, a 500-fold 
increase in free proline to levels as high as 60 mM has been observed in water-stressed 
tomato-plant cells (13). Proline also protects yeast against freeze stress (14-16). Gene-
knockout studies have shown that disruption of proline catabolism in yeast improves 
freeze tolerance and that the mutant yeast strains accumulate up to 9% of the cell’s dry 
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weight in proline (16). In addition, the freeze tolerance of certain fly larva is a 
consequence of elevated levels of proline (17, 18). In some cold-acclimated larvae, for 
example, the proline concentration reaches 147 mM (17). 
The role of proline in freeze tolerance in vivo has prompted the use of the amino 
acid in the cryopreservation of biological samples in vitro. For example, cultured cells of 
maize have been freeze-preserved in 10%(w/v) proline (19). Also, proline at 27 mM has 
been used for the preservation of ram sperm (20). Additionally, low levels of proline 
[1%(w/v)] have been used in conjunction with other solutes in the cryopreservation of 
human stem cells (21). To our knowledge, proline has not been used as a cryoprotectant 
for protein crystals. 
Here, we demonstrate the use of proline in the cryoprotection of crystals of hen 
egg-white lysozyme, xylose isomerase, histidine acid phosphatase and 1-pyrroline-5--
carboxylate dehydrogenase. Proline was found to perform as well as traditional 
cryoprotectants in these cases. 
2.2. Materials and Methods 
2.2.1 Loop diffraction tests 
Loop diffraction tests were performed to determine the proline concentration range 
needed to prevent the formation of crystalline ice in the presence of the two common 
precipitants ammonium sulfate and PEG 3350. For these tests, stock solutions of 6.5 M 
proline, 4 M ammonium sulfate and 50%(w/v) PEG 3350 in water were prepared. We 
note that the pH of 6.5 M aqueous proline is 6.5. Several solutions containing various 
concentrations of proline and either ammonium sulfate or PEG 3350 were then made by 
mixing appropriate volumes of the stock solutions and water. Hampton Research 20 µm 
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diameter nylon loops (0.5 mm loop size) were dipped into these solutions, flash-cooled in 
a cryogenic gaseous N2 stream (Riguku X-stream 2000 set at 123 K) and exposed to X-
rays from a Rigaku RUH3R rotating-anode source coupled to an R-AXIS IV
++
detector. 
The cryostream was blocked with a thin plastic card while the loop was mounted on the 
goniometer and the card was quickly removed after the sample was in place. The loops 
were not blotted prior to transfer to the goniometer. The crystal-to-detector distance was 
150 mm, which corresponds to 2.00 Å resolution at the detector edge. The exposure time 
was 1 min. Each solution was tested three times to ensure reproducibility. 
2.2.2 Crystallization and cryoprotection 
2.2.2.1. General cryoprotection procedure  
The crystals were cryoprotected using the in situserial transfer method described 
previously (2). In our implementation of this method, cryoprotection is initiated by 
adding 20–40 µl of a buffer containing a low concentration of the cryoprotectant to the 
sitting drop in which the crystal was grown (Cryschem plate). The solution bathing the 
crystal is then mixed by drawing 20 µl liquid into the pipette and expelling it back into 
the drop 3–5 times. Next, 20 µl buffer is removed, 20 µl fresh buffer is added and the 
solution is mixed. The cycle of removal, replacement and mixing is repeated until 
schlieren lines are no longer evident upon the addition of fresh buffer (typically 3–5 
cycles). The entire procedure is repeated using a series of buffers with increasing 
amounts of the cryoprotectant until the final desired level of cryoprotectant is achieved. 
The time for cryoprotection was 5–10 min per crystal.The cryoprotected crystals were 
picked up with Hampton Research 20 µm nylon loops and vitrified by plunging them into 
liquid nitrogen. The crystals were not blotted prior to plunging into liquid nitrogen, nor 
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was the cold gas layer above the liquid-nitrogen surface removed (22). The thickness of 
the cold gas layer was estimated to be 1–2 cm. 
2.2.2.2. Lysozyme  
Hen egg-white lysozyme (HEWL) was purchased from Sigma–Aldrich 
(catalogue No. L7651) and a stock solution of 12.5 mg ml
−1
 HEWL in 0.1 M sodium 
acetate buffer pH 4.6 was prepared. Tetragonal crystals were grown in 6 µl sitting drops 
(Cryschem plates) at room temperature using a reservoir solution consisting of 0.5–0.9 
M NaCl, 0.1 M sodium acetate pH 4.6. The protein:reservoir ratio in the drop was varied, 
with the largest crystals obtained at ratios of 4:2 and 3:3. HEWL crystals were 
cryoprotected in 2.8 M proline, 1.2 M NaCl, 0.1 M sodium acetate pH 4.6 (Table 1) via 
the in situ serial transfer method described above. The starting buffer was 0.5 M proline, 
1.2 M NaCl, 0.1 M sodium acetate pH 4.6. The proline concentration in the buffer was 
increased stepwise to 1.0, 1.5, 2.0, 2.5 and finally 2.8 M. 
As a control, HEWL crystals were also cryoprotected in ethylene glycol, a 
cryoprotectant that has previously been used with tetragonal HEWL crystals (23, 24). The 
starting buffer for in situ serial transfer cryoprotection was 10%(v/v) ethylene glycol, 0.9 
M NaCl, 0.1 M sodium acetate pH 4.6. The ethylene glycol concentration was increased 
stepwise to 15, 20 and finally 22.5%. 
2.2.2.3. Xylose isomerase  
Xylose isomerase (XI) from Streptomyces rubiginosus was purchased from 
Hampton Research (catalogue No. HR7-102) as a crystalline suspension at 33 mg ml
−1
. 
The protein was dialyzed into 10 mM HEPES, 1 mM MgCl2 pH 7.0 and was concentrated 
to 25 mg ml
−1
 using a centrifugal device. Crystals were grown at room temperature in 
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Cryschem sitting-drop plates using drops formed by mixing 1.5 µl each of the protein and 
reservoir solutions. 
The I222 crystal form of XI was grown using a reservoir solution consisting of 
1.0–2.2 M ammonium sulfate, 0.1 M Tris–HCl pH 7.0–8.5. The crystals were 
cryoprotected using the in situ stepwise approach described in §2.2.1. The starting buffer 
consisted of 1.0 M proline, 2.0 M ammonium sulfate, 0.1 M Tris–HCl pH 8.5. The proline 
concentration in the buffer was increased by 1.0 M in one step to achieve a final 
cryobuffer of 2.0 M proline, 2.0 M ammonium sulfate, 0.1 M Tris–HCl pH 8.5 (Table 1; 
XI-1). 
For comparison purposes, XI crystals were also cryoprotected in glycerol. We 
note that glycerol has been used previously for I222 crystals of XI grown in ammonium 
sulfate (PDB entry 2GLK). The starting buffer for in situ serial transfer cryoprotection 
was 5%(v/v) glycerol, 2.0 M ammonium sulfate, 0.2 M MgCl2, 0.1 M Tris pH 8.0. The 
concentration of glycerol in the buffer was increased to 20% in steps of 5%. 
The I222 crystal form of XI was also obtained using low ionic strength conditions 
consisting of 4–9%(w/v) PEG 4000, 0.2 M MgCl2, 0.1 M Tris–HCl pH 7.0–8.5. The 
crystals were cryoprotected in situ by first replacing the mother liquor with 20 µl 1.0 
Mproline, 5%(w/v) PEG 4000, 0.2 M MgCl2, 0.1 M Tris pH 8.5. The proline 
concentration was increased in 0.5 M steps to a final cryobuffer of 3.0 M proline, 5% 
PEG 4000, 0.2 M MgCl2, 0.1 M Tris pH 8.5 (Table 1; XI-2). As a control experiment, this 
crystal form of XI was also cryoprotected in PEG 200. The starting buffer for 
cryoprotection was 5%(v/v) PEG 200, 5%(w/v) PEG 4000, 0.2 M MgCl2, 0.1 M Tris pH 
8.0. The PEG 200 concentration in the buffer was increased to 20% in steps of 5%. 
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2.2.2.4. Histidine acid phosphatase  
The H17N/D261A double mutant of the histidine acid phosphatase 
from Francisella tularensis (FtHAP) was expressed using auto-induction (25) and was 
purified and crystallized as described previously (26, 27). Crystals were grown in sitting 
drops using a reservoir solution consisting of 1.7–2.2 M ammonium sulfate, 0.1 M bis-
Tris pH 5.5–6.5. The drop size was 2 µl and equal volumes of the protein and reservoir 
solutions were mixed. The space group of the crystals was P41, with unit-cell 
parameters a = b = 62.0, c = 210.4 Å. The starting buffer for in situ cryoprotection was 
1.0 M proline, 2.0 Mammonium sulfate, 0.1 M bis-Tris pH 6.5. The proline concentration 
was increased in 0.5 M steps to a final cryobuffer of 2.0 M proline, 2.0 M ammonium 
sulfate, 0.1 M bis-Tris pH 6.5 (Table 1). 
For comparison purposes, FtHAP crystals were also cryoprotected in glycerol as 
described previously (27). The starting buffer for cryoprotection was 5%(v/v) glycerol, 
2.0 M ammonium sulfate, 0.1 M bis-Tris pH 6.25. The glycerol concentration was 
increased using in situ serial transfer to 10, 15 and finally 20%. 
2.2.2.5. 1-Pyrroline-5-carboxylate dehydrogenase 
1-Pyrroline-5-carboxylate dehydrogenase from Mus musculus (MmP5CDH) was 
expressed, purified and crystallized as recently described (28). MmP5CDH was 
crystallized using a reservoir consisting of 15–25% PEG 3350, 0.1 M bis-Tris pH 5.5–
6.5. The space group of the crystals was P212121, with unit-cell parameters a = 84.9, b = 
94.0, c = 132.4 Å. The reservoir solution served as the initial buffer for in situ stepwise 
cryoprotection. Cryoprotection was achieved in a single step with a final buffer of 2.4 
M proline, 25% PEG 3350, 0.1 M bis-Tris pH 6.25 (Table 1). 
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2.2.3 Data collection and refinement 
X-ray diffraction data were collected from the HEWL and XI crystals using a 
rotating-anode X-ray source and an R-AXIS IV
++
 detector. For each data set, the crystal-
to-detector distance was 85 mm, the exposure time was 2 min per frame and the 
oscillation width was 0.5°. The resolution of the inscribed circle of the detector at 85 mm 
is 1.52 Å. 
Data from FtHAP crystals were collected on beamline 4.2.2 of the Advanced 
Light Source using a NOIR-1 detector. Each data set consisted of 546 images with a 
crystal-to-detector distance of 160 mm, a detector offset of 8°, an oscillation width of 
0.33° and an exposure time of 2 s per frame. The resolution limits at the top and bottom 
edges of the detector were 1.72 and 3.21 Å, respectively, while the resolution at the side 
of the detector was 2.25 Å. 
Data from an MmP5CDH crystal were collected on beamline 24-ID-E of the 
Advanced Photon Source using an ADSC Q315 detector. The data set was collected 
using a continuous vector scan and consisted of 120 images obtained using a crystal-to-
detector distance of 125 mm, an oscillation width of 1.0° and an exposure time of 1 s per 
frame at 100% transmittance. The resolution of the inscribed circle of the detector was 
1.10 Å. 
All data sets were integrated with XDS (29) and scaled 
with SCALA (30) via the CCP4i interface (31). Data-collection statistics are listed in 
Tables 2, 3, 4 and 5. The mosaicity values in Tables 2–5 are from the CORRECT step 
of XDS. 
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The data sets were used in structure refinement in order to identify proline 
molecules bound to the protein. Refinement was performed with PHENIX (32) starting 
from coordinates derived from the following structures: HEWL, PDB entry 2LYZ (33); 
XI, PDB entry 1XIF (Carrell et al., 1994); FtHAP, PDB entry 3IT2 (27); MmP5CDH, 
PDB entry 3V9J (28). In each case solvent molecules were removed prior to refinement. 
The refinement protocol consisted of rigid-body refinement followed by simulated 
annealing. The B-factor model consisted of an isotropic B factor for each non-H atom 
plus one TLS group per protein chain for HEWL, XI and FtHAP. Anisotropic B factors 
were used for the refinement of MmP5CDH. After the first round of 
refinement, Coot (34) was used to adjust the protein model and to add water molecules. 
The model was then input to PHENIX for a second round of refinement. The resulting 
electron-density maps were inspected, proline molecules were added and 
PHENIX refinement was performed. This procedure was repeated as necessary. 
Refinement statistics are listed in Tables 2–5. Coordinates and structure factors for 
structures containing ordered proline molecules have been deposited in the PDB under 
the accession codes listed in Tables 2–5. 
2.3. Results 
2.3.1 Loop diffraction tests   
Loop diffraction tests were performed to determine the proline concentration 
range needed for cryoprotection. A solution of 4 M proline prevents crystalline ice rings; 
lower proline levels afford cryoprotection when other solutes are present. In particular, 
Fig. 1 shows diffraction images from loops containing 1.0–3.0 M proline together with 
one of two common precipitants: ammonium sulfate (Fig. 1a) or PEG 3350 (Fig. 1b).. 
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The data for mixtures of proline and ammonium sulfate suggest that the sum of the two 
solute concentrations should be at least 4 M to prevent crystalline ice formation (Fig. 1a). 
For example, a combination of 2.0 M ammonium sulfate and 2.0 M proline prevents 
crystalline ice formation. The diffraction pattern from a solution of 1.0 M ammonium 
sulfate and 3.0 M proline is also free of crystalline ice rings, but rings are evident when 
the proline concentration is lowered to 2.5 M. Likewise, a solution of 1.5 M ammonium 
sulfate and 2.5 M proline is cryoprotective, but a combination of 1.5 M ammonium 
sulfate and 2.0 M proline does not prevent crystalline ice formation. 
Solutions containing proline and PEG 3350 were also tested (Fig. 1b). Crystalline 
ice formation is suppressed by 15%(w/v) PEG 3350 and 2.5 M proline. If the PEG 
concentration is increased to 20% the proline concentration may be decreased to 2.0 M. 
Increasing the PEG concentration further to 25% allows the proline concentration to be 
lowered to 1.5 M. Thus, a rule of thumb is that 0.5 M proline is roughly equivalent to 5% 
PEG 3350 in terms of cryoprotective capacity. 
2.3.2 Diffraction data  
HEWL is a standard test case for protein-crystallography methods development; 
therefore, we tested proline cryoprotection of HEWL crystals. A diffraction data set was 
collected from a HEWL crystal that had been cryoprotected in 2.8 M proline. To facilitate 
the assessment of proline as a cryoprotectant, a comparison data set was collected from 
another crystal that had been cryoprotected in 22.5% ethylene glycol. Both crystals 
diffracted to beyond 1.5 Å resolution using a rotating-anode source and the data sets were 
truncated at 1.5 Å resolution owing to the limitation of the minimum detector distance on 
our system (Table 2). The mosaicity of the proline-soaked crystal was about 50% higher 
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than that of the ethylene glycol-soaked crystal. Otherwise, the two data sets were 
comparable in terms of global indicators of quality such as R merge, R meas,R p.i.m. and I/σ(I)
. It is difficult to know whether such small differences in data-quality statistics are a 
consequence of the cryoprotectant or simply reflect crystal-to-crystal variation. 
Nevertheless, these data certainly show that proline does not substantially degrade the 
diffraction characteristics of HEWL crystals, which suggests that proline is a potentially 
promising cryoprotectant. Thus, proline passes the lysozyme test. 
XI is another test case that is routinely used for methods development. The I222 
form of XI was grown under two different conditions corresponding to high (XI-1) and 
low (XI-2) ionic strength. XI-1 crystals were cryoprotected in 2.0 M proline and a data 
set was collected using a rotating-anode system (Table 3; XI-1-pro). A comparison data 
set was collected from an XI-1 crystal that had been cryoprotected in 20% glycerol 
(Table 3; XI-1-gol). Similarly, data sets from XI-2 crystals cryoprotected in proline 
(Table 3; XI-2-pro) and PEG 200 (Table 3; XI-2-peg) were also obtained. All four 
crystals diffracted to beyond 1.50 Å resolution. The mosaicities of the XI-1 crystals are 
about 0.2°, whereas those of the XI-2 crystals are 0.1°. The data-quality statistics are very 
similar for the XI-1-pro, XI-2-pro and XI-2-peg data sets. Interestingly, those for the XI-
1-gol data set are noticeably worse. In particular, the R factors of this data set are about 
two times higher than those of the other three data sets. Likewise, the I/σ(I)  for XI-1-gol 
is substantially lower (Table 3). These differences are most evident in the high-resolution 
bin. As with the HEWL data, it is difficult to know whether these differences reflect 
crystal variation or the cryoprotectant. However, the data appear to suggest that proline 
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performs as well as PEG 200 for XI-2 crystals and possibly better than glycerol for XI-1 
crystals. 
In addition to the two above-mentioned test cases, we investigated two other 
proteins available in our laboratory: FtHAP and MmP5CDH. FtHAP was crystallized at 
high ionic strength with ammonium sulfate, whereas MmP5CDH crystals grew at lower 
ionic strength with PEG 3350 as the precipitant. Thus, these two cases represent quite 
different regions of crystallization space and provide an opportunity to assess the 
generality of proline as a cryoprotectant. 
Data from a proline-soaked FtHAP crystal were collected on Advanced Light 
Source beamline 4.2.2 (Table 4). Another data set using identical data-collection 
parameters was collected from a crystal that was cryoprotected in glycerol (Table 4). 
Both data sets were processed to 1.75 Å resolution. Although it is difficult to account for 
the effects of crystal-to-crystal variation, the data seem to suggest that proline is superior 
to glycerol for cryoprotecting FtHAP crystals. For example, the mosaicity of the proline-
soaked crystal (0.18°) is slightly lower than that of the glycerol-soaked crystal (0.24°). 
Furthermore, the R factors for the proline data set are about half those for the glycerol 
data set. Also, the I/σ(I)  of the proline data is about twice that of the glycerol data. 
These results suggest that proline is a good cryoprotectant for FtHAP crystals. 
Finally, a 1.24 Å resolution data set was collected on Advanced Photon Source 
beamline 24-ID-E from a crystal of MmP5CDH that was cryoprotected in 2.4 M proline 
(Table 5). For reference, we have recently reported structures of MmP5CDH complexed 
with sulfate ion, the product glutamate and the cofactor NAD
+
 which were determined 
from crystals that were cryoprotected in 25% glycerol (28). The high-resolution limits of 
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those structures ranged from 1.30 Å for the sulfate complex to 1.50 Å for the glutamate 
and NAD
+
 complexes. The mosaicity of the proline-soaked crystal is 0.17°, whereas the 
mosaicities of the glycerol-soaked crystals were 0.12–0.15°. Thus, soaking with proline 
did not degrade the resolution or substantially increase the mosaicity of MmP5CDH 
crystals. 
2.3.3 Ordered Proline Molecules 
Electron-density maps were inspected to identify ordered proline molecules bound to 
the protein and this analysis clearly indicated that proline molecules were bound to all 
four enzymes (Tables 2–5). One proline molecule binds to HEWL in a crystal contact 
region formed by residues 19, 22 and 24 of one protein and Arg114 of a symmetry-
related protein (Fig. 8). One proline site was also identified for XI. Electron density for 
proline was observed at this location in both crystal forms, but the density was much 
stronger in the ammonium sulfate form (XI-1-pro). Proline binds in a water-filled trough 
on the surface of XI and interacts with Ser281 (Fig. 9). 
The active site of FtHAP contains one proline molecule, which is wedged between 
Phe23 and Tyr135 and forms no direct hydrogen bonds to the enzyme (Fig. 2). 
Interestingly, Phe23 and Tyr135 form an aromatic clamp that binds the adenine base of 
the substrate 3′-AMP (27). As shown in Fig. 2(b), the proline molecule occupies the 
substrate adenine site. A sulfate ion is also bound in the active site and occupies the 
substrate phosphoryl binding pocket. Thus, proline and sulfate together appear to mimic 
the substrate 3′-AMP. 
Seven proline molecules are bound to MmP5CDH (Fig. 3). Three prolines are bound 
to each of the two proteins in the asymmetric unit (labeled 1, 2 and 3 in Fig. 3) and an 
25 
 
additional proline binds in a crystal contact (labeled 4 in Fig. 3). Proline 1 binds in the 
active site and forms hydrogen bonds to Gly512 and Ser513 (Fig. 3, inset 1). The electron 
density suggests that the bound proline possibly exhibits conformational disorder or has 
less than full occupancy. Interestingly, this location corresponds to the binding site for 
the aldehyde substrate (and the glutamate product) (28). In fact, the backbone of the 
bound proline superimposes almost perfectly with that of the product glutamate (Fig. 3, 
inset 1). That proline binds in this site is consistent with the fact that proline is a 
competitive inhibitor of P5CDH (35). Proline 2 binds in the crevice between the NAD
+
-
binding and catalytic lobes and forms electrostatic interactions with Arg399 and Asp393 
(Fig. 3, inset 2). Also, the nonpolar part of the pyrrolidine ring of proline 2 contacts 
Phe210. Proline 3 contacts both protomers of the dimer (Fig. 3). Proline 3 forms 
electrostatic interactions with Lys292 of one chain and the 303–308 loop of the other 
chain (Fig. 3, inset 3). Also, the pyrrolidine ring of proline 3 makes nonpolar contacts 
with Leu302 and Phe308 of one chain of the dimer and Ala525 of the other chain. 
Finally, proline 4 binds in a crystal contact region. This proline interacts with the 
backbone of Gln184 of the protein in the asymmetric unit and is linked via two water 
molecules to Glu46 of a symmetry-related molecule (Fig. 3, inset 4). 
2.4. Discussion 
The results reported here suggest that proline is a suitable cryoprotectant for 
protein crystals. Our test cases included two ‘model’ proteins, HEWL and XI, as well as a 
phosphatase and an aldehyde dehydrogenase. None of these crystals exhibited any signs 
of deterioration, such as cracking or melting, while soaking with proline. Furthermore, 
the diffraction images obtained from these crystals were free of crystalline ice rings. 
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Moreover, the diffraction quality is similar to that obtained from crystals of these 
enzymes cryoprotected with conventional reagents such as ethylene glycol, glycerol and 
PEG 200. 
The crystallization recipes of our test cases are representative of those used in 
protein crystallography. The precipitants include ammonium sulfate, NaCl and PEG 
3350, which are commonly used in protein crystallization. The pH values of the 
crystallization solutions span a wide range: 4.6–8.5. Thus, proline is compatible with the 
kinds of solutions that are typically used in protein crystallization, suggesting that proline 
is widely applicable as a cryoprotectant for protein crystals. 
Electron-density maps clearly indicated ordered proline molecules bound to the 
protein in four of the five crystal structures. This result is expected because penetrating 
cryoprotectants frequently bind to proteins. In fact, as of 29 April 2012 the PDB 
contained 6620 entries with glycerol as a ligand, 2720 entries with ethylene glycol as a 
ligand and 702 entries with 2-methyl-2,4-pentanediol as a ligand. Typically, these 
compounds are present at 10–30%(v/v) in the cryobuffer, which corresponds to 1–5 M. 
This concentration range is similar to that of proline used here (2.0–3.0 M). Furthermore, 
like glycerol, ethylene glycol and 2-methyl-2,4-pentanediol, proline has both hydrogen-
bond donors and acceptors. The similarities of proline to traditional cryoprotection agents 
suggest that one should expect to find proline bound to the protein. 
Finally, we note that we have not attempted to perform a systematic head-to-head 
comparison between proline and other cryoprotectants. Such a study is challenging 
because it is difficult to account for crystal-to-crystal variation of the diffraction quality. 
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Rather, our goal was to demonstrate that proline is an effective and generally applicable 
cryoprotectant for protein crystals. Our data support this assertion. 
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Table 2.1. Proline-based cryobuffers 
 Lysozyme GI-1 GI-2 FtHAP MmP5CDH 
Buffer 0.1 M 
Na acetate 
0.1 M Tris-HCl 0.1 M Tris-
HCl 
0.1 M Bis-Tris 0.1 M Bis-Tris 
pH 4.6 8.5 8.5 6.5 6.25 
Precipitant 1.2 M NaCl 2.0 M 
(NH4)2SO4 
5 % PEG 4000 2.0 M 
(NH4)2SO4 
25 % PEG 3350 
Salt N/A N/A N/A N/A 0.2 M Li2SO4 
Proline  2.8 M 2.0 M 3.0 M 2.0 M 2.4 M 
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Table 2.2. Data collection and refinement statistics for HEWL. 
Values in parentheses are for the outer resolution shell. 
Cryoprotectant 2.8 M proline 22.5% ethylene glycol 
Space group P43212 P43212 
Unit-cell parameters (Å) a = b = 78.0, c = 37.7 a = b = 78.9, c = 36.9 
Wavelength (Å) 1.54 1.54 
Resolution (Å) 19.50-1.50 (1.58-1.50) 19.50-1.50 (1.58-1.50) 
No. of observations 205088 228617 
Unique reflections 19076 19082 
Rmerge(I) 0.028 (0.241) 0.028 (0.148) 
Rmeas(I) 0.029 (0.257) 0.029 (0.157) 
Rp.i.m.(I) 0.008 (0.085) 0.008 (0.051) 
Mean I/ (I) 46.1 (7.6) 58.6 (12.9) 
Completeness (%) 99.6 (97.6) 99.9 (99.5) 
Multiplicity 10.8 (8.2) 12.0 (8.8) 
Mosaicity (°) 0.21 0.13 
No. of protein atoms 976  
No. of water molecules 99  
No. of proline molecules 1  
Rcryst 0.185  
Rfree
#
 0.216  
R.m.s. deviations
+
 
  Bond lengths (Å) 0.005  
  Bond angles (°) 1.012  
Ramachandran plot
§
, residues in 
  Favored regions 126  
  Allowed regions 1  
  Outliers 0  
Average B factor (Å
2
) 
  Protein 16  
  Water 25  
  Proline 22  
PDB code 4E3U  
 
#
5 % test set.   
†
Compared to the parameters of Engh and Huber (Engh & Huber, 1991). 
‡
The Ramachandran plot was generated with RAMPAGE (Lovell et al., 2003). 
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Table 2.3. Data collection and refinement statistics for XI. 
Values in parentheses are for the outer resolution shell. 
 XI-1-pro XI-1-gol XI-2-pro XI-2-peg 
Cryoprotectant 2.0 M proline 20% glycerol 3.0 M proline 20% PEG 200 
Space group I222 I222 I222 I222 
Unit-cell 
parameters (Å) 
a = 92.5, b = 
98.0, c = 102.4 
a = 92.5, b = 
98.2, c = 101.8 
a = 92.8, b = 
98.1, c = 102.7 
a = 93.0, b = 
97.8, c = 102.9 
Wavelength (Å) 1.54 1.54 1.54 1.54 
Resolution (Å) 19.5-1.50 (1.58-
1.50) 
19.5-1.50 
(1.58-1.50) 
19.7-1.50 (1.58-
1.50) 
19.7-1.50 (1.58-
1.50) 
No. of 
observations 
470488 490567 463654 487593 
Unique reflections 72416 72675 73511 73858 
Rmerge(I) 0.037 (0.183) 0.071 (0.552) 0.037 (0.174) 0.046 (0.160) 
Rmeas(I) 0.040 (0.203) 0.077 (0.608) 0.040 (0.194) 0.500 (0.178) 
Rp.i.m.(I) 0.015 (0.085) 0.029 (0.249) 0.016 (0.082) 0.019 (0.076) 
Mean I/ (I) 30.1 (8.5) 20.6 (3.1) 31.3 (8.7) 27.5 (9.2) 
Completeness (%) 97.8 (89.5) 98.5 (93.1) 98.8 (92.2) 99.0 (94.2) 
Multiplicity 6.5 (5.2) 6.8 (5.4) 6.3 (4.9) 6.6 (4.8) 
Mosaicity (°) 0.19 0.25 0.13 0.12 
No. of protein 
atoms 
3052  3086  
No. of water 
molecules 
324  292  
No. of proline 
molecules 
1  0  
Rcryst 0.164  0.172  
Rfree
#
 0.179  0.187  
R.m.s. deviations
+
 
  Bond lengths (Å) 0.006  0.006  
  Bond angles (°) 1.107  1.066  
Ramachandran plot
§
, residues in 
  Favored regions 372  373  
  Allowed regions 10  12  
  Outliers 1  1  
Average B factor (Å
2
) 
  Protein 11  10  
  Water 21  17  
  Proline 20  -  
PDB code 4E3V    
#
5 % test set.   
†
Compared to the parameters of Engh and Huber (Engh & Huber, 1991). 
‡
The Ramachandran plot was generated with RAMPAGE (Lovell et al., 2003). 
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Table 2.4. Data collection and refinement statistics for FtHAP. 
Values in parentheses are for the outer resolution shell. 
Cryoprotectant 2.0 M proline 20% glycerol 
Space group P41 P41 
Unit-cell parameters (Å) a = b = 62.0, c = 210.4 a = b = 62.0, c = 211.0 
Wavelength (Å) 1.00 1.00 
Resolution (Å) 48.6-1.75 (1.84-1.75) 46.5-1.75 (1.84-1.75) 
No. of observations 341312 308938 
Unique reflections 78960 76942 
Rmerge(I) 0.032 (0.130) 0.065 (0.153) 
Rmeas(I) 0.036 (0.160) 0.072 (0.199) 
Rp.i.m.(I) 0.015 (0.092) 0.030 (0.126) 
Mean I/ (I) 25.8 (5.7) 13.1 (3.1) 
Completeness (%) 99.1 (95.3) 96.6 (81.1) 
Multiplicity 4.3 (2.8) 4.0 (1.9) 
Mosaicity (°) 0.18 0.24 
No. of protein atoms 5035  
No. of water molecules 365  
No. of proline molecules 2  
Rcryst 0.182  
Rfree
#
 0.203  
R.m.s. deviations
+
 
  Bond lengths (Å) 0.006  
  Bond angles (°) 1.007  
Ramachandran plot
§
, residues in 
  Favored regions 648  
  Allowed regions 6  
  Outliers 0  
Average B factor (Å
2
) 
  Protein 19  
  Water 23  
  Proline 24  
PDB code 4E3W  
#
5 % test set.   
†
Compared to the parameters of Engh and Huber (Engh & Huber, 1991). 
‡
The Ramachandran plot was generated with RAMPAGE (Lovell et al., 2003). 
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Table 2.5. Data collection and refinement statistics for MmP5CDH 
Values in parentheses are for the outer resolution shell. 
Cryoprotectant 2.4 M proline 
Space group P212121 
Unit-cell parameters (Å) a = 85.0, b = 93.9, c = 132.4 
Wavelength (Å) 0.979 
Resolution (Å) 45.6-1.24 (1.31-1.24) 
No. of observations 1144056 
Unique reflections 279378 
Rmerge(I) 0.051 (0.550) 
Rmeas(I) 0.058 (0.644) 
Rp.i.m.(I) 0.027 (0.326) 
Mean I/ (I) 15.0 (2.3) 
Completeness (%) 94.1 (87.3) 
Multiplicity 4.1 (3.3) 
Mosaicity (°) 0.17 
No. of protein atoms 8304 
No. of water molecules 882 
No. of proline molecules 7 
Rcryst 0.155 
Rfree
#
 0.180 
R.m.s. deviations
+
 
  Bond lengths (Å) 0.005 
  Bond angles (°) 1.078 
Ramachandran plot
§
, residues in 
  Favored regions 1066 
  Allowed regions 19 
  Outliers 0 
Average B factor (Å
2
) 
  Protein 12 
  Water 22 
  Proline 18 
PDB code 4E3X 
#
5 % test set.   
†
Compared to the parameters of Engh and Huber (Engh & Huber, 1991). 
‡
The Ramachandran plot was generated with RAMPAGE (Lovell et al., 2003). 
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Figure legends 
Figure 2.1 
X-ray diffraction images from loops containing proline and either (a) ammonium sulfate 
or (b) PEG 3350.  
 
Figure 2.2 
Electron density for proline bound to HEWL.  The cage represents a simulated annealing 
σA-weighted Fo - Fc omit map contoured at 3.0 σ.   The protein in the asymmetric unit is 
colored gray.  The protein related by the crystallographic symmetry operation (y-1/2, -
x+1/2, z+1/4) is colored cyan.   
 
Figure 2.3 
Electron density for proline bound to GI-1.  The cage represents a simulated annealing 
σA-weighted Fo - Fc omit map contoured at 3.0 σ.    
 
Figure 2.4 
Proline bound to the active site of FtHAP.  (a) Ribbon drawing of the dimer with the 
bound proline molecules drawn as spheres. (b) Electron density for proline bound to the 
active site of HAP.  The cage represents a simulated annealing σA-weighted Fo - Fc omit 
map contoured at 3.0 σ. The 3’-AMP bound to FtHAP mutant D261A (PDB code 3IT3) 
is shown in thin cyan sticks.     
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Figure 2.5 
Proline molecules bound to Mm5CDH. The two protomers of the dimer are colored red 
and blue.  The insets show close-up views of the bound proline ligands.  The cage 
represents a simulated annealing σA-weighted Fo - Fc omit map contoured at 3.0 σ.  In 
inset 4, the protein in the asymmetric unit is colored gray, and the protein related by (x-
1/2, -y+1/2, -z) is colored cyan.   
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Fig 2.1. 
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Fig 2.2. 
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Fig 2.3. 
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Fig 2.4. 
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Fig 2.5. 
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Abstract 
The enzyme 1-pyrroline-5-carboxylate (P5C) dehydrogenase (aka P5CDH and 
ALDH4A1) is an aldehyde dehydrogenase that catalyzes the oxidation of -glutamate 
semialdehyde to L-glutamate.  The crystal structures of mouse P5CDH complexed with 
glutarate, succinate, malonate, glyoxylate, and acetate are reported.  The structures are 
used to build a structure-activity relationship that describes the semialdehyde carbon 
chain length and the position of the aldehyde group in relation to the cysteine nucleophile 
and oxyanion hole.  Efficient 4- and 5-carbon substrates share the common feature of 
being long enough to span the distance between the anchor loop at the bottom of the 
active site and the oxyanion hole at the top of the active site.  The inactive 2- and 3-
carbon semialdehydes bind the anchor loop but are too short to reach the oxyanion hole.  
Inhibition of P5CDH by glyoxylate, malonate, succinate, glutarate, and L-glutamate is 
also examined.  The Ki values are 0.27 mM for glyoxylate, 58 mM for succinate, 30 mM 
for glutarate, and 12 mM for L-glutamate.  Curiously, malonate is not an inhibitor.  The 
trends in Ki likely reflect a trade-off between the penalty for desolvating the carboxylates 
of the free inhibitor and the number of compensating hydrogen bonds formed in the 
enzyme-inhibitor complex.  
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3.1. Introduction 
1-pyrroline-5-carboxylate (P5C) dehydrogenase (P5CDH) is an NAD+-dependent 
aldehyde dehydrogenase that catalyzes the last step of proline catabolism, the oxidation 
of -glutamate semialdehyde (GSA) to L-glutamate (Fig. 1, upper reactions) (1).  The 
aldehyde substrate for P5CDH in this pathway is generated by the hydrolysis of P5C, 
which is produced from the oxidation of proline by the flavoenzyme proline 
dehydrogenase (PRODH), known as proline oxidase in humans.  Mammalian P5CDHs 
also function in hydroxyproline catabolism (2).  This pathway begins with the oxidation 
of hydroxyproline by hydroxyproline oxidase and ends with the P5CDH-catalyzed 
oxidation of 4-hydroxyglutamate semialdehyde to 4-erythro-hydroxy-L-glutamate (Fig. 
1, lower reactions) (3).  In eukaryotes, P5CDH is a nuclear-encoded mitochondrial matrix 
enzyme, whereas in some bacteria P5CDH is combined with PRODH into a single 
bifunctional enzyme known as proline utilization A (1).  
P5CDHs are of considerable biomedical importance.  Mutations in the P5CDH gene 
(ALDH4A1) that abrogate enzyme activity cause the metabolic disorder type II 
hyperprolinemia (4-6).  Both proline catabolic genes are activated by the tumor 
suppressor p53 (7, 8), indicating a role for the pathway in apoptosis, stress, and cancer (9-
11). In this context, the coordination of P5CDH, proline oxidase, and the proline 
biosynthetic enzyme P5C reductase is required for maintaining the proper balance of 
mitochondrial reactive oxygen species (12).  In the fungal pathogen Cryptococcus 
neoformans, P5CDH is required for optimal production of the major virulence factors 
(13).  And bacterial P5CDHs are being considered as components of vaccines against 
Staphylococcus aureus (14).  
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P5CDH belongs to the aldehyde dehydrogenase (ALDH) superfamily and is known 
as ALDH4A1. The ALDH superfamily comprises hundreds of distinct genes from all 
three domains of life, including 19 human ALDHs (15).  ALDHs share a common protein 
fold (Fig. 2) and catalytic mechanism for the oxidation of aldehydes to carboxylates. The 
mechanism (16-18) begins with the binding of the substrate aldehyde group in the 
oxyanion hole, which positions the C atom of the aldehyde for nucleophilic attack by the 
essential Cys residue.  Nucleophilic attack results in formation of a hemithioacetal 
intermediate.   Hydride transfer to NAD(P)
+
 generates NAD(P)H and the thioacylenzyme 
intermediate. Finally, hydrolysis of the thioacylenzyme yields the carboxylate product 
and regenerates the Cys nucleophile.  
P5CDH was first characterized in the late 1980s (19-22).  In this early work 
performed on placental and liver P5CDHs, several potential substrates were tested in 
steady-state kinetic assays in order to help establish P5C/GSA as the physiological 
substrate (19, 21, 22).  The human enzyme exhibits good activity with glutarate 
semialdehyde and adipate semialdehyde.  The catalytic efficiencies (V/Km) for these 
substrates at pH 7.0 are about 50 % of that of the physiological substrate, P5C/GSA.  The 
shorter semialdehyde, succinate semialdehyde, was also found to be a substrate, but the 
efficiency was somewhat lower at 16 % of the value for P5C/GSA.  Activity was 
undetectable with malonate semialdehyde, glyoxylate, and aspartate semialdehyde.  
These studies clearly suggested that semialdehyde chain length is an important factor in 
substrate selectivity, however; the structural basis for this aspect of substrate recognition 
has not been explored.  
To better understand the basis of substrate selectivity by P5CDH, we have determined 
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the high resolution crystal structures of Mus musculus P5CDH (MmP5CDH, 92% 
identical to human P5CDH) complexed with carboxylate ligands having chain lengths 
ranging from 5 carbons to 2 carbons: glutarate (1 in Fig. 3), succinate (2), malonate (3), 
glyoxylate (4), and acetate (5).  The structures explain the relationship between 
semialdehyde chain length and enzyme activity.   
3.2. Experimental procedures 
3.2.1 Crystallization and soaking   
MmP5CDH was expressed, purified, and crystallized as described previously (23). 
Briefly, the stock enzyme solution used for crystallization contained 10 mg/mL 
MmP5CDH in a buffer of 50mM Tris, 50mM NaCl, 0.5mM EDTA, 0.5mM THP, and 
5% glycerol at pH 7.5.  This His-tag was not removed.  Crystallization experiments were 
performed in sitting drops at room temperature with drops formed by mixing 1 L of the 
enzyme solution and 1 L of reservoir solution. The latter consisted of 15 - 25 % (w/v) 
PEG 3350, 0.2 M Li2SO4, and 0.1 M Bis-Tris at pH 5.0 - 6.5. The space group is P212121 
with unit cell lengths of a = 85 Å, b = 94 Å, and c = 132 Å.  The asymmetric unit 
contains two protein molecules, which form a dimer.  
Crystals of Mm5CDH complexed with the anions in Fig. 3 were obtained by soaking 
the aforementioned crystals in a solution containing cryobuffer (24% PEG 3350, 0.1 M 
Bis-Tris at pH 6.5, 15 - 20 % PEG 200) supplemented with high concentration of the 
ligand (440 mM acetate, 220 mM glyoxylate, 220 mM malonate, 270 mM succinate, or 
270 mM glutarate).  We note that the high concentration was necessary to displace the 
adventitious sulfate ion that binds to the active site.  The crystals were soaked for about 
15 minutes, harvested with Hampton loops, and flash-cooled in liquid nitrogen.   
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3.2.2 X-ray data collection and refinement   
X-ray diffraction data were collected using a Rigaku rotating anode source with an R-
AXIS IV++ detector.   Each data set consisted of 240 – 260 images collected with an 
exposure time of 5 minutes per frame, oscillation width of 0.5°, and detector distance of 
110 mm or 130 mm.  The data were integrated in XDS (24) and scaled in SCALA (25).  
Data processing statistics are listed in Table 1.  
Refinement with PHENIX (26) was initiated from a 1.3 Å resolution structure of 
MmP5CDH (PDB code 4V9J).  A common test set of reflections was used for cross 
validation, which was based on the one used previously for refinements of MmP5CDH 
(23, 27).  COOT was used for model building (28).  The PHENIX elbow utility (29) was 
used to create ligand restraint files from ideal coordinates downloaded from PDB Ligand 
Expo (30).  Refinement statistics are listed in Table 1.  
3.2.3 Steady-state inhibition kinetics  
P5CDH activity was measured at 20 °C by monitoring the production of NADH at 
340 nm as described previously for HsP5CDH (23).  The assay buffer contained 0.1 M 
(0.15 M), except for the measurements performed in the presence of malonate, which 
M).  Inhibition of MmP5CDH by glyoxylate, 
malonate, succinate, glutarate, and L-glutamate was studied using succinate 
semialdehyde as the variable substrate at fixed NAD
+
 concentration of 1.0 mM.  (We 
note that P5C/GSA is not commercially available.)  The substrate range was 10 – 400 M 
when glyoxylate, succinate or glutarate was the inhibitor, 10 – 300 M with malonate as 
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the inhibitor, and 10 - 350 M with L-glutamate as the inhibitor.  In each case, 10 – 12 
substrate concentrations were used (Supplemental Figure S1).  The inhibitors were 
present at the following concentrations: glyoxylate, 1 mM and 4 mM; malonate, 50 mM 
and 100 mM; succinate, 100 mM and 200 mM; glutarate, 100 mM and 200 mM; L-
glutamate, 50 mM and 100 mM.   
The kinetic data were analyzed by global fitting to the competitive (eq. 1), 
noncompetitive (eq. 2), and mixed (eq. 3) inhibition models using Origin 9 software.  The 
fits to the competitive model had R
2
 in the range 0.981 – 0.991 (Supplemental Figure S1), 
whereas the fits to the noncompetitive model were consistently worse (R
2 
< 0.956).  The 
fits to the mixed model  (R
2
 = 0.980 – 0.992) were indistinguishable from those of the 
competitive model, and since the competitive model has one fewer parameter than the 
mixed model, the competitive model was selected for the final determination of kinetic 
parameters.  
V = Vmax[S]/{ Km(1 + [I]/Ki) + [S] }                (1) 
V = Vmax[S]/{ (Km + [S])(1 + [I]/Ki) }    (2) 
V = Vmax[S]/{ Km(1 + [I]/Ki) + [S]( 1 + [I]/Ki) }   (3) 
 
 
3.3. Results 
3.3.1   5- and 4-carbon carboxylate ligands: glutarate and succinate 
The location of the aldehyde substrate-binding site has been deduced from crystal 
structures of P5CDHs complexed with the product L-glutamate (23, 31).  L-glutamate 
binds in the cleft between the catalytic and NAD
+
-binding domains, as demonstrated by 
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glutarate bound to MmP5CDH (Fig. 2).  The -carboxylate of L-glutamate represents the 
aldehyde group of GSA and binds in the oxyanion hole near the catalytic Cys residue, 
while the backbone of L-glutamate is anchored to a loop that connects the final strand of 
the catalytic domain to the NAD
+
-binding domain.  This loop is the second of two 
crossover peptides that connect the major domains of the enzyme and will be referred to 
as the anchor loop. 
The canonical aldehyde-binding mode is exhibited by glutarate, the longest ligand 
used in the present study (Fig. 4A).  One of the carboxylate groups of glutarate binds to 
the anchor loop by forming hydrogen bonds with Gly512 and Ser513.  This carboxylate 
also forms a hydrogen bond with Ser349 of the catalytic loop.  These interactions are 
identical to those formed by the -carboxylate of L-glutamate (Fig. 4C), and by 
inference, GSA. The three methylene carbons of glutarate are sandwiched between 
Phe512 and Phe520 (Fig. 2, inset), which is also reminiscent of the L-glutamate complex.  
These residues are part of a more general aromatic box that is common to ALDHs (32).  
The upper carboxylate of glutarate binds near catalytic Cys348 and thus represents the 
aldehyde group of glutarate semialdehyde (Fig. 4A).  One of the O atoms of the upper 
carboxylate occupies the oxyanion hole and accepts hydrogen bonds from the side chain 
of Asn211 and the backbone of Cys348.  The other O atom of the upper carboxylate 
extends toward a solvent cavity and represents the atom derived from nucleophilic attack 
of water on the thioacyl intermediate.  The interactions of the upper carboxylate of 
glutarate are nearly identical to those of the -carboxylate of L-glutamate (Fig. 4C). 
The position of the upper carboxylate is consistent with efficient nucleophilic attack 
by Cys348.  In the glutarate complex, Cys348 has 1 = -65°, which is the most favored 
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rotamer for Cys but not the one that is populated during nucleophilic attack (1 = 55°).  
We note that the 1 = -65° rotamer is typically observed in P5CDH structures that lack 
NAD
+
, as is the case here.  Rotation of Cys348 to 1 = 55° brings the nucleophile into 
attack position and places the S atom 2.3 Å from the carboxylate C atom (Fig. 4C).  For 
reference, this distance is also 2.3 Å in the MmP5CDH-L-glutamate complex.  The 
structural similarity between the glutarate and L-glutamate poses is consistent with 
glutarate semialdehyde being a good substrate for human P5CDH (19, 21, 22).  
The conformation of succinate is close to the canonical one.  As observed for 
glutarate, the lower carboxylate group mimics the backbone of L-glutamate and is 
anchored to Gly512, Ser513, and Ser349 (Fig. 4B). The upper carboxylate, however, 
deviates from the canonical conformation. One of the O atoms of the upper carboxylate is 
in the oxyanion hole, as expected for a product, but the other one engages Ser349 rather 
than pointing to the water-filled cavity.  As a result, when Cys348 is rotated into attack 
position (1 = 55°), the distance between the S atom and the carboxylate C atom is 2.6 Å, 
which is 0.3 Å longer than observed for L-glutamate and glutarate.  The suboptimal 
placement of the upper carboxylate of succinate is consistent with succinate 
semialdehyde being a less efficient substrate than GSA and glutarate semialdehyde (19, 
21, 22).  
3.3.2   3- and 2-carbon ligands: malonate, glyoxylate, and acetate 
The pose of malonate (Fig. 5A) deviates substantially from the canonical pose. 
Although malonate binds to the anchor loop and Ser349, it is too short to occupy the 
oxyanion hole.  Rather, a water molecule fills the oxyanion hole.  As a result, the upper 
carboxylate of malonate is too far from Cys348 for nucleophilic attack.  Specifically, 
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when Cys348 is rotated into the attack rotamer, the S-C distance is 3.2 Å.  This result is 
consistent with the lack of enzymatic activity observed with malonate semialdehyde (21).  
Electron density maps suggest that glyoxylate has two conformations that are related 
by a 180° rotation around the C-C bond axis (Fig. 5B).  In both conformations, the 
carboxylate group is bound to the anchor residues.  In conformation A (occupancy 0.6), 
the carbonyl is directed toward the substrate entrance channel and hydrogen bonds to 
Ser513.  In conformation B (occupancy 0.4), the carbonyl points in the direction of the 
oxyanion hole.    As observed with malonate, glyoxylate is too short to simultaneously 
occupy the anchor site and the oxyanion hole.  This result is consistent with the lack of 
activity observed with glyoxylate (21).  
The carboxylate group of acetate binds to the aldehyde backbone anchor residues 
(Fig. 5C).  Obviously, if acetaldehyde binds similarly, the aldehyde group is out of reach 
of the Cys nucleophile. The fact that activity, albeit weak, is observed with acetaldehyde 
suggests that the acetate complex is not representative of enzyme-acetaldehyde complex.  
3.3.3 Inhibition of Mm5CDH  
The discovery that glyoxylate and malonate bind in the active site, yet neither 
glyoxylate nor malonate semialdehyde is a substrate for mammalian P5CDHs (21, 22), 
suggested the possibility that glyoxylate and malonate could be inhibitors.  This idea was 
tested with steady-state kinetic measurements.  As a control, we verified that enzymatic 
activity was undetectable with glyoxylate as the substrate, in agreement with previous 
studies (21, 22).  The analogous check with malonate semialdehyde was not performed 
due to the lack of a commercial source for this compound.  
Glyoxylate is a sub-millimolar competitive inhibitor of MmP5CDH (Table 2).  Initial 
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rate data could be fit satisfactorily to the competitive inhibition model (Supplemental 
Figure S1A), yielding Ki of 0.27 mM.  
Surprisingly, malonate does not appear to be an inhibitor of MmP5CDH.  Inhibition 
was not apparent even when malonate was present at 50 - 100 mM (Supplemental Figure 
S1B). Inhibition studies using succinate, glutarate, and L-glutamate were also performed.  
All three compounds are millimolar competitive inhibitors. The estimated Ki values are 
58 mM for succinate, 30 mM for glutarate, and 12 mM for L-glutamate.  The Ki for L-
glutamate agrees with value of 14 mM determined previously for human P5CDH (20).  
3.4. Discussion 
Pioneering studies of mammalian P5CDHs showed that the length of the 
semialdehyde chain is an important determinant of substrate selectivity (21).  The 
catalytic efficiency is highest for the 5-carbon substrates GSA and glutarate 
semialdehyde, somewhat lower for the 4-carbon succinate semialdehyde, and essentially 
zero with 3- and 2-carbon semialdehydes malonate semialdehyde and glyoxylate.   
The structures reported here, along with that of the L-glutamate complex reported 
previously, provide a satisfying explanation for the substrate selectivity of mammalian 
P5CDH.  Analysis of these structures suggests a structure-activity relationship consisting 
of four distances that describe the E-S complex (Figure 6, Table 3).  These parameters 
include the distance between the two terminal C atoms of the bound substrate (LS), the 
nucleophilic attack distance (dN), and the distances between the aldehyde carbonyl 
oxygen atom and the two hydrogen bond donors of the oxyanion hole (dOH1, dOH2).  GSA 
is the most efficient substrate for P5CDH, and thus the distance parameters from the 
enzyme-L-glutamate complex represent the optimal case.   
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The distances describing the E-S complex for glutarate semialdehyde are nearly 
identical to those of GSA (Table 3), which is consistent with the observation that 
glutarate semialdehyde also has high catalytic efficiency.  The somewhat higher 
efficiency of GSA is likely due to the fact that it forms an extra hydrogen bond that is not 
possible for glutarate semialdehyde (noted in Figure 4C).   
The parameters describing the E-S complex of succinate semialdehyde differ from 
those of the 5-carbon substrates GSA and glutarate semialdehyde. In particular, LS is 1.7 
Å shorter, dN is 0.3 Å longer, and the oxyanion hole hydrogen bonding distances are 0.1 - 
0.2 Å longer.  These values reflect the fact that the aldehyde of succinate semialdehyde is 
not optimally positioned for nucleophilic attack and are consistent with the lower 
efficiency of succinate semialdehyde.   
The deduced parameters for the inactive semialdehydes, malonate semialdehyde and 
glyoxylate, are clearly suboptimal.  The chain lengths are only 2.5 Å and 1.5 Å for 
malonate semialdehyde and glyoxylate, respectively, and since these ligands bind to the 
anchor loop, the aldehyde groups are poorly positioned for nucleophilic attack.  In 
particular, the attack distances are 3.2 and 4.4 Å for malonate semialdehyde and 
glyoxylate, respectively.  Furthermore, the oxyanion hole distances are 3.6 – 5.7 Å, 
which is beyond optimal hydrogen bonding range. The parameters describing malonate 
semialdehyde and glyoxylate are thus consistent with the lack of activity observed with 
these semialdehydes.  In summary, active semialdehyde substrates share the common 
feature of being long enough to span the distance between the anchor loop and the 
oxyanion hole, which is required to position the aldehyde group for nucleophilic attack 
by the catalytic Cys.  
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Absent structural information, the lack of catalytic activity observed with malonate 
semialdehyde and glyoxylate might lead one to suspect that these compounds and their 
respective dicarboxylates do not bind the enzyme active site.  Our studies show 
otherwise; glyoxylate and malonate mimic actual substrates by binding to the anchor loop 
(Figures 5A, 5B).   
Glyoxylate was found to be a competitive inhibitor (Ki = 0.27 mM).  In fact, it is the 
most potent inhibitor reported to date for P5CDH. The pose of glyoxylate is similar to 
that of another known P5CDH inhibitor, L-proline.  L-proline is a competitive inhibitor 
(with GSA) of human P5CDH with Ki of 3 mM (20), and we previously determined the 
structure of MmP5CDH complexed with L-proline (27).  Glyoxylate and L-proline bind 
to P5CDH similarly and form identical hydrogen bonds with the enzyme (Figure 7).  
Note that the amine of proline and the aldehyde oxygen atom of glyoxylate 
(conformation A) form a hydrogen bond with the hydroxyl of Ser513.  An analogous 
interaction is present in the L-glutamate complex (Figure 4C) but absent in the glutarate, 
succinate, and malonate complexes.   
The trends in Ki (i.e., affinity) of the ligands investigated here are perhaps unexpected 
but nonetheless consistent with the structures.   Glyoxylate has the highest affinity of the 
ligands tested.  The extra hydrogen bond with Ser513 may partly account for this 
observation.  Also, glyoxylate is accommodated in the active site in two orientations, 
suggesting a more favorable (or less unfavorable) entropy of binding.  The desolvation of 
carboxylate versus aldehyde groups provides another possible explanation.  The free 
energy of hydration of the acetate ion is approximately -80 kcal/mol, whereas that of 
acetaldehyde is only about -4 kcal/mol (33-35), implying that a larger desolvation penalty 
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must be paid to bind a carboxylate group to the enzyme than an aldehyde group.  Thus, 
binding a dicarboxylate ligand, such as malonate, presumably requires a larger 
desolvation penalty than glyoxylate, which contains only one carboxylate group.  The 
higher affinity of glutarate compared to succinate likely reflects the better oxyanion hole 
hydrogen bonding of glutarate (Table 3).  The higher affinity of L-glutamate compared to 
glutarate is probably due to the extra hydrogen bond between the amine of L-glutamate 
and Ser513.  Comparing the Ki values for L-glutamate and glutarate suggests that this 
hydrogen bond contributes about -0.5 kcal/mol to the free energy of binding.  Finally, it is 
puzzling that malonate does not bind to MmP5CDH in solution.  This result perhaps 
reflects the fact that whereas two carboxylate groups must be desolvated, only the lower 
carboxylate forms compensating hydrogen bonds when bound to the enzyme (Figure 5A).  
The upper carboxylate fails to engage the hydrogen bond donors of the oxyanion.  These 
ideas about the trade-off between the desolvation penalty of the inhibitor and the 
compensating hydrogen bonds formed in the enzyme-inhibitor complex could potentially 
aid the discovery of new ALDH inhibitors (32, 36).   
 
 
 
 
 
 
 
 
57 
 
Acknowledgements 
Research reported in this publication was supported by the National Institute of General 
Medical Sciences of the National Institutes of Health via Grant GM065546.  We thank 
Dr. Dhiraj Srivastava for advice on expression, purification, and crystallization of 
MmP5CDH. 
 
References 
1. Tanner, J. J. (2008) Structural biology of proline catabolism, Amino Acids 35, 
719-730. 
2. Adams, E., and Frank, L. (1980) Metabolism of proline and the hydroxyprolines, 
Annu. Rev. Biochem. 49, 1005-1061. 
3. Valle, D., Goodman, S. I., Harris, S. C., and Phang, J. M. (1979) Genetic evidence 
for a common enzyme catalyzing the second step in the degradation of proline 
and hydroxyproline, J. Clin. Invest. 64, 1365-1370. 
4. Geraghty, M. T., Vaughn, D., Nicholson, A. J., Lin, W. W., Jimenez-Sanchez, G., 
Obie, C., Flynn, M. P., Valle, D., and Hu, C. A. (1998) Mutations in the Delta1-
pyrroline 5-carboxylate dehydrogenase gene cause type II hyperprolinemia, Hum. 
Mol. Genet. 7, 1411-1415. 
5. Phang, J. M., Hu, C. A., and Valle, D. (2001) Disorders of proline and 
hydroxyproline metabolism, In Metabolic and molecular basis of inherited 
disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., Eds.), pp 1821-
1838, McGraw Hill, New York. 
6. Valle, D., Goodman, S. I., Applegarth, D. A., Shih, V. E., and Phang, J. M. (1976) 
Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase 
deficiency in cultured skin fibroblasts and circulating lymphocytes, J. Clin. Invest. 
58, 598-603. 
7. Yoon, K. A., Nakamura, Y., and Arakawa, H. (2004) Identification of ALDH4 as 
a p53-inducible gene and its protective role in cellular stresses, J. Hum. Genet. 49, 
134-140. 
8. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. (1997) A 
model for p53-induced apoptosis, Nature 389, 300-305. 
58 
 
9. Phang, J. M., Donald, S. P., Pandhare, J., and Liu, Y. (2008) The metabolism of 
proline, a stress substrate, modulates carcinogenic pathways, Amino Acids 35, 
681-690. 
10. Phang, J. M., Pandhare, J., and Liu, Y. (2008) The metabolism of proline as 
microenvironmental stress substrate, J Nutr 138, 2008S-2015S. 
11. Phang, J. M., Liu, W., Hancock, C., and Christian, K. J. (2012) The proline 
regulatory axis and cancer, Front. Oncol. 2, 60. 
12. Liang, X., Zhang, L., Natarajan, S. K., and Becker, D. F. (2013) Proline 
Mechanisms of Stress Survival, Antioxid. Redox. Signal. 
13. Lee, I. R., Lui, E. Y., Chow, E. W., Arras, S. D., Morrow, C. A., and Fraser, J. A. 
(2013) Reactive Oxygen Species Homeostasis and Virulence of the Fungal 
Pathogen Cryptococcus neoformans Requires an Intact Proline Catabolism 
Pathway, Genetics, doi: 10.1534/genetics.1113.150326. 
14. Lijek, R. S., Luque, S. L., Liu, Q., Parker, D., Bae, T., and Weiser, J. N. (2012) 
Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-
reactive antibody to a pneumococcal dehydrogenase, Proc. Natl. Acad. Sci. USA 
109, 13823-13828. 
15. Sophos, N. A., and Vasiliou, V. (2003) Aldehyde dehydrogenase gene 
superfamily: the 2002 update, Chem. Biol .Interact. 143-144, 5-22. 
16. Perez-Miller, S. J., and Hurley, T. D. (2003) Coenzyme isomerization is integral 
to catalysis in aldehyde dehydrogenase, Biochemistry 42, 7100-7109. 
17. Steinmetz, C. G., Xie, P., Weiner, H., and Hurley, T. D. (1997) Structure of 
mitochondrial aldehyde dehydrogenase: the genetic component of ethanol 
aversion, Structure 5, 701-711. 
18. Farres, J., Wang, T. T., Cunningham, S. J., and Weiner, H. (1995) Investigation of 
the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase 
by site-directed mutagenesis, Biochemistry 34, 2592-2598. 
19. Farres, J., Julia, P., and Pares, X. (1988) Aldehyde oxidation in human placenta. 
Purification and properties of 1-pyrroline-5-carboxylate dehydrogenase, Biochem. 
J. 256, 461-467. 
20. Forte-McRobbie, C., and Pietruszko, R. (1989) Human glutamic-gamma-
semialdehyde dehydrogenase. Kinetic mechanism, Biochem. J. 261, 935-943. 
21. Forte-McRobbie, C. M., and Pietruszko, R. (1986) Purification and 
characterization of human liver "high Km" aldehyde dehydrogenase and its 
identification as glutamic gamma-semialdehyde dehydrogenase, J Biol Chem 261, 
2154-2163. 
59 
 
22. Small, W. C., and Jones, M. E. (1990) Pyrroline 5-carboxylate dehydrogenase of 
the mitochondrial matrix of rat liver. Purification, physical and kinetic 
characteristics, J Biol Chem 265, 18668-18672. 
23. Srivastava, D., Singh, R. K., Moxley, M. A., Henzl, M. T., Becker, D. F., and 
Tanner, J. J. (2012) The Three-Dimensional Structural Basis of Type II 
Hyperprolinemia J. Mol. Biol. 420, 176-189. 
24. Kabsch, W. (2010) XDS, Acta Crystallogr. D Biol. Crystallogr. 66, 125-132. 
25. Evans, P. (2006) Scaling and assessment of data quality, Acta Cryst. D62, 72-82. 
26. Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., Echols, 
N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. 
J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., 
Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: a comprehensive Python-
based system for macromolecular structure solution, Acta Crystallogr. D Biol. 
Crystallogr. 66, 213-221. 
27. Pemberton, T. A., Still, B. R., Christensen, E. M., Singh, H., Srivastava, D., and 
Tanner, J. J. (2012) Proline: Mother Nature's cryoprotectant applied to protein 
crystallography, Acta Crystallogr. D Biol. Crystallogr. 68, 1010-1018. 
28. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular 
graphics, Acta Cryst. D60, 2126-2132. 
29. Moriarty, N. W., Grosse-Kunstleve, R. W., and Adams, P. D. (2009) electronic 
Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand 
coordinate and restraint generation, Acta Crystallogr. D Biol. Crystallogr. 65, 
1074-1080. 
30. Feng, Z., Chen, L., Maddula, H., Akcan, O., Oughtred, R., Berman, H. M., and 
Westbrook, J. (2004) Ligand Depot: a data warehouse for ligands bound to 
macromolecules, Bioinformatics 20, 2153-2155. 
31. Inagaki, E., Ohshima, N., Takahashi, H., Kuroishi, C., Yokoyama, S., and 
Tahirov, T. H. (2006) Crystal structure of Thermus thermophilus Delta1-
pyrroline-5-carboxylate dehydrogenase, J. Mol. Biol. 362, 490-501. 
32. Riveros-Rosas, H., Gonzalez-Segura, L., Julian-Sanchez, A., Diaz-Sanchez, A. 
G., and Munoz-Clares, R. A. (2013) Structural determinants of substrate 
specificity in aldehyde dehydrogenases, Chem. Biol. Interact. 202, 51-61. 
33. Pearson, R. G. (1986) Ionization potentials and electron affinities in aqueous 
solution, J. Am. Chem. Soc. 108, 6109-6114. 
34. Hawkins, G. D., Cramer, C. J., and Truhlar, D. G. (1997) Parametrized Model for 
Aqueous Free Energies of Solvation Using Geometry-Dependent Atomic Surface 
Tensions with Implicit Electrostatics, J. Phys. Chem. B 101, 7147-7157. 
60 
 
35. Wang, J., Wang, W., Huo, S., Lee, M., and Kollman, P. A. (2001) Solvation 
Model Based on Weighted Solvent Accessible Surface Area, J. Phys. Chem. B 
105, 5055-5067. 
36. Koppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., 
Juvonen, R. O., Petersen, D., Deitrich, R. A., Hurley, T. D., and Vasiliou, V. 
(2012) Aldehyde dehydrogenase inhibitors: a comprehensive review of the 
pharmacology, mechanism of action, substrate specificity, and clinical 
application, Pharmacol. Rev. 64, 520-539. 
37. Weiss, M. (2001) Global indicators of X-ray data quality, J. Appl. Cryst. 34, 130-
135. 
38. Lovell, S. C., Davis, I. W., Arendall, W. B., 3rd, de Bakker, P. I., Word, J. M., 
Prisant, M. G., Richardson, J. S., and Richardson, D. C. (2003) Structure 
validation by Calpha geometry: phi,psi and Cbeta deviation, Proteins 50, 437-
450. 
39. DeLano, W. L. (2002) The PyMOL User's Manual, DeLano Scientific, Palo Alto, 
CA, USA. 
 
 
  
61 
 
Table 3.1. Data Collection and Refinement Statistics
a
 
 Acetate Glyoxylate Malonate Succinate Glutarate 
Space group P212121 P212121 P212121 P212121 P212121 
Unit-cell 
parameters (Å) 
a = 84.9 
b = 93.9 
c = 132.1 
a = 84.9 
b = 94.2 
c = 132.1 
a = 84.9 
b = 94.0 
c = 132.1 
a = 84.9 
b = 94.1 
c = 132.3 
a = 84.9 
b = 94.0 
c = 132.2 
Wavelength 1.541 1.541 1.541 1.541 1.541 
Resolution (Å) 19.64 – 1.67  
(1.76 – 1.67) 
19.67 – 1.67 
(1.76 – 1.67) 
19.65 – 1.67 
(1.76 – 1.67) 
19.68 – 1.67  
(1.76 – 1.67) 
19.66 – 1.81  
(1.91 – 1.81) 
No. of 
observations 
529175 541047 524924 551588 459704 
Unique 
reflections 
119816 120763 120594 118798 94657 
Rmerge(I)
b
 0.067 (0.297) 0.068 (0.259) 0.076 (0.436) 0.062 (0.363) 0.092 (0.676) 
Rmeas(I)
b
 0.076 (0.350) 0.077 (0.305) 0.086 (0.520) 0.070 (0.422) 0.116 (0.789) 
Rpim(I)
b
 0.035 (0.181) 0.035 (0.157) 0.040 (0.278) 0.031 (0.209) 0.052 (0.397) 
Mean I/σ(I) 14.1 (3.9) 14.8 (4.7) 13.3 (2.8) 16.0 (3.6) 11.3 (2.2) 
Completeness 
(%) 
98.2 (89.0) 98.7 (91.9) 98.5 (91.2) 97.0 (87.9) 98.3 (90.9) 
Multiplicity 4.4 (3.3) 4.5 (3.5) 4.4 (3.2) 4.6 (3.5) 4.9 (3.7) 
No. of protein 
atoms 
8189 8185 8204 8208 8203 
No. of waters 660 742 748 799 711 
No. of PEG 
fragments 
2 2 2 2 2 
No. of ligands 4 3 2 2 2 
Rcryst 0.168 0.159 0.170 0.164 0.166 
Rfree
c
 0.194 0.183 0.198 0.191 0.203 
R.m.s. 
deviations† 
     
   bond lengths 
(Å) 
0.006 0.006 0.006 0.006 0.006 
   bond angles (°) 1.041 1.054 1.032 1.037 1.029 
Ramachandran 
plot
d
 (%) 
     
   favored 98.1 98.1 98.3 98.0 98.2 
   allowed 1.9 1.9 1.7 2.0 1.8 
   outliers 0 0 0 0 0 
Average B (Å
2
)      
   protein 14.4 12.5 14.6 15.2 16.7 
   ligand  17.8 18.6 18.7 18.1 24.3 
   water 20.6 19.5 21.2 22.8 22.3 
   PEG 24.1 21.5 24.2 27.5 29.0 
PDB Code 4LGZ 4LH0 4LH1 4LH2 4LH3 
a
Values for the outer resolution shell of data are given in parenthesis.  
b
Definitions of Rmerge, Rmeas, and Rpim can be found in Weiss (37). 
c
Common 5% test set. 
d
The Ramachandran plot was generated with RAMPAGE (38). 
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Table 3.2. Kinetic parameters for the inhibition of MmP5CDH
a 
 kcat (s
-1
) Km (M) kcat/Km (s
-1 
M
-1
) Ki (mM) 
glyoxylate 0.160 ± 0.002 26 ± 2 6200 ± 500 0.27 ± 0.02
 
succinate 0.150 ± 0.002 31 ± 2 4800 ± 300 58 ± 4 
glutarate 0.150 ± 0.004 40 ± 4 3800 ± 400 30 ± 3 
L-glutamate 0.150 ± 0.004 28 ± 3  5400 ± 600 12 ± 1 
a
Enzyme activity was measured at 20 °C with succinate semialdehyde as the variable 
substrate and the NAD
+
 concentration fixed at 1 mM.  
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Table 3.3. Inferred geometrical parameters for active and inactive semialdehydes
 
 
LS
a
 (Å) dN
b
 (Å) dOH1
c
 (Å) 
 
dOH2
c
 (Å) 
 
Relative  
kcat / Km
d
 
GSA 5.0 2.3 2.7 3.1 1.0 
Glutarate 
semialdehyde 
5.0 2.3 2.6 3.1 0.5 
Succinate 
semialdehyde 
3.3 2.6 2.8 3.3 0.2 
Malonate 
semialdehyde 
2.5 3.2 3.6 5.4 0 
Glyoxylate 1.5 4.4 5.0 5.7 0 
a
Semialdehyde chain length, defined as the distance between the two terminal C atoms of the 
substrate in the E-S complex (Figure 6). 
b
Nucleophilic attack distance, defined as the distance between the C atom of the substrate 
aldehyde group and the S atom of Cys348 (Figure 6).  
c
Oxyanion hole hydrogen bond distances.  dOH1 is the distance between the O atom of the 
substrate aldehyde group and the N atom of Cys348.  dOH2 is distance between the O atom of the 
substrate aldehyde group and the side chain N atom of Asn211 (Figure 6). 
d
Data from reference (21) expressed relative to P5C/GSA.  
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Figure Legends 
 
Figure 3.1. The reactions of proline (upper) and hydroxyproline (lower) catabolism in 
mammals. 
 
Figure 3.2. Structure of MmP5CDH complexed with glutarate (cyan).  The NAD
+
-
binding, catalytic, and oligomerization domains are colored red, blue, and green, 
respectively.  The side chains of selected active site residues are shown. The inset shows 
the essential elements of substrate recognition. This figure and others were created with 
PyMOL (39).  
 
Figure 3.3. Ligands used in crystal structure determinations: (1) glutarate, (2) succinate, 
(3) malonate, (4) glyoxylate, and (5) acetate. 
 
Figure 3.4.  The binding of products to MmP5CDH.  Electron density and interactions 
for (A) glutarate and (B) succinate.  The cages represent simulated annealing σA-
weighted Fo - Fc omit maps contoured at 3.0 σ. (C) Stereographic view (relaxed) of a 
superposition of the active sites of MmP5CDH complexed with L-glutamate (salmon 
carbons, black dashes, PDB 3V9K), glutarate (green carbons, green dashes), and 
succinate (gold carbons, gold dashes).  The protein for the L-glutamate complex is shown 
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in white. The red dashes represent the inferred nucleophilic attack distances (2.3 Å for 
GSA and glutarate semialdehyde; 2.6 Å for succinate semialdehyde).     
 
Figure 3.5.  The binding of 3- and 2-carbon ligands to MmP5CDH.  Electron density and 
interactions for (A) malonate, (B) glyoxylate, and (C) acetate. The cages represent 
simulated annealing σA-weighted Fo - Fc omit maps contoured at 3.0 σ.  In panel B, 
conformations A and B of glyoxylate are colored gold and cyan, respectively. 
 
Figure 3.6.  Cartoon representation of the essential elements of semialdehyde recognition 
by MmP5CDH.   
 
Figure 3.7.  Comparison of the binding of L-proline and glyoxylate to MmP5CDH.  The 
L-proline complex is colored gray with black hydrogen bonds.  The glyoxylate complex 
is colored gold with gold hydrogen bonds.  Conformations A and B of glyoxylate are 
colored gold and cyan, respectively. 
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Figure 3.8. Steady-state inhibition kinetics of MmP5CDH. The following potential 
inhibitors were tested: (A) glyoxylate (Ki = 0.27 ± 0.02 mM), (B) malonate (no inhibition 
observed), (C) succinate (Ki = 58 ± 4 mM), (D) glutarate (Ki = 30 ± 3 mM), and (E) L-
glutamate (Ki = 12 ± 1 mM). The curves represent global fits to the competitive 
inhibition model. For malonate (B), the global fit collapses to the Michaelis-Menten 
equation, consistent with no observed inhibition. 
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Fig 3.1. 
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Fig 3.2. 
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Fig 3.3. 
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Fig 3.4. 
 
 
 
  
71 
 
Fig 3.5. 
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Fig 3.6. 
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Fig 3.7. 
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Fig 3.8. 
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Chapter 4: 
Crystal Structure and Unexpected Oligomeric State of Put2p, the 
Mitochondrial 
1
-Pyrroline-5-Carboxylate Dehydrogenase from 
Saccharomyces cerevisiae 
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Abstract 
The proline catabolic enzyme Δ(1)-pyrroline-5-carboxylate dehydrogenase (ALDH4A1) 
catalyzes the NAD(+)-dependent oxidation of γ-glutamate semialdehyde to l-glutamate. 
In Saccharomyces cerevisiae, ALDH4A1 is encoded by the PUT2 gene and known as 
Put2p. Here we report the steady-state kinetic parameters of the purified recombinant 
enzyme, two crystal structures of Put2p, and the determination of the oligomeric state and 
quaternary structure from small-angle X-ray scattering and sedimentation velocity. Using 
Δ(1)-pyrroline-5-carboxylate as the substrate, catalytic parameters kcat and Km were 
determined to be 1.5 s(-1) and 104 μM, respectively, with a catalytic efficiency of 14000 
M(-1) s(-1). Although Put2p exhibits the expected aldehyde dehydrogenase superfamily 
fold, a large portion of the active site is disordered in the crystal structure. Electron 
density for the 23-residue aldehyde substrate-binding loop is absent, implying substantial 
conformational flexibility in solution. We furthermore report a new crystal form of 
human ALDH4A1 (42% identical to Put2p) that also shows disorder in this loop. The 
crystal structures provide evidence of multiple active site conformations in the substrate-
free form of the enzyme, which is consistent with a conformational selection mechanism 
of substrate binding. We also show that Put2p forms a trimer-of-dimers hexamer in 
solution. This result is unexpected because human ALDH4A1 is dimeric, whereas some 
bacterial ALDH4A1s are hexameric. Thus, global sequence identity and domain of life 
are poor predictors of the oligomeric states of ALDH4A1. Mutation of a single Trp 
residue that forms knob-in-hole interactions across the dimer-dimer interface abrogates 
hexamer formation, suggesting that this residue is the center of a protein-protein 
association hot spot. 
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4.1. Introduction 
The mitochondrial enzymes Put1p and Put2p catalyze proline catabolism in 
Saccharomyces cerevisiae (Figure 1).  Put1p is a flavin - dependent dehydrogenase that 
catalyzes the oxidation of L-proline to 1-pyrroline-5-carboxylate (P5C) and directly 
couples proline oxidation to reduction of ubiquinone (1).  The hydrolysis of P5C yields 
the substrate for Put2p, -glutamate semialdehyde (GSA).  Put2p catalyzes the NAD+-
dependent oxidation of -glutamate semialdehyde to L-glutamate.  Put2p is a P5C 
dehydrogenase (P5CDH, EC 1.5.1.12) and is also known as ALDH4A1 in reference to its 
membership in family 4 of the aldehyde dehydrogenase (ALDH) superfamily.  In total, 
the proline catabolic pathway affects a 4-electron oxidation of proline, and these 
reactions enable yeast to use proline as the sole source of nitrogen.   
Several studies have shown that proline is important in various organisms for stress 
protection (2). Proline accumulation in yeast leads to improved freeze tolerance (3).  In 
contrast to proline, accumulation of P5C is associated with toxicity effects and induced 
cell death in yeast (4, 5). Coordinated expression of PUT1 and PUT2 is important for 
avoiding buildup of P5C. The PUT1 and PUT2 genes are upregulated by proline in 
nitrogen limiting conditions and together with glutamate dehydrogenase, enable yeast to 
utilize proline as nitrogen source (6). The mechanism of P5C toxicity involves inhibition 
of mitochondrial respiration and increased production of reactive oxygen species (4). 
Interestingly, a N-acetyltransferase enzyme known as Mpr1 acetylates P5C thereby 
diminishing its accumulation and harmful effects in yeast (7). 
Mammalian P5CDHs have been characterized biochemically.  Early studies on the 
human (HsP5CDH) and rat enzymes established the order of substrate binding and 
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product release, as well as substrate preferences (8-10).  More recent work on HsP5CDH 
and mouse P5CDH (MmP5CDH) provided additional details of the kinetic mechanism 
and the molecular basis of type II hyperprolinemia,(11)  a metabolic disorder caused by a 
defect in HsP5CDH function (12-14).   
The three-dimensional structures of P5CDHs have been studied intensely.  Tahirov's 
group reported the first P5CDH structure using the enzyme from Thermus thermophilus 
(TtP5CDH) (15, 16).   We subsequently determined the structures of HsP5CDH and 
MmP5CDH (11, 17), and the New York Structural Genomics Research Consortium has 
deposited structures of two Bacillus P5CDHs in the Protein Data Bank (PDB codes 
3QAN and 3RJL).  Collectively, the structures confirmed P5CDH as a member of the 
ALDH superfamily, contributed additional information about the catalytic mechanism, 
and provided insight into the structural basis of cofactor and semialdehyde selectivity.  
We also determined the solution oligomeric states and quaternary structures of several 
P5CDHs using a variety of biophysical techniques (18). The human, mouse, and Bacillus 
enzymes are dimeric in solution, whereas TtP5CDH and Deinococcus radiodurans 
P5CDH (DrP5CDH) form trimer-of-dimers hexamers in solution.  Thus, the protein fold, 
but not the oligomeric state, is conserved within the ALDH4A1 family.  
Although the yeast PUT genes were identified over 30 years ago, the Put1p and Put2p 
enzymes have remained relatively understudied. Wanduragala et al. reported the 
purification and characterization of Put1p in 2010 (1), but analogous studies of Put2p 
have not appeared in the literature.  We therefore have created a recombinant bacterial 
expression system for Put2p, measured the steady-state kinetic parameters of the purified 
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enzyme, determined the crystal structure, and deduced the oligomeric state and 
quaternary structure in solution from small-angle X-ray scattering (SAXS).  
4.2. Experimental Procedures 
4.2.1 Subcloning and Mutagenesis  
The PUT2 gene encoding the 575-residue preprotein was obtained from Dr. Marjorie 
Brandriss of the Rutgers New Jersey Medical School and subcloned into vectors pET14b 
using NdeI and XhoI and pKA8H between NdeI and BamHI restriction sites resulting in 
pET14b-PUT2 and pKA8H-PUT2 constructs.  DNA encoding residues 20-575 (Accoding 
to the sequence I got from W193A and the one I have of the wt gene, it should start at 
20), which lacks the N-terminal mitochondrial targeting peptide (19), was amplified from 
pKA8H using AAACATATGAAGCCCCCCAAGCACATAAG as the forward primer 
and the T7 terminator as the reverse primer. The resulting fragment was subcloned into 
pKA8H using NdeI and BamHI to give the construct pKA8H-PUT2∆22.  The expressed 
protein has an N-terminal His8 tag and Tobacco Etch Virus protease (TEVP) cleavage 
site.  
The W193A mutant of Put2p was created from pKA8H-PUT2∆22 with the Quick-
Change II site-directed mutagenesis kit (Agilent) using the forward primer (5′-
GGTACAATCTACCGTTTGCTGACAGATCTGC-3′) and reverse primer (5′-
GCAGATCTGTCAGCAAACGGTAGATTGTACC-3′).  The mutation was confirmed using 
DNA sequencing. 
4.2.2 Expression and Purification of Put2p 
 Put2p and Put2p mutant W193A were expressed in Bl21(DE3)pLysS cells.  Cells 
were grown at 37 °C and 250 rpm until an OD600 of 0.6 and induced with 0.5 mM IPTG 
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for 8 hours at 22
 
°C at 200 rpm.  The cells were harvested by centrifugation at 3500 rpm 
for 30 minutes and resuspended in 20 mM HEPES, 60 mM NaCl, and 5 % glycerol at pH 
8.0.  Cells were quick frozen in liquid nitrogen and stored at -80
 
°C until further 
purification.   
Thawed cells were broken by sonication and centrifuged at 16500 rpm for one hour. 
The supernatant was applied to a HisTrap HP column that had been charged with Ni
2+
 
and equilibrated with 20 mM HEPES, 300 mM NaCl, and 5 % glycerol at pH 8.0. The 
column was washed with equilibration buffer supplemented with 30 mM imidazole, and 
the enzyme was eluted with 300 mM imidazole. Fractions containing Put2p were pooled 
and dialyzed into 50 mM Tris, 0.5 mM EDTA, 0.5 mM THP, and 5 % glycerol at pH 8.0 
and loaded onto a HiTrap Q anion exchange column. Put2p was eluted with a linear 
gradient of NaCl from 0 to 1 M.  Fractions were analyzed with SDS-PAGE, pooled, and 
dialyzed into 50 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5 % 
glycerol at pH 8.0. 
4.2.3 Crystallization of Put2p   
Crystallization trials were performed in sitting drops at 20 °C using drops formed by 
mixing 1 L each of the enzyme and reservoir solutions.   Crystal screening using 
commercially available kits (Hampton Research) was used to identify promising 
crystallization conditions.   
Put2p expressed from pKA8H-PUT2∆22, including the N-terminal His tag, was used 
for crystallization.  Optimized crystals were grown using the enzyme at 8 mg/mL and a 
reservoir containing 8 - 14 % (w/v) polyethylene glycol (PEG) 3350, 0.1 M (NH4)2SO4, 
and 0.1 M Bis-Tris at pH 5.5 - 6.5. The crystals were cryoprotected with 15 % PEG 3350, 
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0.1 M (NH4)2SO4, 0.1 M Bis-Tris at pH 6.0, and 20 % glycerol. The cryoprotected 
crystals were harvested with nylon loops (Hampton Research) and plunged into liquid 
nitrogen. The space group is P63 with a = 109 Å and c = 181 Å.  The asymmetric unit 
contains one dimer and 51 % solvent (20).  
Crystals of Put2p complexed with NAD
+
 were obtained by adding 10mM NAD
+
 to a 
7 mg/mL protein stock. Optimized crystals were grown from combining this stock and a 
reservoir containing 8-14% PEG 3350, 0.1 M (NH4)2SO4 and 0.1 M Bis-Tris at pH 5.5 - 
6.5. These crystals were cryoprotected with 12% PEG 3350, 0.1 M (NH4)2SO4, 10mM 
NAD
+
,  0.1 M Bis-Tris at pH 5.5 and 15% PEG 200. The cryoprotected crystals were 
harvested with nylon loops and plunged into liquid nitrogen. The space group is P63 with 
a = 108 Å and c = 181 Å. The asymmetric unit was the same as before. 
4.2.4 Expression, Purification, and Crystallization of Tag-free HsP5CDH  
 HsP5CDH residues 18-563 with an N-terminal His tag was expressed and purified as 
described previously (11).  The His tag was removed with thombin as follows.  The 
purified protein was dialyzed into thrombin cleavage buffer (20 mM Tris, 150 mM NaCl, 
2.5 mM CaCl2, and 5 % glycerol at pH 8.0) and incubated with thrombin (1 unit of 
thrombin per 4 mg of HsP5CDH) for one day at 4 °C.  Thrombin was removed using a 
HiTrap Benzamidine FF affinity column.  The cleaved His tag and residual unprocessed 
HsP5CDH were removed by passing the sample through a Ni
2+
-charged HisTrap HP 
column.  The tag-free enzyme was collected in the flow-through, dialyzed into 50 mM 
Tris, 50 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5 % glycerol at pH 8.0, and 
concentrated to 6 mg/mL for crystallization trials. 
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Monoclinic crystals of HsP5CDH were grown using a reservoir of 20 - 25 % (w/v) 
PEG3350, 0.2 M MgCl2, and 0.1 M HEPES at pH 7.0 - 8.0.  The crystals were 
cryoprotected with 25 % (w/v) PEG 3350, 0.2 M MgCl2, 0.1 M HEPES at pH 7.5, and 20 
% (v/v) PEG 200.  The cryoprotected crystals were harvested with nylon loops and 
plunged into liquid nitrogen.  The space group is P21 with a = 92.0 Å, b = 121.3 Å, c = 
93.4 Å, and  = 104.2°.  The asymmetric unit contains two dimers and 39 % solvent (20). 
4.2.5 X-ray Diffraction Data Collection, Phasing, and Refinement  
Crystals were analyzed at NE-CAT beam lines 24-ID-C and 24-ID-E at the Advanced 
Photon Source using a Quantum 315 detector (Table 1).  The Put2p data set was obtained 
at 24-ID-C and consisted of 105 frames collected with an oscillation width of 1°, detector 
distance of 225 mm, and exposure time of 1.0 s/frame at 7 % transmission. The data were 
processed to 1.95 Å resolution using HKL2000 (21).  Data from Put2p-NAD
+
 crystals 
were collected 24-ID-E and processed with XDS (22).  The 2.2 Å resolution data set 
consisted of 70 frames collected with an oscillation width of 1°, detector distance of 200 
mm, and exposure time of 1.0 s/frame at 55 % transmission.  Data from HsP5CDH 
crystals were collected at beam line 24-ID-C.  The data set used for refinement consisted 
of 180 frames collected with an oscillation width of 1°, detector distance of 250 mm, and 
exposure time of 1.0 s/frame at 4 % transmission. The data were processed to 1.95 Å 
resolution using HKL2000.  
The phase problem was solved using molecular replacement as implemented in 
MOLREP (23).  The search model for Put2p was derived from a 1.3 Å resolution 
structure of mouse P5CDH (PDB code 3V9J (11), 43 % sequence identity over 543 
residues).  The search model for HsP5CDH was obtained from a 2.5 Å resolution 
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structure of HsP5CDH (PDB code 3V9G(11)). The models from molecular replacement 
were used as the starting points for several rounds of model building with COOT (24) 
and refinement with PHENIX (25).  The refined Put2p structure was used as the starting 
point for refinement of the Put2p-NAD
+
 structure. 
4.2.6 Small-Angle X-ray Scattering of Put2p  
In preparation for SAXS studies, wild-type Put2p was purified in a similar manner as 
that used for crystallization. However, after the first Ni column, TEVP was added to the 
pooled fractions and incubated at 28 °C for 2 hours. The protein was then placed in a 
dialysis buffer, overnight, consisting of 20mM HEPES, 100mM NaCl and 5% glycerol at 
pH 8.2. The protein was then run over a Ni column again and the protein eluted at 30mM 
imidazole. The fractions were collected, pooled, and placed in a dialysis buffer of 50mM 
Tris, pH 7.5, 0.5mM EDTA, 0.5mM THP, and 5% glycerol overnight. The protein was 
then run over an anion exchange column and dialyzed by the same procedure for the 
crystallization. For the last step of purification this protein was run on a gel filtration 
column. The aggregate was discarded and homogeneous protein was collected. The 
fractions were pooled and concentration was estimated using the BCA method to be 3 
mg/mL. The protein was concentrated in a Millipore centrifugal filter unit to 7 mg/mL. 
This protein was used for SAXS and the buffer from the flow through of the centrifugal 
unit was used as a reference.  
The Put2p mutant W193A was also analyzed with SAXS.  The sample was prepared 
for SAXS analysis as follows. W193A followed the same purification process as the wild 
type with two exceptions. First, the final buffer used was 50mM Tris, 300mM NaCl, 
0.5mM EDTA, 0.5mM THP, and 5% glycerol at pH 7.5. Second, This protein was run 
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over a size exclusion chromatography column and no aggregation peak was observed. 
Fractions were collected and pooled and concentrated to a final concentration of 
3mg/mL.  
SAXS experiments were performed at SIBYLS beamline 12.3.1 of the Advanced 
Light Source through the mail-in program (26, 27). For each sample, scattering intensities 
were measured at three nominal protein concentrations.  Data were collected for each 
protein concentration at exposure times of 0.5 s, 1.0 s. 3.0 s, and 6.0 s. The scattering 
curves collected from the protein samples were corrected for background scattering using 
intensity data collected from the reference buffer.   
The SAXS data were analyzed as follows.  Composite scattering curves were 
generated with PRIMUS (28) by scaling and merging the background-corrected low q 
region data from the 0.5 s exposure (wild-type) or 0.1 s exposure (W193A) with the high 
q region data from the 3.0 s exposure (wild-type) or 6.0 s exposure (W193A).  PRIMUS 
was also used to perform Guinier analysis.  FoXS was used to calculate theoretical 
scattering profiles from atomic models.(29)  GNOM was used to calculate pair 
distribution functions (30). The SASTBX server (31) was used for shape reconstruction 
calculations.  
4.2.7 Analytical Ultracentrifugation   
W193A was analyzed by sedimentation velocity using a Beckman XL-I analytical 
ultracentrifuge. The protein was purified as described above.  The His-tag was removed 
by adding 1mg of TEVP to the pooled fractions. This sample was incubated at 28 °C for 
2 hours and then moved into dialysis at 4 °C for about 14 hours.  Following dialysis to 
equilibrium against the buffer (50 mM Tris, 300 mM NaCl, 0.5 mM EDTA, 0.5 mM 
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THP, and 5% glycerol at pH 7.5), the protein solution was diluted with dialysis buffer to 
yield an absorbance (at 280 nm) of 0.95 in a 1.0 cm path length cuvette.  A 400 L 
aliquot was loaded into the sample compartment of a double-sector cell, assembled with a 
1.2 cm charcoal-epon centerpiece and quartz windows. A slightly larger volume (430 L) 
of dialysis buffer was placed in the reference compartment. The sample cell was placed 
in the rotor and allowed to equilibrate to 20 C in the rotor chamber for two hours under 
vacuum, prior to beginning the experiment. The sample was then sedimented at 30000 
rpm, acquiring data at 4 min intervals, until a total of 170 scans had been collected. The 
resulting data set was analyzed by SEDFIT v9.4 (32), using the continuous c(s) and 
continuous c(M) distribution models, allowing the frictional ratio to float. 
4.2.8 Steady-State Kinetics  
Put2p activity was measured by monitoring the formation of NADH at 20 
o
C as 
described previously for human P5CDH (11). The assay buffer contained 50 mM 
potassium phosphate (pH 7.5) and 25 mM NaCl. Put2p enzyme concentration was 0.4 
µM (25.6 g/ml) and NAD+ concentration was held constant at 0.2 mM. Initial velocity 
data were collected using L-P5C concentrations from 1 to 300 µM. Initial velocity data 
were fitted to the Michaelis-Menten equation to estimate Km and kcat.  
4.3. Results 
4.3.1 Steady-State Kinetics Measurements   
Brandriss and coworkers previously measured Put2p enzymatic activity in cellular 
and mitochondrial extracts to verify the identity of the enzyme and determine the 
subcellular location (33-35).  To our knowledge, the catalytic properties of the purified 
enzyme have not been studied.  We therefore performed steady-state kinetic 
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measurements of recombinant Put2p. Kinetic parameters for Put2p were Km = 104 ± 4 
µM L-P5C and kcat = 1.5 ± 0.3 sec
-1 
with
 
kcat/Km = 14423 M
-1
 s
-1
. The measured activity of 
Put2p is lower than human P5CDH which has a Km of 32 µM L-P5C and kcat of 10.0 s
-1 
(kcat/Km = 312500 M
-1
 s
-1
) (11).  
4.3.2 Protomer Structure of Put2p   
The 1.95 Å resolution crystal structure of Put2p was determined (Table 1).  Put2p 
exhibits the expected ALDH fold, which consists of three domains (Figure 2A). The N-
terminal half of the polypeptide chain contains a Rossmann fold domain and binds NAD
+
 
(residues 43-181, 200-319, 536-553).  The catalytic domain (residues 320-535) interrupts 
the NAD
+
-binding domain and exhibits an open α/β fold featuring a twisted 7-stranded β-
sheet with all but one strand in parallel.  This domain furnishes the essential cysteine 
nucleophile (Cys351), which is situated at the interface of the NAD
+
-binding and 
catalytic domains.  The third domain is a bipartite β substructure consisting of residues 
182-199 and 554-565 that protrudes from the NAD
+
-binding domain.  This domain is 
involved in oligomerization.  As with other ALDHs, Put2p forms a dimer in which the 
oligomerization domain of one protomer engages the catalytic domain of the other 
protomer (Figure 2B).  The asymmetric unit contains one dimer. As described below, 
three Put2p dimers assemble into a hexamer in solution. 
The most conspicuous feature of the Put2p structure is that which is unseen. ALDHs 
have a ~25 residue peptide that connects the last strand of the catalytic domain to the 
second piece of the oligomerization domain.  This section corresponds to residues 523 - 
547 of Put2p.  Electron density for these residues is very weak, implying substantial 
conformational disorder (Figure 3A).   The lack of density for this part of the protein 
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gives the impression of a large void running lengthwise through the middle of the dimer 
(Figure 3A).   
The omission of residues 524 – 546 from the Put2p model is notable because this 
region of ALDHs anchors the aldehyde substrate in the active site (Figure 3B).  In other 
P5CDHs (and ALDHs in general) the 25-residue aldehyde-binding loop folds into a 2-
stranded antiparallel β-sheet that forms the floor of the aldehyde substrate entrance 
tunnel.  In P5CDHs, the beginning of the peptide provides critical hydrogen bonding 
groups that anchor the backbone of GSA, as well as a conserved Phe that packs against 
the aliphatic chain of GSA (Figure 3B) (11, 15, 17).  The observation of disorder in the 
aldehyde anchor peptide suggests the hypothesis that in solution the anchor peptide 
samples conformations other than the one that binds the substrate.   
4.3.3 Structure of Put2p-NAD
+
 Complex   
The structure of Put2p complexed with NAD
+
 was determined (Table 1). Electron 
density for the ADP group of NAD
+
 is strong in both protomers (Figure 4).  Density for 
the nicotinamide ribose is strong in one protomer and somewhat weaker in the other one.  
Density for the nicotinamide is diffuse in both protomers, implying disorder, and thus the 
nicotinamide was omitted from the final model deposited in the PDB.  Disorder of the 
nicotinamide has been reported for ALDHs (11, 15, 36).   
NAD
+
 binds in the expected location, with the adenine ring wedged between valine 
and proline residues belonging to helices of the Rossmann fold domain (Figure 4). The 
adenine ribose forms hydrogen bonds with Lys234, and the pyrophosphate interacts with 
Ser288. The nicotinamide ribose hydrogen bonds with Glu458.  These interactions are 
also observed in the structure of MmP5CDH-NAD
+
 (11). 
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Binding of the cofactor is accompanied by conformational changes outside of the 
anchor peptide (Figure 4). Phe460 rotates around 1 by 96° to avoid steric clash with the 
nicotinamide ribose. Glu458 rotates by 120°, enabling a hydrogen bond with the 
nicotinamide ribose. These conformational changes have not been reported for other 
P5CDHs. 
4.3.4 Structure of Monoclinic HsP5CDH   
To further explore the idea that the aldehyde anchor peptide is flexible in solution, the 
structure of a second eukaryotic P5CDH without a ligand bound in the aldehyde site was 
determined.  The structure of ligand-free HsP5CDH was determined from a new 
monoclinic crystal form that was obtained only after cleaving the N-terminal His tag.  
As in the Put2p structure, electron density for the aldehyde anchor peptide of 
monoclinic HsP5CDH (residues 514-535) is very weak (Figure 3C).   Electron density for 
these residues is essentially absent in chains A and D, and the entire loop was omitted.  In 
the other two chains in the asymmetric unit, the binding of Mg
2+
 from the crystallization 
buffer stabilizes residues 522 - 535 in a non-native conformation, but the other residues 
of the loop remain disordered.  Thus, the disordered active site is not an idiosyncrasy of 
Put2p.   
4.3.5 Oligomeric State and Quaternary Structure of Put2p   
The oligomeric state of Put2p in solution was investigated using SAXS (Figure 5).  
Guinier plots of data from three samples having different protein concentrations yield a 
radius of gyration (Rg) in the range 47 – 48 Å. Calculations of the pair distribution 
function suggest a maximum particle dimension of 140 – 150 Å and Rg of 45 Å.  The Rg 
of the Put2p dimer in asymmetric unit (Figure 2B) is only 31.5 Å, which suggests that a 
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higher order oligomer is formed in solution.  Furthermore, the theoretical SAXS curve 
calculated from the dimer deviates substantially from the experimental one (Figure 5A).   
The Put2p crystal lattice was inspected to identify a higher order assembly that is 
consistent with the SAXS data. Application of the crystallographic three-fold rotation to 
the dimer in the asymmetric unit generates a point group 32 hexamer with Rg of 43.9 Å 
(Figure 5B), which is close to the experimental Rg of 48 Å.  The scattering profile 
calculated from the Put2p hexamer shows good agreement with the experimental profile 
(Figure 5A).  Slightly better agreement is obtained with the hexamer of TtP5CDH (Figure 
5A), which includes the sections that are disordered in Put2p.  Consideration of a mixture 
of hexamers and dimers using minimum ensemble search (37) did not improve the fit.  
The hexamer oligomeric state was confirmed by estimating the molecular mass from 
SAXS data using the volume of correlation (Vc) invariant (38).  The Vc of Put2p is 1459 
Å
2
, which corresponds to a molecular mass of 363 kDa. This value is within 6 % of the 
expected molecular mass of 387 kDa for a hexamer of the His-tagged Put2p protein that 
was used for SAXS.  It is concluded that the predominant form of Put2p in solution is the 
trimer-of-dimers hexamer observed in the crystal lattice.  
Finally, shape reconstruction calculations are also consistent with the hexamer. The 
shape reconstruction was performed with the SASTBX server (31), which makes no 
explicit assumptions about the molecular mass, number of residues, or oligomeric state of 
the particle under consideration.  The envelope is consistent with the crystallographic 
hexamer (Figure 5B).     
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4.3.6 Hexamerization Hot Spot of Put2p   
We previously identified a hexamerization hot spot in bacterial P5CDHs.  The hot 
spot is located in the interface between two dimers and is formed by 3 of one molecule 
and the oligomerization domain of another molecule.  An Arg residue of 3 (e.g., Arg100 
of TtP5CDH) was shown to be essential for hexamer formation, as mutation of this 
residue to Ala abrogates hexamerization of TtP5CDH and DrP5CDH.  Interestingly, 
Ala126 of Put2p replaces this important arginine, while Trp193 of the Put2p 
oligomerization domain occupies the space corresponding to the Arg side chain of 
TtP5CDH.  The indole of Trp193 fits into a hole formed by several residues of 3 
(Phe121, Tyr122, Ser125, Ala126, Leu129) as well as Val174 of 5 (Figure 6).  We 
therefore hypothesized that Trp193 is the center of the hexamerization hot spot of Put2p, 
analogous to the essential Arg of Tt5CDH and DrP5CDH.  This idea was tested by 
creating the Put2p variant W193A. 
The oligomeric state of W193A was determined using sedimentation velocity.  
Several of the velocity profiles are displayed in Figure 7A, together with the 
corresponding least-squares fits.  Analysis of the entire data set with SEDFIT yielded a 
symmetric sedimentation coefficient distribution centered at 4.65 S (Figure 7B). The 
corresponding molecular mass distribution is centered at 121 kDa (Figure 7C), which is 
within 2 % of the theoretical M of the W193A dimer (124 kDa).  Thus, mutation of 
Trp193 to Ala appears to have disrupted the hexamer, as intended.     
W193A was also analyzed using SAXS (Figure 8).  Guinier plots of data from three 
samples having different protein concentrations yield an Rg in the range of 34.5 – 34.7 Å. 
Calculations of the pair distribution function suggest a maximum particle dimension of 
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110-115 Å and an Rg of 34.7 Å. As stated above the Rg of the Put2p dimer in the 
asymmetric unit is 31.5 Å, which is close to the experimental Rg. The theoretical SAXS 
curve calculated from the Put2p dimer is in good agreement with the experimental one, 
while the hexamer curve shows significant deviation (Figure 8A). Also, shape 
reconstruction calculations, performed with the SASTBX server, are consistent with the 
crystallographic dimer (Figure 8B). Thus, the SAXS data are also consistent with W193A 
being primarily dimeric in solution. 
4.4. Discussion 
It is tempting to speculate that the Put2p and HsP5CDH structures reported here 
represent the enzyme conformation prior to aldehyde binding, implying that aldehyde 
binding stabilizes the active site.  This interpretation is supported by the fact that all other 
structures of eukaryotic P5CDHs (human and mouse) have ligands bound in the aldehyde 
site, including sulfate ion from the crystallization buffer (PDB entries 3V9J, 3V9H) (11), 
the product glutamate (3V9K) (11), and proline (4E3X) (39), which is a competitive 
inhibitor with respect to GSA.
 
 Although a ligand was not modeled in two other structures 
(3V9L, 3V9G), a strong electron density feature consistent with a sulfate ion is 
nevertheless evident.  Thus, none of the previously determined structures of eukaryotic 
P5CDHs are truly representative of the aldehyde-free conformation. Bacterial P5CDH 
structures, however, provide a counterargument; a few bacterial P5CDHs have an ordered 
active site in the absence of a ligand in the aldehyde site (e.g., PDB entries 2EHQ, 2BHP, 
3RJL).  Nevertheless, the observation that the aldehyde anchor peptide is disordered in 
two different P5CDHs that were crystallized in unrelated lattices suggests that the 
disorder may be functionally relevant, at least for eukaryotic P5CDHs. At the very least, 
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the structures demonstrate that the aldehyde-binding loop is inherently flexible, possibly 
sampling active and inactive conformations in solution. In this view, substrate binding to 
Put2p would be an example of conformational selection.  
Disorder in enzyme active sites on the scale described here has precedent, and retinal 
dehydrogenase II is the most germane example.  Also a member of the ALDH 
superfamily, retinal dehydrogenase II catalyzes the oxidation of retinal to retinoic acid, 
and is thus involved in retinoic acid signaling.  As in Put2p, the aldehyde binding loop is 
disordered in the crystal structure of retinal dehydrogenase II (PDB code 1BI9).  It has 
been proposed that the disordered loop plays a role in discriminating retinal from smaller 
potential substrates (40, 41).  It is likewise possible that the flexibility of ALDH4A1 
plays a role in enforcing substrate selectivity.   
The discovery that Put2p is hexameric is unexpected.  Put2p and HsP5CDH are 
eukaryotic P5CDHs that share 42 % amino acid sequence identity, yet Put2p is 
hexametric and HsP5CDH is dimeric (11).  The trimer-of-dimers hexamer described here 
for Put2p is also formed by TtP5CDH and DrP5CDH (18), although Put2p is only 30 % 
identical in sequence to these bacterial P5CDHs.  Curiously other bacterial P5CDHs, 
such as those from Bacillus species are dimeric (18).  Thus, global sequence identity and 
domain of life are poor predictors of the oligomeric states of P5CDHs.  Instead, we 
suggest that the hot spot theory of protein-protein association provides a better 
explanation for the oligomeric states of P5CDHs (42, 43).  
We previously proposed the existence of a hot spot that is essential for hexamer 
formation of P5CDH, based on biophysical and mutagenesis studies of the two hexameric 
P5CDHs TtP5CDH and DrP5CDH (18).  The hot spot involves residues in the 
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oligomerization domain and 3.  Bacterial hexametric P5CDHs have an essential Arg 
that forms intermolecular electrostatic interactions in the hot spot.  Interestingly, this key 
Arg residue is Ala in Put2p (Figure 6), and so the discovery that Put2p is hexameric in 
solution was quite unexpected.  The Put2p structure revealed Trp193 that forms nonpolar, 
knob-in-hole interactions in the hot spot region (Figures 6B, 6C).  Mutation of Trp193 to 
Ala abrogates hexamer formation, suggesting that these nonpolar interactions substitute 
for the electrostatic interactions that stabilize the bacterial P5CDH hexamers.  Thus, the 
hot spot appears to be a unique region of P5CDH three-dimensional structural space that 
must be occupied by residues capable of forming attractive intermolecular forces in order 
for hexamerization to occur.  Interestingly, the precise nature of these forces appears to 
be less important that than their location.     
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Table 4.1. X-ray Diffraction Data Collection and Refinement
a 
 
 Put2p Put2p-NAD
+
 HsP5CDH 
Space group P63 P63 P21 
Unit cell  
parameters (Å, °) 
a = 109.0, c = 181.2 a = 108.0, c = 181.0 a = 92.0, b = 121.3, 
c = 93.4,  = 104.2 
Wavelength 0.979 0.979 0.979 
Resolution (Å) 50.0 – 1.95 (2.02 – 1.95) 93.6 – 2.17 (2.29 – 2.17) 50.0 – 1.95 (2.02 – 1.95) 
Observations 579452 277102 489835 
Unique reflections 88348 63148 139296 
Rmerge(I) 0.061 (0.525) 0.057 (0.583) 0.049 (0.453) 
Mean I/σ 32.1 (3.4) 16.5 (2.3) 24.2 (2.2) 
Completeness (%) 99.9 (100.0) 99.8 (98.09 96.5 (93.0) 
Multiplicity 6.6 (6.5) 4.4 (4.4) 3.5 (3.3) 
No. of protein residues 960 960 2054 
No. of atoms 7611 7485 15436 
No. of NAD
+
 atoms  0 62 0 
No. of water 
molecules 
199 177 241 
Rcryst  0.181 (0.208) 0.180 (0.285) 0.194 (0.229) 
Rfree
b
 0.207 (0.236) 0.220 (0.319) 0.237 (0.302) 
rmsd bond lengths (Å) 0.007 0.007 0.007 
rmsd bond angles (°) 1.04 1.09 1.00 
Ramachandran plot
c
    
  Favored (%) 98.62 98.09 98.23 
  Outliers (residues) 0 0 0 
Average B (Å
2
)    
  Protein 30.5 40.0 33.3 
  NAD
+
 - 42.6 - 
  Water 29.1 35.7 27.2 
Coordinate error (Å)
d
 0.21 0.27 0.24 
PDB code 4OE6 4OE4 4OE5 
a
Values for the outer resolution shell of data are given in parenthesis.  
b
5 % test set.  A common set was used for refinement of the Put2p structures.  
c
The Ramachandran plot was generated with RAMPAGE.(44) 
d
Maximum likelihood-based coordinate error estimate reported by PHENIX. 
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Figure Legends 
Figure 4.1. The reactions catalyzed by the yeast proline catabolic enzymes Put1p and 
Put2p.  
Figure 4.2. Structure of Put2p. (A) The protomer is shown with the catalytic domain in 
green, NAD
+
-binding domain in blue, and oligomerization domain in gold.  The red 
section represents the aldehyde-binding loop of MmP5CDH, which is disordered in 
Put2p. (B) Structure of the Put2p dimer in the asymmetric unit. The two protomers are 
colored blue and gold.  Red sections represent the aldehyde-binding loop of MmP5CDH, 
which is disordered in Put2p 
Figure 4.3. Electron density evidence for disorder in the aldehyde-binding loops of Put2p 
and HsP5CDH. (A) The Put2p dimer with 2Fo - Fc electron density (1.0 σ).  The red 
sections represent the aldehyde-binding loops of MmP5CDH.  The green spheres 
represent the product glutamate bound to MmP5CDH.  (B) Close-up view of the expected 
conformation of the aldehyde-binding loop in Put2p.  Put2p is colored gray. The 
aldehyde-binding loop (pink), bound glutamate ligand (green), and NAD
+
 of MmP5CDH 
have been fitted onto Put2p.  (C)  A dimer of monoclinic HsP5CDH with 2Fo - Fc 
electron density (1.0 σ). The red sections represent the aldehyde-binding loops of 
MmP5CDH, which are disordered or form a nonnative conformation in HsP5CDH.  The 
green spheres represent the product glutamate bound to MmP5CDH.        
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Figure 4.4. Electron density and interactions for NAD
+
 bound to Put2p.  The cage 
represents a simulated annealing σA-weighted Fo - Fc omit map contoured at 3.0 σ.  The 
conformations of Glu458 and Phe460 prior to NAD
+
 binding are shown in cyan.  
Figure 4.5. SAXS analyses of Put2p. (A) Experimental and calculated SAXS curves. The 
inset shows a Guinier plot spanning the range of qRg = 0.508 - 1.29.   The linear fit of the 
Guinier plot has R
2
 of 0.9995.  (B) Superposition of the SAXS shape reconstruction and 
the Put2p hexamer generated from crystallographic symmetry. Two orthogonal views are 
shown.  
Figure 4.6. Hexamer hot spot of Put2p. (A) A view of the hexamer showing the location 
of Trp193 (shown in spheres).  The six chains have different colors.  (B and C) Close-up 
views of the environment around Trp193.  The chains are colored as in panel A. 
Figure 4.7. Sedimentation velocity analysis of W193A. (A) Experimental velocity 
profiles (circles) and least squares fits. (B) Sedimentation coefficient distribution.  (C) 
Molecular mass distribution.   
Figure 4.8. SAXS analysis of W193A. (A) Experimental and calculated SAXS curves. 
The inset shows a Guinier plot spanning the range of qRg = 0.346 – 1.34. The linear fit of 
the Guinier plot has R
2
 of 0.997. (B) Superposition of the SAXS shape reconstruction and 
the Put2p dimer from the asymmetric unit. Two orthogonal views are shown.   
102 
 
Fig 4.1. 
 
  
103 
 
Fig 4.2.  
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Fig 4.3. 
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Fig 4.4. 
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Fig 4.5. 
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Fig 4.6. 
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Fig 4.7. 
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Chapter 5: 
Kinetic and Structural Characterization of Tunnel-Perturbing 
Mutants in Bradyrhizobium japonicum Proline Utilization A 
(PutA)
 
111 
 
Abstract 
 Proline utilization A (PutA) from Bradyrhizobium japonicum (BjPutA) is a 
bifunctional flavoenzyme that catalyzes the oxidation of proline to glutamate using fused 
proline dehydrogenase (PRODH) and Δ1-pyrroline-5-carboxylate dehydrogenase 
(P5CDH) domains.  Recent crystal structures and kinetic data suggest an intramolecular 
channel connects the two active sites, promoting substrate channeling of the intermediate 
Δ1-pyrroline-5-carboxylate/glutamate-γ-semialdehyde (P5C/GSA).  In this work, the 
structure of the channel was explored by inserting large side chain residues at four 
positions along the channel in BjPutA. Kinetic analysis of the different mutants revealed 
replacement of D779 with Tyr (D779Y) or Trp (D779W) significantly decreased the 
overall rate of the PRODH-P5CDH channeling reaction. X-ray crystal structures of 
D779Y and D779W revealed that the large side chains caused a constriction in the central 
section of the tunnel thus likely impeding travel of P5C/GSA in the channel. The D779Y 
and D779W mutants have similar PRODH activity relative to wild-type BjPutA but 
exhibit significantly lower P5CDH activity, suggesting that exogenous P5C/GSA enters 
the channel upstream of Asp779. Replacement of nearby Asp778 with Tyr (D778Y) did 
not impact BjPutA channeling activity. Consistent with the kinetic results, the X-ray 
crystal structure of D778Y shows that the main channel pathway is not impacted, 
however, an off-cavity pathway is closed off from the channel. These findings provide 
evidence that the off-cavity pathway is not essential for substrate channeling in BjPutA. 
Structural analysis also shows that the tunnel constrains GSA in a linear conformation 
with the aldehyde directed toward the P5CDH active site. 
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5.1. Introduction  
 The proline catabolic pathway catalyzes the oxidation of proline to glutamate 
(Scheme 1).  In the first step, proline dehydrogenase (PRODH) uses an FAD cofactor to 
remove two electrons (as H
-) from proline, resulting in Δ1-pyrroline-5-carboxylate (P5C).  
P5C then undergoes a non-enzymatic hydrolysis, which opens the pyrroline ring to create 
glutamate-γ-semialdehyde (GSA).  Finally, GSA is oxidized to glutamate by the NAD+-
dependent P5C dehydrogenase (P5CDH) to complete the overall 4-electron oxidation 
process.  Proline and proline metabolism are important for the pathogenicity of 
Helicobacter pylori and H. hepaticus (1, 2), energy production in procyclic trypanosomes 
(3, 4), and regulation of metabolites linked to pathogenesis in Photorhabdus and 
Xenorhabdus (5). In humans, inborn errors in proline catabolism lead to hyperprolinemia 
disorders, and defects in PRODH are linked to schizophrenia (6, 7). Also, PRODH is 
regulated by p53 and has been shown to function in tumor suppression (8).   
 PRODH and P5CDH are combined into a single polypeptide chain known as proline 
utilization A (PutA) in Gram-negative bacteria and Corynebacterium (9).  The covalent 
linking of enzymes catalyzing consecutive reactions in a metabolic pathway affords the 
possibility of substrate channeling, i.e., the intermediate is transferred between the 
enzymes without equilibrating with the bulk medium.  Several physiological benefits of 
substrate channeling versus free diffusion have been identified.  For example, channeling 
improves kinetic efficiency by decreasing the transit time between active sites and 
preventing the loss of intermediates (10, 11).  Thus, channeling enzymes can operate at 
maximum rates when cellular substrate concentrations are below saturating levels (12). 
Also, labile intermediates can be concealed from the bulk environment, preventing decay 
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or interaction with other molecules (13, 14). Finally, channeling can influence metabolic 
flux by segregating intermediates from competing pathways (15). 
 Substrate channeling of P5C/GSA in proline catabolism may be necessary to retain 
proper metabolic flux and avoid metabolic futile cycling (14). In addition, free P5C/GSA 
is an inhibitor of three different enzymes in Escherichia coli including glucosamine-6-
phosphate synthase, cytidine 5’-triphosphate synthase, and the amidotransferase domain 
of carbamoyl phosphate synthetase (16-18). P5C has also been shown to form adducts 
with other metabolites such as oxaloacetic acid, pyruvic acid, and acetoacetic acid (19). 
Consistent with the physiological importance of controlling P5C/GSA release, kinetic 
studies have firmly established substrate channeling in PutAs. Early studies of 
Salmonella typhimurium PutA using 
14
C-labeled proline are consistent with a channeling 
mechanism (20). More recent steady-state and rapid reaction transient time measurements 
of PutAs from Bradyrhizobium japonicum (BjPutA) and Geobacter sulfurreducens 
(GsPutA) also indicate substrate channeling (21, 22). Furthermore, a comprehensive 
analysis of the complete kinetic mechanism of E. coli PutA showed that substrate 
channeling is rate limiting, and the rate constant for the channeling step is slowest during 
the first enzyme turnover and increases with subsequent turnovers, establishing PutA as a 
new example of a hysteretic enzyme (23).  
 With the kinetic data firmly demonstrating substrate channeling in PutA, the goal of 
this study is to gain insight into the structural basis of channeling.  The crystal structures 
of BjPutA and GsPutA revealed that the two active sites are separated by a linear distance 
of 41 - 45 Å, implying that substrate channeling involves substantial movement of the 
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intermediate P5C/GSA (21, 22). Analysis of potential channeling pathways predicts a 
curved, 75-Å long tunnel that connects the two active sites (Figure 1).   
 Here we use site-directed mutagenesis, kinetics, and X-ray crystallography to gain 
further insight into the structural features that facilitate substrate channeling in BjPutA. 
Several residues between the two active sites have been mutated in an effort to obstruct 
molecular traffic.  Kinetic and structural analysis of the mutant enzymes shows that 
channeling is hindered in some of the variants but not others, which provides information 
about the pathway traversed by the intermediate. Furthermore, steric considerations 
suggest that GSA is threaded through the tunnel in a linear conformation, with the 
aldehyde group facing the P5CDH end of the tunnel.  This aspect of substrate channeling 
in PutA might be considered an example of shape selective catalysis.   
5.2. Experimental Procedures 
5.2.1 Chemicals  
 All chemicals were purchased from Sigma-Aldrich or Fisher Scientific unless 
otherwise noted.  (DL)-P5C (50/50 mixture) was synthesized according to the method of 
Williams and Frank and stored in 1 M HCl at 4 
o
C. The concentration of (DL)-P5C was 
determined as previously reported (24, 25).  E. coli strain BL21 (DE3) pLysS was 
purchased from Novagen, and DH5α strain was purchased from Invitrogen.  All 
experiments used Nanopure water.  
5.2.2 Site-Directed Mutagenesis  
 Mutagenic primers (Table 1) were purchased from Integrated DNA Technologies or 
Eurofins MWG Operon.  GeneTailor Mutagenesis Kit (Invitrogen) was used to generate 
all mutants except T348Y and D779Y (QuikChange II kit, Agilent Technologies).  
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Mutant plasmids were transformed into DH5α cells, and the resulting plasmids were 
sequenced by Eurofins MWG Operon to confirm the mutations.   
5.2.3 Expression and Purification of BjPutA Proteins  
 BjPutA wild-type and mutant proteins were expressed as reported previously, except 
that induction with isopropyl β-D-1-thiogalactopyranoside was performed at 20 °C for 16 
h (26). Cells were harvested by centrifugation and frozen at -80°C.  Frozen cells were 
resuspended in 50 ml binding buffer (20 mM Tris-base, 0.5 M NaCl, 5 mM imidazole, 
10% glycerol, pH 7.9) and 100 μM flavin at 4°C.  Protease inhibitors ε-amino-N-caproic 
acid (3 mM), phenylmethylsulfonyl fluoride (0.3 mM), leupeptin (1.2 μM), tosyl 
phenylalanyl chloromethyl ketone (48 μM), and tosyllysine chloromethyl ketone 
hydrochloride (78 μM) were added, and cells were disrupted via sonication.  The cell 
lysate was centrifuged for 1 h at 19,000 rpm in a JA-20 rotor (Beckman) and filtered 
through a 0.2 μm filter (VWR).   Cell-free lysate was loaded onto a Ni-NTA Superflow 
resin (Qiagen) equilibrated with binding buffer.  Wash buffer (60 mM imidazole) 
followed by elution buffer (500 mM imidazole) were applied to the column. Elution 
fractions containing PutA protein were pooled and dialyzed into buffer containing 50 mM 
Tris (pH 7.5), 10 mM NaCl, 0.5 mM EDTA, and 10% glycerol and loaded onto an anion 
exchange column (HiTrap Q HP column, GE Life Sciences) equilibrated with dialysis 
buffer.  BjPutA proteins were eluted using a linear 0-1 M NaCl gradient (1 L) in dialysis 
buffer.  Purified enzyme was then dialyzed into a final buffer of 50 mM Tris (pH 7.5), 50 
mM NaCl, 0.5 mM EDTA, 0.5 mM Tris(3-hydroxypropyl)phosphine, and 10 % glycerol. 
The His-tag was retained in the subsequent kinetic experiments. The amount of flavin 
bound in the purified proteins was quantified as described previously (ε451nm = 13.62 mM
-
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1
 cm
-1
 for bound flavin) (26). Protein concentration was determined from the amount of 
bound flavin to normalize for differences in flavin content, and the protein was flash-
frozen in liquid nitrogen and stored at -80 °C.   
5.2.4 Steady-State Kinetic Assays  
 Steady-state kinetic assays were performed at 23 °C.  Kinetic parameters for the 
PRODH domain were determined for proline and ubiquinone-1 (CoQ1) by following 
reduction of CoQ1 at 278 nm (ε278nm = 14.5 mM
-1
 cm
-1
) (Table 2) (27). All assays were 
performed in 50 mM potassium phosphate buffer (pH 7.5) with 0.5 μM PutA enzyme. 
The Km and kcat values for proline were determined by varying proline (1-200 mM) while 
holding CoQ1 constant (250 μM) and CoQ1 kinetic parameters were determined by 
varying CoQ1 (10-350 μM) while holding proline fixed at 150 mM.  Data were collected 
on a Hi-Tech Scientific SF-61DX2 stopped-flow instrument using a 0.15 cm pathlength.  
Initial velocities were fit to the Michaelis-Menten equation using SigmaPlot 12.0. 
 Kinetic parameters of P5CDH activity were determined for P5C/GSA (Table 3) using 
exogenous (DL)-P5C and 0.25 μM PutA enzyme. (DL)-P5C was neutralized with 10 M 
NaOH immediately prior to assays. The concentration of L-P5C is considered to be half 
the total (DL)-P5C concentration. To maintain a constant ionic strength, all assays with 
exogenous (DL)-P5C were performed in 600 mM NaCl as described previously (23). Km 
and kcat for P5C/GSA were determined by varying L-P5C (0.01 - 6 mM) while holding 
NAD
+
 constant at 0.2 mM in 50 mM potassium phosphate (pH 7.5, 600 mM NaCl).  The 
effective concentration of GSA was estimated from the pH dependence of the P5C-GSA 
equilibrium reported previously (16).  Initial velocities were determined by following 
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NAD
+
 reduction at 340 nm (ε340nm = 6200 M
-1
 cm
-1
). All assays were performed using a 
Powerwave XS 96 well plate reader (Biotek).   
 P5CDH activity of BjPutA wild-type and mutants D779A/Y/W using smaller 
aldehyde substrates relative to GSA was tested. All assays were performed in 50 mM 
potassium phosphate (pH 7.5, 25 mM NaCl) containing 0.2 mM NAD
+
 and variable 
concentrations of succinate semialdehyde (0.05-20 mM) and propionaldehyde (5-500 
mM). For assays with succinate semialdehyde, the concentrations of BjPutA wild-type 
and mutant D779A were 0.25 μM while mutants D779W and D779Y were at 1 μM.  For 
propionaldehyde, the concentrations of BjPutA wild-type and mutant D779A were 0.25 
μM, D779W was 1 μM, and D779Y was 2 μM.  Initial velocities were determined by 
following NAD
+
 reduction at 340 nm. All assays were performed using a Powerwave XS 
96 well plate reader (Biotek).   
 The coupled PRODH-P5CDH activity of BjPutA wild-type and mutants was 
monitored by following NADH formation at 340 nm or by fluorescence excitation at 340 
nm and monitoring fluorescence emission at 460 nm using a Cary Eclipse fluorescence 
spectrophotometer. Assays were performed at 23°C in 50 mM potassium phosphate 
buffer (pH 7.5, 25 mM NaCl, 10 mM MgCl2) containing 0.1 mM CoQ1, 0.2 mM NAD
+
, 
40 mM proline, and BjPutA enzyme as previously described (28).   To determine the 
kinetic parameters of the overall PRODH-P5CDH reaction for BjPutA wild-type and the 
D778Y mutant, assays were performed by varying proline (0.1-550 mM) and holding 
CoQ1 (0.1 mM) and NAD
+ 
(0.2 mM) fixed in 50 mM potassium phosphate buffer (pH 
7.5, 25 mM NaCl).  NADH formation was followed at 340 nm.  Data were fitted to a 
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substrate inhibition equation (eq 1) using SigmaPlot 12.0, where [S] is the substrate 
concentration and Ki is the substrate inhibition constant. 
  
       
       (
    
   
)
 (1) 
5.2.5 NAD
+
 binding to BjPutA  
 The binding of NAD
+
 to BjPutA was determined by intrinsic tryptophan fluorescence 
quenching of BjPutA as described (23).  Tryptophan fluorescence was excited at 295 nm 
and fluorescence emission was recorded at 330 nm.  Increasing concentrations of NAD
+
 
(0-20 μM) were added to BjPutA (0.25 μM) in 50 mM potassium phosphate (pH 7.5).  
The inner filter effect caused by the absorption of incident light by NAD
+
 at 295 nm was 
corrected using eq 2. (27) Fcorr and Fobs are the corrected and observed fluorescence, 
respectively, and Aex and Aem are the absorbance values of NAD
+
 at the excitation and 
emission wavelengths, respectively.   
          10
(
 ex  em
2
)
     (2) 
A dissociation constant (Kd) for the BjPutA-NAD
+
 complex was determined by plotting 
the fraction of BjPutA bound by NAD
+
 (θ) versus free [NAD+] using eq 3, where n is 
number of binding sites. 
   
  NAD      
 d   NAD
      
      (3)  
The concentration of free NAD
+
 was determined using eq 4.   
[NAD ]
    
   NAD          BjPutA           (4) 
The value of θ is obtained from the fluorescence measurements 
      
         
, where F0 is 
fluorescence intensity without NAD
+
, F is fluorescence intensity in the presence of 
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NAD
+
, and Fmax is the maximum fluorescence intensity under saturating concentrations of 
NAD
+
.  
 NAD binding to wild-type BjPutA was also estimated by isothermal titration 
calorimetry (ITC).  Titrations were performed at 4°C using a MicroCal VP-ITC 
microcalorimeter. Wild-type BjPutA was dialyzed into a buffer composed of 50 mM Tris 
(pH 7.5), 50 mM NaCl, 0.5 mM EDTA, and 10% glycerol.  A NAD
+ 
stock solution of 0.5 
mM was made in dialysis buffer.  For each titration, 23.4 μM BjPutA was titrated with 2 
μl injections (40 total) of 0.5 mM NAD+ at 160 sec intervals, while stirring at 310 
revolutions per min (rpm).  Data were analyzed using a one-site binding model with 
Origin ITC Analysis software provided with the instrument.    
 Prior to performing the above assays, the amount of NAD
+
 bound to purified BjPutA 
was estimated by HPLC. BjPutA was denatured with 5% vol/vol trichloroacetic acid and 
centrifuged at 13,000 rpm for 5 min to release bound FAD and NAD
+
 cofactors.  Samples 
were then filtered with a 0.45 micron filter before being loaded onto the column.  FAD 
and NAD
+ 
were separated on a C18 column using 50 mM potassium phosphate (pH 5.3) 
and 100% methanol.  The cofactors were eluted using a flow rate of 1 ml/min with 5 min 
of isocratic phosphate buffer, followed by a 25 min linear gradient to 50% methanol, and 
finally a 5 min linear gradient to 75% methanol.  Both cofactors were detected at 280 nm.  
NAD
+ 
and FAD
 
eluted from the column at 7.9 and 16.6 min, respectively.  The 
concentration of NAD
+
 was determined using standard solutions of NAD
+
 (10, 25, 50, 
100, and 200 µM). From this analysis, it was estimated that 74% of purified BjPutA 
contained bound NAD
+
. Thus, the NAD
+
 binding experiments report on the remaining 
26% of BjPutA that purified without NAD
+
 bound.  
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5.2.6 Single-Turnover Kinetic Experiments  
 Single-turnover experiments were performed at 21 
o
C under anaerobic conditions as 
described previously (28).  Briefly, equal volumes of BjPutA enzyme (21.3 μM wild-type 
and 17.9 μM D779Y) were pre-incubated with 0.1 mM NAD+ in 50 mM potassium 
phosphate (pH 7.5, 25 mM NaCl) and rapidly mixed with 40 mM proline in 50 mM 
potassium phosphate buffer (pH 7.5, 25 mM NaCl) (all concentrations reported as final 
concentrations after mixing) (29).  Anaerobic conditions were achieved by degassing 
buffer, substrate, and enzyme solutions by performing repeated vacuum/nitrogen cycles 
followed by addition of protocatechuate dioxgenase (PCD) (0.05 U/mL) and 
protocatechuic acid (PCA) (100 µM), which scrub dissolved oxygen. All enzyme 
manipulations were performed in an anaerobic glovebox (Belle Technology) prior to the 
experiments. Rapid-reaction experiments were performed with a Hi-Tech Scientific SF-
61DX2 stopped flow instrument equipped with a photodiode array detector. The stopped-
flow mixing cell and tubing were thoroughly washed and incubated overnight with 
PCA/PCD buffer before loading stopped-flow syringes with anaerobic substrate and 
enzyme solutions. Multiwavelength data (300-700 nm) were recorded and single 
wavelength traces of FAD (451 nm) and NAD
+
 (340 nm) were extracted and fitted to a 
single exponential equation to estimate observed rate constants for FAD and NAD
+
 
reduction as previously reported (28).  
5.2.7 Crystal Structure Determination and Structure Analysis  
 BjPutA wild-type and mutants were expressed, purified, and crystallized as described 
previously for wild-type BjPutA (30).  Briefly, crystals were grown in sitting drops at 
room temperature in the presence of ~ 2 M ammonium sulfate and cryoprotected with 
121 
 
glycerol. For some of the mutants, microseeding was used with a seed stock made 
initially by crushing crystals of the wild-type enzyme.  Seed stocks made from crystals of 
the mutant enzymes were used in subsequent rounds of crystallization trials.  The space 
group is C2 with a BjPutA dimer in the asymmetric unit.  X-ray diffraction data sets were 
collected at beamline 4.2.2 of the Advanced Light Source using a NOIR-1 detector.  The 
data were integrated with MOSFLM(31) and scaled with SCALA (32). Refinements in 
PHENIX (33) were initiated from models derived from the structure of wild-type BjPutA 
(Protein Data Bank (PDB) entry 3HAZ).  COOT (34) was used for model building.  The 
structures were validated with MolProbity (35) and the PDB (36) validation server. Data 
collection and refinement statistics are listed in Table 5.  
 The substrate-channeling cavity/tunnel system was analyzed and visualized with 
VOIDOO (37), which characterizes cavities,  and MOLE (38, 39),  which finds tunnels 
that connect cavities to the bulk medium. Hydrogen atoms were added to the protein with 
the WHAT IF web services prior to the these calculations (40). VOIDOO was run in 
probe-occupied mode (option O) with a probe radius of 2.9 Å, which approximates 
P5C/GSA.  This radius was chosen based on molecular volume calculations performed 
with VOIDOO; P5C and GSA have volumes of 104 and 124 Å
3
, respectively, which 
correspond to spheres of radii 2.9 and 3.1 Å.  Mole was run with default options and 
using Arg456 of the PRODH active site as the starting point.   
 Models of P5C and GSA were built into the cavity/tunnel system to understand the 
steric relationships and estimate the number of intermediates that the system 
accommodates.  The starting models were downloaded from the NCBI PubChem 
database (compound identification numbers 193305 (GSA) and 11966181 (P5C)).  A 
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model of P5C bound in the BjPutA PRODH active site was built using the structure of 
GsPutA complexed with the proline analog L-tetrahydro-2-furoic acid (PDB code 
4NMA).  A model of GSA bound in the BjPutA P5CDH active site was built using the 
structure of mouse P5CDH complexed with glutamate (PDB code 3V9K).  Models of 
GSA were fitted manually into the tunnel between the two active sites and the off-
pathway cavity.  
5.3. Results 
5.3.1 Rationale for Channel-Blocking Mutagenesis and Purification of BjPutA 
Mutant Enzymes 
 The BjPutA dimer (PDB entry 3HAZ) was analyzed with the PyMOL plug-in 
CAVER (41, 42) and MOLE 2.0 to identify residues lining the cavity/tunnel system that, 
upon mutation to a larger side chain, might eliminate sections of the channeling 
apparatus.  Using starting points in the PRODH site, the programs identified several 
channels leading to the bulk solvent, including some that connect the two active sites 
(Figure 1A).  (Although the tunnel appears to be open to the bulk medium as shown for 
the protomer in Figure 1A, we note that it is buried by the dimerization flap of the 
corresponding protomer in the tetramer that forms in solution.)  This tunnel features a 
prominent central section that runs between and parallel to two helices, the 5a helix of 
the PRODH domain (residues 346-356) and the 770s helix of the P5CDH domain 
(residues 773-785).  Side chains of these helices contribute to the walls of the tunnel. The 
central section is 25 Å in length and 4 – 8 Å in diameter, and can accommodate 2-3 
molecules of GSA (Figure 1B).   
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 Analysis with the program VOIDOO also identifies a cavity that is connected to the 
central section of the predicted tunnel (Figure 1C).  This “off-pathway” cavity has a 
volume of ~700 Å
3
, which is sufficient to accommodate another 2-3 molecules of GSA.      
 Four residues lining the central section of the tunnel were selected for mutagenesis: 
Thr348, Ser607, Asp778, and Asp779.  Thr348 and Ser607 sit near the beginning and end 
of the central section, respectively, while Asp778 and Asp779 are closer to the middle of 
the central section, near the off-pathway cavity (Figure 1B). Each of the targeted residues 
were mutated to Tyr, which retains polarity while increasing steric bulk.  Additionally, 
Asp779 was mutated to Trp and Ala.  The Trp mutation further increases side chain bulk, 
whereas Ala decreases size and removes the functional property of the side chain 
carboxylate.   
 All six BjPutA mutant proteins, T348Y, S607Y, D778Y, and D779Y/W/A were 
purified and shown to have flavin spectra similar to wild-type BjPutA with flavin peak 
absorbances at 380 and 451 nm.  From the flavin absorbance spectra, the percent bound 
flavin was estimated to be 74-99% per monomer for the mutants, which is similar to 79% 
bound flavin for wild-type BjPutA.   
5.3.2 Channeling Assays of BjPutA Mutants  
 The impact of the mutations on channeling was evaluated by measuring coupled 
PRODH-P5CDH activity.  The assay involves monitoring the progress curve of NADH 
production from proline and determining whether an initial lag phase is apparent in 
NADH formation (28). As shown in Figure 2, NADH production by wild-type BjPutA 
does not exhibit a perceptible lag time, which is consistent with channeling. The progress 
curves of NADH formation with BjPutA mutants T348Y, S607Y, D778Y, and D779A 
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likewise show no substantial lag phase indicating that substrate channeling is unperturbed 
in these mutants (Figure 2). The linear rate of NADH formation achieved with these 
mutants is similar to wild-type (~ 1.4 µM/min) at the same enzyme concentration (0.187 
μM). No significant NADH formation, however, was observed with the BjPutA mutants 
D779Y and D779W (Figure 2).  
 Mutants D779Y and D779W were then assayed using up to 10-fold higher 
concentration of enzyme (1.87 μM) and fluorescence spectroscopy to detect NADH 
formation (Figure 3).  Increasing D779Y concentration to 10-fold higher than wild-type 
BjPutA (0.187 μM) resulted in a similar rate of NADH formation suggesting that the 
coupled PRODH-P5CDH activity of D779Y is about 10-fold lower than wild-type 
BjPutA (Figure 3A). At 10-fold higher D779W, NADH formation remained very slow 
indicating that the D779W mutant is severely impaired (Figure 3B). 
5.3.3 Steady-state Kinetic Properties of BjPutA Wild-type and Mutants  
 The PRODH and P5CDH kinetic parameters were then determined for BjPutA wild-
type and the mutants. The steady-state kinetic parameters of the PRODH domain were 
determined using proline and CoQ1 as substrates (Table 2). Similar kcat/Km values (within 
~ two-fold) were found for BjPutA wild-type and all the mutants except for D778Y.  
D778Y exhibited comparable Km values for proline (91 mM) and CoQ1 (82 μM), but the 
kcat value was nearly 9-fold lower than wild-type BjPutA resulting in a significantly lower 
kcat/Km. This result was unexpected because D778Y exhibited similar activity to that of 
wild-type BjPutA in the channeling assays (Figure 2).   
 The P5CDH kinetic parameters were also determined for BjPutA wild-type and 
mutants (Table 3).  The kcat/Km values for P5CDH activity in the mutants were similar to 
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wild-type BjPutA except for mutants D779Y and D779W. The kcat/Km values for D779Y 
and D779W were 81-fold and 941-fold lower than wild-type BjPutA. To determine 
whether perturbations in NAD
+
 binding account for the severe loss in P5CDH activity, 
NAD
+
 binding was measured for wild-type BjPutA and the mutants (Table 3). For wild-
type BjPutA, dissociation constants (Kd) of 0.6 μM and 1.5 uM were determined by 
intrinsic tryptophan fluorescence quenching (Figure 4A) and ITC (Figure 4B), 
respectively. The Kd values of NAD
+
 binding to the BjPutA mutants were shown by 
intrinsic tryptophan fluorescence quenching to be similar to wild-type BjPutA (Table 3). 
Thus, NAD
+
 binding is unchanged in the mutants suggesting that the severe decrease in 
P5CDH activity of D779Y and D779W is not caused by alterations in the Rossmann fold 
domain. 
5.3.4 Single Turnover Rapid-reaction Kinetics  
 To further corroborate impaired channeling activity in the D779Y mutant, single 
turnover experiments were performed anaerobically without an electron acceptor for the 
flavin cofactor. In this experiment, PutA enzyme and NAD
+
 were rapidly mixed with 
proline and the absorbance spectrum was recorded (Figure 5). Observed rate constants for 
FAD reduction and NADH formation were estimated by single exponential fits of 
absorbance changes at 451 nm and 340 nm, respectively. The observed rate constant for 
FAD reduction was faster for the BjPutA mutant D779Y (0.46 s
-1
) than wild-type BjPutA 
(0.18 s
-1
).  In contrast, the observed rate constant for NADH formation is 10-fold slower 
in D779Y (0.003 s
-1
) relative to wild-type BjPutA (0.03 s
-1
) consistent with severely 
impaired P5CDH activity.  
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5.3.5 Alternative P5CDH Substrates  
 The potential tunnel constriction in the mutants D779Y/W was explored by 
measuring P5CDH activity with smaller aldehyde substrates.  Table 4 shows the kinetic 
parameters of BjPutA wild-type and mutants D779A/Y/W with exogenous GSA/P5C and 
smaller substrates succinate semialdehyde and propionaldehyde.  Succinate semialdehyde 
contains one less carbon and no amino group, whereas propionaldehyde is a three-carbon 
aldehyde.  The kcat/Km values were significantly lower for each enzyme using the smaller 
substrates (Table 4).  To assess whether succinate semialdehyde and propionaldehyde are 
more effective substrates in the mutants relative to P5C/GSA, the kcat/Km ratio of wild-
type BjPutA and each mutant (kcat/Km (WT)/kcat/Km (mut)) was determined for all the 
substrates.  For D779A, the kcat/Km (WT)/kcat/Km (mut) ratio remained ~ 1 with each substrate. 
For the mutants D779Y and D779W, the ratios of kcat/Km (WT)/kcat/Km (mut) were 81 and 
941, respectively, with P5C/GSA. The kcat/Km (WT)/kcat/Km (mut) ratios decreased to 30 
(D779Y) and 38 (D779W) with succinate semialdehyde, suggesting that relative to 
GSA/P5C this smaller substrate more readily accesses the P5CDH active site in the 
mutants D779Y and D779W. A further decrease in the kcat/Km (WT)/kcat/Km (mut) ratio, 
however, was not observed with propionaldehyde.  
5.3.6 Crystal structures of D778Y, D779Y, and D779W  
 The structures of D778Y, D779Y, and D779W were determined at 2.2 – 2.3 Å 
resolution (Table 5).  The electron density features representing the mutated side chains 
are strong in all three mutant enzymes (Figure 6A, B, C).The mutations induce rotations 
of neighboring side chains but otherwise have minimal impact on the protein structure 
(Figure 6D).  In the wild-type enzyme structure, Asp778 and Arg200 are within 2.8 Å of 
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each other and form an ion pair; the mutation of Asp778 to the larger Tyr would result in 
steric clash in the absence of conformational changes.  Clash is avoided because Tyr778 
has rotated by 100° around 1 relative to Asp778 of the wild-type enzyme.  This 
movement is accompanied by rotation of Arg200 into the space occupied by the 
carboxylate of Asp778 in the wild-type enzyme.  In contrast to D778Y, mutation of 
Asp779 to Tyr or Trp does not change1.  Nevertheless, these mutations cause rotations 
of His919 and Gln775 to avoid steric clash with the new, bulkier side chain at residue 
779 (Figure 6D).  Aside from these local perturbations, no other significant structural 
changes are evident.  In particular, the active site structures are essentially unchanged.  
 Mutation of Asp778 to Tyr substantially changes the off-pathway cavity located near 
the central section of the predicted channeling pathway.  Asp778 borders this cavity in 
wild-type BjPutA (Figure 1C).  Because of the aforementioned 100° rotation around1, 
the phenol ring of Tyr778 invades the space corresponding to the off-pathway cavity of 
the wild-type enzyme (Figure 7).  The presence of Tyr778 in this region reduces the 
volume of the cavity by 70 % to 200 Å
3
, so that just a residual cavity remains (Figure 7, 
blue surface).  Furthermore, the close approach of Tyr778 to Arg356 severs the 
connection between the cavity and the predicted channeling tunnel (using a 2.9 Å probe).  
Thus, the structure suggests that P5C/GSA molecules that are moving through the tunnel 
of D778Y cannot enter the off –pathway cavity.   
 In contrast to D778Y, the mutation of Asp779 to Tyr constricts the predicted 
channeling tunnel without affecting the off-cavity pathway (Figure 8).  The side chain of 
Tyr779 pokes into the space corresponding to the central section of the tunnel in the wild-
type enzyme (Figure 8A).  As a result, the predicted tunnel of D779Y has a 2.0-Å 
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invagination near the phenol hydroxyl (Figure 8B).  This narrowing of the tunnel reflects 
a decrease in distance between the 770s and 5a helices.  In particular, the distance 
between the side chains of residue 779 and Lys351 decreases from 9.3 Å in the wild-type 
enzyme to only 6.8 Å in D779Y.  Thus, the gap between these side chains decreases by 
about 2.5 Å, which accounts for the invagination of the tunnel near Tyr779.  
 The mutation of Asp779 to Trp similarly reshapes the predicted channeling tunnel 
(Figure 9). As in D779Y, the bulky side chain of Trp779 penetrates the space 
corresponding to the tunnel in the wild-type enzyme (Figure 9A).  Also, Gln775, which 
has rotated relative to the wild-type enzyme, protrudes into the tunnel just upstream from 
Trp779.  The invasion of these residues into the tunnel reshapes the predicted channeling 
pathway, essentially shaving a 2 Å slice off one side of the tunnel (Figure 9B).  
5.4. Discussion 
 Introducing residues with bulkier side chains in a predicted channeling path is a 
useful approach for validating substrate channeling and exploring the structural 
architecture of an interconnecting path between active sites. In tryptophan synthase, 
substitution of βCys170 with Trp in the tunnel pathway significantly hindered passage of 
the indole intermediate between active sites and also impacted communication between 
subunits (43). In the bifunctional enzyme dethiobiotin synthetase (DTBS)-
diaminopelargonic acid aminotransferase (DAPAT-AT) from Arabidopsis, two mutations 
were made in a crevice on the surface connecting the two active sites (44).  The surface 
crevice was proposed to be a channel pathway for movement of the intermediate from 
DAPA-AT to DTBS.  Mutation of two crevice residues, Ser360 to Tyr and Ile793 to Trp 
resulted in long lag times (~ 10-12 min) for product formation, whereas no lag phase was 
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observed with the wild-type enzyme. These results were consistent with the predicted 
function of the crevice as a channeling path.  
 Here, we substituted four residues at different points along the predicted channeling 
path in BjPutA with bulkier side chains. Although Thr348 and Ser607 are located at 
apparent bottleneck regions and Asp778 points toward the middle of the channel, Tyr 
substitutions of these residues did not impact PRODH-P5CDH channeling activity in 
BjPutA. Only replacement of Asp779 with Tyr or Trp disrupted coupled PRODH-
P5CDH activity. Substitution of Asp779 with Ala did not diminish channeling, indicating 
that the carboxylate group of Asp779 is not critical for channel function. The decrease in 
substrate channeling activity of the D779Y/W mutants correlates with a significant drop 
in P5CDH activity whereas the PRODH activity of the mutants is similar to wild-type 
BjPutA. The X-ray crystal structures of the D779Y/W mutants show that the PRODH and 
P5CDH domains are essentially unchanged from wild-type BjPutA. The only structural 
perturbations are in the side chain conformations of residues near Asp779. Thus, the 
severely impaired substrate channeling and P5CDH activities of the D779Y/W mutants 
are likely caused by local effects of substituting a larger side chain in the channel. 
Replacing Asp779 with Tyr decreased the internal width of the predicted channeling path 
between the 770s and 5a helices by 2.5 Å or ~ 25%. In D779W, the Trp residue carves 
into the channel by 2.0 Å. These changes result in a narrowing of the tunnel that is 
sufficient to disrupt substrate channeling and illustrates that the channel structure is finely 
tuned for transporting P5C/GSA. The results with D779Y/W also validate the tunnel in 
BjPutA identified by X-ray crystallography as the path for channeling the P5C/GSA 
intermediate. 
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 An outstanding question in PutA enzymes is how P5C/GSA accesses the P5CDH 
active site. Because the X-ray crystal structures of D779Y/W show no changes in the 
P5CDH active site relative to wild-type BjPutA, the significantly lower P5CDH activity 
of the D779Y/W mutants indicates exogenous P5C enters the tunnel upstream of Asp779 
possibly via the PRODH active site. If P5C/GSA were able to enter the P5CDH active 
site from a point downstream of Asp779, the P5CDH activity of the D779Y/W mutants 
would be expected to be similar to the wild-type enzyme. These results indicate that 
exogenous P5C/GSA must access the P5CDH domain through the channel. The kinetic 
results using smaller aldehydes as exogenous substrates are consistent with this 
interpretation. Although the activity of D779W with succinate semialdehyde is still lower 
than wild-type BjPutA, the difference in kcat/Km between wild-type BjPutA and D779W is 
reduced by 25-fold relative to GSA.   
 Even though it neighbors Asp779, replacing Asp778 with Tyr did not diminish the 
substrate channeling and P5CDH activities of BjPutA. Similar to the D779Y/W mutants, 
the X-ray crystal structure of D778Y shows no changes in the PRODH and P5CDH 
domains as only perturbations in local residues of the channel were observed. Introducing 
a bulkier side chain at Asp778 appears to close the off-pathway cavity from the main 
channeling path. The coupled PRODH-P5CDH activity of the D778Y mutant is similar to 
wild-type BjPutA demonstrating that the off-pathway cavity is not required for substrate 
channeling. The function of the off-cavity pathway in substrate channeling thus remains 
unknown. An interesting finding with the D778Y mutant was its significantly lower 
PRODH activity. This result may provide additional evidence of a communication link 
between the PRODH domain and the channel. Recently we have shown in PutA from E. 
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coli that a substrate channeling step becomes activated during enzyme turnover thereby 
increasing overall PRODH-P5CDH activity by nearly 40-fold (23). PutA also undergoes 
a conformational change upon flavin reduction, with a conserved ion pair (Arg456-
Glu197) proposed to act as a gate between the PRODH domain and the main channeling 
pathway (28, 45). Residues that are critical for communication between the PRODH 
domain and the channel are unknown, but the findings with D778Y suggest that the 770s 
helix may be involved. Despite having 9-fold lower PRODH activity, D778Y exhibited 
similar substrate channeling activity to that of wild-type BjPutA consistent with the rate 
of the coupled PRODH-P5CDH reaction being limited by a channeling step as found 
previously for E. coli PutA (23).   
 Structural analysis of the channeling path in BjPutA provides new insight into how 
P5C/GSA is shuttled between the PRODH and P5CDH active sites. Our results suggest 
that the off-pathway cavity is dispensable for channeling, which implies that the 
intermediate is constrained to travel through the cylindrical middle section of the tunnel 
that runs parallel to the α5a and 770s helices (Figure 1B).  The dimensions of this section 
are consistent with a maximum of 2-3 intermediates simultaneously occupying the 
middle section.  Furthermore, since the tunnel diameter is similar to the length scales of 
P5C and GSA, rotational and torsional motions of the intermediates are constrained.  In 
particular, it is unlikely that P5C or GSA can flip orientation while in the tunnel, and 
torsional motion of GSA is probably restricted.  Thus, if the hydrolysis reaction occurs 
upstream of the P5CDH active site, GSA likely travels through the tunnel with the 
aldehyde group directed toward the P5CDH active site, as shown in Figure 1B.   
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Potentially the amino and carboxylic groups of GSA may have a critical role in properly 
directing its movement and orientation in the tunnel.  
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Schemes 
 
 
Scheme 5.1.  Overall reaction catalyzed by proline utilization A (PutA).  Flavin-
dependent proline dehydrogenase (PRODH) catalyzes the oxidation of proline to Δ1-
pyrroline-5-carboxylate (P5C).  P5C undergoes a non-enzymatic hydrolysis, resulting in 
glutamate-γ-semialdehyde (GSA). GSA is oxidized to glutamate by P5C dehydrogenase 
(P5CDH) using an NAD
+
 cofactor. 
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Table 5.1.  Primers used for Site-Directed Mutagenesis 
Mutant Primers 
T348Y 
Fwd 5’-GCGCCTATTGGGACTACGAGATCAAGCGCGCG-3’ 
Rev 5’-CGCGCGCTTGATCTCGTAGTCCCAATAGGCGC-3’ 
S607Y  
Fwd 5’-AGACGCTCGACGATGCGCTCTATGAGCTGCGCG-3’ 
Rev 5’-GAGCGCATCGTCGAGCGTCTTGCCGCCCTCG-3’ 
D778Y  
Fwd 5’-GCTGCCGGAGCAGGTCGCCTACGACGTTGTCACC-3’ 
Rev 5’-GGCGACCTGCTCCGGCAGCGCGGTGGCATCG-3’ 
D779A  
Fwd 5’-TGCCGGAGCAGGTCGCCGACGCCGTTGTCACCTCC 3’ 
Rev 5’-GTCGGCGACCTGCTCCGGCAGCGCGGTGGC-3’ 
D779W  
Fwd 5’-TGCCGGAGCAGGTCGCCGACTGGGTTGTCACCTCC-3’ 
Rev 5’-GTCGGCGACCTGCTCCGGCAGCGCGGTGGC-3’ 
D779Y 
Fwd 5’-CCGGAGCAGGTCGCCGACTACGTTGTCACCTCCGC-3’ 
Rev 5’-GCGGAGGTGACAACGTAGTCGGCGACCTGCTCCGG-3’ 
 
 
 
  
Table 5.2.  PRODH Kinetic Parameters 
 Proline
a
 CoQ1
b
 
BjPutA Km (mM) kcat (s
-1
) 
kcat/Km (M
-1
 s
-
1
) Km (μM) kcat (s
-1
) 
kcat/Km (M
-1 
s
-1
) 
wild-
type 
43 ± 5 3.1 ± 0.1 72 ± 8.6 105 ± 6 2.9 ± 0.1 27619 ± 
1713 
T348Y 30 ± 2 1.8 ± 0.1 60 ± 4.0 59 ± 2 1.9 ± 0.1 32203 ± 
1204 
S607Y 46 ± 6 1.6 ± 0.1 35 ± 4.8 131 ± 16 2.0 ± 0.1 15267 ± 
1987 
D778Y 91 ± 38 0.36 ± 
0.07 
4.0 ± 1.8 82 ± 15 0.33 ± 
0.02 
4024 ± 775 
D779A 56 ± 7 1.8 ± 0.1 32 ± 4.2 188 ± 22 2.5 ± 0.1 13297 ± 
1725 
D779Y 43 ± 2 2.7 ± 0.1 63 ± 3.1 56 ± 2 3.1 ± 0.1 55357 ± 
2102 
D779W 30 ± 4 1.9 ± 0.1 63 ± 8.6 109 ± 12 2.3 ± 0.1 21100 ± 
2593 
a
1-200 mM proline, 250 μM CoQ1, 0.5 μM enzyme, 50 mM potassium phosphate (pH 
7.5) 
b
150 mM proline, 10-350 μM CoQ1, 0.5 μM enzyme, 50 mM potassium phosphate (pH 
7.5) 
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Table 5.3. P5CDH Kinetic and NAD
+
 Binding Parameters 
BjPutA kcat (s
-1
)
a
 Km (mM)
a
 kcat/Km (M
-1
 s
-1
) Kd (μM, 
NAD
+
)
b
 
wild-type 3.4 ± 0.1 0.42 ± 0.04 8095 ± 822 0.60 ± 0.04 
T348Y 4.2 ± 0.2 0.42 ± 0.04 10000 ± 1017 0.75 ± 0.06 
S607Y 4.5 ± 0.2 0.48 ± 0.03 9375 ± 664 1.00 ± 0.04 
D778Y 3.8 ± 0.1 0.38 ± 0.02 10000 ± 567 0.67 ± 0.04 
D779A 5.0 ± 0.1 0.38 ± 0.03 13157 ± 1102 0.64 ± 0.05 
D779Y 0.02 ± 0.01 0.20 ± 0.03 100 ± 16 0.65 ± 0.04 
D779W 0.003 ± 0.001 0.35 ± 0.15 8.6 ± 4 0.78 ± 0.05 
a
0.01-6 mM L-P5C, 0.2 mM NAD
+, 0.25 μM enzyme, 50 mM potassium phosphate (pH 
7.5, 600 mM NaCl) 
b
from fluorescence quenching with 0.1-25 μM  NAD+, 0.25 μM enzyme, 50 mM 
potassium phosphate (pH 7.5) 
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Table 5.4. X-ray Diffraction Data Collection and Refinement
a
 
 D779W D779Y D778Y 
space group C2 C2 C2 
unit cell parameters (Å, °) a = 166.9 
b = 195.3 
c = 108.8 
 = 121.6 
a = 167.1 
b = 196.0 
c = 108.7 
 = 121.4 
a = 166.1 
b = 195.1 
c = 108.4 
 = 121.5 
wavelength (Å) 1.000 1.000 1.000 
diffraction resolution (Å) 32.0 - 2.20     
(2.32 - 2.20) 
32.0 – 2.30 
(2.42 – 2.30) 
46.9 - 2.30 
(2.42 - 2.30) 
no. of observations 549668 490658 485882 
no. of unique reflections 149604 130815 130019 
Rmerge(I) 0.106 (0.464) 0.103 (0.515) 0.095 
(0.524) 
Rmeas(I) 0.124 (0.556) 0.120 (0.602) 0.112 
(0.612) 
Rpim(I) 0.063 (0.302) 0.061 (0.310) 0.058 
(0.314) 
mean I/σ 6.8 (2.1) 8.1 (2.2) 10.0 (2.5) 
completeness (%) 99.9 (99.3) 99.3 (98.8) 99.9 (100) 
multiplicity 3.7 (3.3) 3.8 (3.6) 3.7 (3.8) 
no. of protein chains 2 2 2 
no. of protein residues 1943 1943 1941 
no. of protein atoms 14390 14386 14490 
no. of FAD atoms 106 106 106 
no. of water molecules 531 296 419 
no. of sulfate ions 6 6 8 
no. of glycerol molecules 4 3 4 
Rcryst 0.208 0.216 0.195 
Rfree
b 
0.241 0.251 0.235 
rmsd bond lengths (Å)
 
0.008 0.008 0.009 
rmsd bond angles (deg.) 1.102 1.107 1.106 
Ramachandran plot
c 
   
favored (%) 98.8 98.1 98.1 
outliers (residues) 2 2 0 
average B-factors (Å
2
)    
protein 31.5 38.9 34.5 
FAD 20.0 29.3 25.2 
water 28.5 31.8 30.4 
sulfate 61.4 67.6 74.3 
glycerol 36.5 47.3 45.3 
coordinate error (Å)
d 
0.27 0.31 0.28 
PDB accession code 4Q71 4Q72 4Q73 
a
Values for the outer resolution shell of data are given in parenthesis.  
b
5 % random test set.  A common set was used for refinement of all structures.  
c
The Ramachandran plot was generated with RAMPAGE.(46) 
d
Maximum likelihood-based coordinate error estimate reported by PHENIX. 
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Figures and Legends 
Figure 5.1.  The tunnel/cavity system of BjPutA. (A) BjPutA protomer with PRODH in 
blue, P5CDH in pink, and oligomerization flap in green.  The FAD and NAD
+
 are shown 
in yellow and green sticks, respectively.  Catalytic Cys792 of the P5CDH active site is 
indicated.  The gray surface represents the predicted channeling pathway calculated with 
MOLE. The 5a and 770s helices are colored gold and cyan, respectively.  We note that 
in a tetramer of BjPutA, the dimerization flap of one protomer covers the tunnel of the 
other protomer.  (B) Details of the predicted channeling pathway.  The predicted path 
from MOLE is shown in mesh.  Models of P5C and GSA in the tunnel are shown for 
scale (green).  (C) Another view of the tunnel/cavity system, with the predicted 
channeling tunnel calculated from MOLE in gray mesh and the off-pathway cavity 
calculated using VOIDOO in red mesh.  
 
Figure 5.2.  Channeling assays of BjPutA wild-type and mutants. Assays were performed 
in 50 mM potassium phosphate (pH 7.5, 25 mM NaCl, 10 mM MgCl2) with 0.187 µM 
BjPutA enzyme, 40 mM proline, 100 μM CoQ1, and 200 μM NAD
+
.  
 
Figure 5.3.  Channeling assays with increasing concentrations of D779Y (A) and D779W 
(B).  NADH formation was monitored using fluorescence by exciting at 340 nm and 
recording the emission at 460 nm.  Assays were performed with BjPutA wild-type (0.187 
µM) and increasing concentration of mutants (0.187-1.87 μM) in 50 mM potassium 
phosphate (pH 7.5, 25 mM NaCl, 10 mM MgCl2) containing 40 mM proline, 100 μM 
CoQ1, and 200 μM NAD
+
. 
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Figure 5.4. NAD
+
 binding to BjPutA. (A) Wild-type BjPutA (0.25 μM) was titrated with 
increasing concentrations of NAD
+
 (0-20 μM NAD+) in 50 mM potassium phosphate 
buffer (pH 7.5). Inset is a plot of the change in tryptophan fluorescence versus NAD
+
 
fitted to a single site binding isotherm. A Kd value of 0.60 ± 0.04 μM was estimated for 
NAD
+
-BjPutA. (B) ITC analysis of NAD
+
 binding to wild-type BjPutA. Upper panel is 
the raw data of wild-type BjPutA (23.4 μM) titrated with increasing amounts of NAD+ in 
50 mM Tris buffer (pH 7.5). Lower panel is the integration of the titration data. The 
binding of NAD
+
 to BjPutA is shown to be exothermic and a best fit of the data to a 
single site binding isotherm yielded a Kd value of 1.5 ± 0.2 μM. 
 
Figure 5.5. Electron density maps and local conformational changes. (A) Electron 
density map for D778Y. (B) Electron density map for D779Y. (C) Electron density map 
for D779W. (D) Superposition of BjPutA (gray), D778Y (gold), D779Y (cyan), and 
D779W (magenta). The cages in panels A-C represent simulated annealing σA-weighted 
Fo - Fc omit maps contoured at 2.5 σ.    
 
Figure 5.6. Constriction of the channeling tunnel by Tyr779 in D779Y. (A) The gray 
cylinder represents the channeling pathway calculated from the wild-type BjPutA 
structure (PDB code 3HAZ) using MOLE, and the view is from the P5CDH active site 
looking through the tunnel toward the PRODH site.  (B) Comparison of the predicted 
channeling pathway of wild-type BjPutA (gray surface) and D779Y (red mesh).  
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Figure 5.7. Constriction of the channeling tunnel by Trp779 in D779W. (A) The gray 
cylinder represents the channeling pathway calculated from the wild-type BjPutA 
structure (PDB code 3HAZ) using MOLE, and the view is from the P5CDH active site 
looking through the tunnel toward the PRODH site.  (B) Comparison of the predicted 
channeling pathway of wild-type BjPutA (gray surface) and D779W (red mesh). 
 
Figure 5.8. Constriction of the channeling tunnel by Trp779 in D779W. (A) The gray 
cylinder represents the channeling pathway calculated from the wild-type BjPutA 
structure (PDB code 3HAZ) using MOLE, and the view is from the P5CDH active site 
looking through the tunnel toward the PRODH site.  (B) Comparison of the predicted 
channeling pathway of wild-type BjPutA (gray surface) and D779W (red mesh). 
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Fig 5.2. 
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Fig 5.3. 
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Fig 5.4. 
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Fig 5.5. 
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Chapter 6: 
Understanding Access to an Internal Cavity Discovered in 
Bradyrhizobium japonicum Proline Utilization A (PutA)  
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Abstract 
 The two step oxidation of proline to glutamate is catalyzed through two enzymes, 
proline dehydrogenase (PRODH) which catalyzes the oxidation of proline to Δ1-
pyrroline-5-carboxylate (P5C) and P5C dehydrogenase (P5CDH) which catalyzes the 
oxidation of glutamic γ-semialdehyde (GSA) to glutamate using NAD+ as a cofactor. 
GSA and P5C exists in a pH dependent equilibrium with one another. In Gram-negative 
bacteria, these two enzymes are fused together into a single, bifunctional enzyme known 
as proline utilization A (PutA). The structure of PutA from Bradyrhizobium japonicum 
(BjPutA) has been solved previously and the structure illuminated the enzyme housing a 
large internal cavity. In conjunction with kinetic experiments, this cavity was proposed as 
a channel that moved the intermediate between the two active sites. Access to this 
channel for the intermediate from the PRODH domain was proposed to be modulated by 
an ion pair gate (R456-E197). Here we show that reduction of the flavins by proline 
breaks this ion pair and opens the gate, allowing access to the cavity. Further, disruption 
of the ion pairs via mutations severely hurts enzyme function (E460A and E197A) or 
completely kills it (R456M). Destruction of the ion pair also induces large 
conformational changes in the important helix 8, implicated in large movements between 
the closed and opened states.  
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6.1. Introduction 
 The proline catabolism pathway catalyzes the two-step oxidation of proline to 
glutamate (Scheme 1). Proline dehydrogenase (PRODH) catalyzes the first oxidation by 
transferring 2 electrons, in the form of H
-
, from proline to the FAD cofactor. The product, 
Δ1-pyrroline-5-carboxylate (P5C), goes through a non-enzymatic hydrolysis to glutamate-
γ-semialdehyde (GSA). GSA is the substrate for the NAD+-dependent P5C 
dehydrogenase (P5CDH), which catalyzes the final oxidation to glutamate. 
 In Gram-negative bacteria PRODH and P5CDH are combined into a single, 
bifunctional enzyme known as proline utilization A (PutA) (1). The original full length 
structure of the enzyme showed the presence of an internal, water filled cavity linking the 
two active sites together (2). An internal cavity connecting the two active sites is 
indicative of substrate channeling which is the transfer of an intermediate between two 
active sites without equilibration to the bulk solvent (3). Channeling provides an increase 
in kinetic efficiency by providing a direct path between active sites and eliminating 
diffusion into the surrounding environment, resulting in a decrease in transit time (4). As 
seen in dimethylglycine oxidase (DMGO) reactive intermediates cannot be allowed to 
diffuse to bulk solvent without devastating results (5). Enzymes, such as DMGO, utilize 
channels to prevent intermediate escape (6-8). 
 P5C/GSA release needs to be tightly controlled as free P5C is a known inhibitor 
of three separate enzymes in Escherichia coli, cytidine 5’-triphosphate synthase, the 
amidotransferase domain of carbamoyl phosphate synthase, and glucosamine-5-
phosphate synthase (9-11). It is also known to form adducts with important metabolites 
such as pyruvic acid (12). Such a volatile and interactive intermediate needs control and 
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indeed initial studies monitoring production with a 
14
C-labeled proline of Salmonella 
typhimurium PutA hinted at the idea of substrate channeling (13). More recent studies 
using Bradyrhizobium japonicum (BjPutA) and Geobacter sulfurreducens (GsPutA) have 
further cemented the idea of substrate channeling (2, 14). Further, a complete kinetic 
mechanistic analysis was performed on E. coli PutA and brought to light PutA as a 
hysteretic enzyme, with the first turnover being slower than subsequent turnovers (15). 
 The kinetic analysis clearly establishes that transfer of the intermediate happens 
through a substrate channeling mechanism. Both structures of BjPutA and GsPutA 
indicate an internal cavity separated from the PRODH active site by a conserved ion pair 
between an arginine and glutamate (R456 and E197 in BjPutA) (2, 14). The initial 
hypothesis put forward was that this ion pair acts as a gate that closes upon proline 
binding and opens to release the product P5C into the internal cavity. The GsPutA 
oxidized and reduced structures confirmed this by providing snap shots of an open and 
closed form of the gate, which is a common mechanism seen in tryptophan synthase, 
glutamine amidotransferase, and glucosamine-6-phosphate synthase (16-18). A BjPutA-
lactate structure (unpublished) has shown that a second ion pair between E460 and R457 
also forms during substrate binding. Sequence alignments have also revealed a conserved 
glycine (G196) before the conserved glutamate (E197) involved in the gate acting ion-
pair. The GE is seen in bifunctional and trifunctional PutAs but also the monofunctional 
PRODH (19). 
 The original hypothesis of a gating mechanism facilitating entrance into the 
internal cavity is established in GsPutA (14). Here we study the reduction of the oxidized 
BjPutA enzyme using the natural substrate, proline. Also, disruption of the two ion pairs 
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via mutations is analyzed to determine their influence on substrate binding and the gating 
mechanism. This study utilizes mutation, kinetic, and X-ray crystallography to gain 
further insight into how conformational changes in the PRODH domain allow access to 
the cavity. Proline soaking of the crystals is performed to monitor conformational 
changes that occur when the active enzyme interacts with the real substrate. The ion pairs 
have been disrupted with mutations in an effort to establish their role in substrate binding 
and movement into the cavity. Kinetic and structural analysis of the mutant enzymes 
shows large changes to the helix 8 that highlight their role in stability of the PRODH 
active site. 
6.2. Materials and Methods 
6.2.1 Cloning and PCR 
Mutagenic primers were purchased from Integrated DNA Technologies. 
QuikChange II kit (Agilent Technologies) was used to generate all mutants. Mutant 
plasmids were transformed into DH5α cells, and the resulting plasmids were sequenced 
by DNA Core facilities to confirm the mutations. Plasmid was purified from DH5α cells 
using the QIAprep Spin miniprep Kit (Qiagen) and the plasmid was stored at -20 °C. The 
plasmid, pKA8H, contains an N-terminal His tag that is cleavable with Tobacco Etch 
Virus protease (TEVP). 
6.2.2 Protein Expression and Purification  
Plasmid was retransformed into BL21DE3(pLysS) cells, plated on LB Agar 
plates, and incubated at 37 °C for about 12 hours. Afterwards they were removed from 
incubation and stored at 4 °C. Single colonies were picked and used in about 10 mL of 
LB Broth for a starter culture and allowed to grow overnight. The starter culture was used 
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to inoculate 1 L of LB Broth and then put in a shaker at 37 °C and 250 rpm. When the 
cells reached an OD600 of about 0.8, the cultures were induced with 50 µM isopropyl β-
D-1- 
Thiogalactopyranoside (IPTG) and the temperature reduced to 20 °C and rpm dropped to 
200(20). The cells were then incubated for another 16 hours at the lower temperature. 
Cells were harvested by centrifugation, resuspended in 50 mM HEPES, 150 mM NaCl 
and 5% glycerol at a pH of 8.0, and flash frozen at -80 °C. 
 Frozen cells were thawed and 0.3 mM protease inhibitor 
phenylmethanesulfonylfluoride (PMSF) was added. The cells were disrupted via 4 rounds 
of sonication, with each round consisting of 30 seconds of use, and then 2 minutes to cool 
down. The cell lysate was centrifuged for 1 hour at 16,500 rpm in a SS-34 rotor.  
 The supernatant was decanted off and filtered through a 0.2 µm filter. This 
filtered cell lysate was loaded onto a Ni-NTA column equilibrated with 20 mM HEPES, 
50 mM NaCl and 5% glycerol at pH 8.2. The column was washed with the same buffer 
with 30 mM imidazole to remove impurities and then 300 mM imidazole at which point 
the protein eluted off the column. Fractions were collected in 2 mL aliquots. The 
fractions were pooled and TEV protease was added to the pooled fractions at a final 
concentration of 1 mg/mL. The enzyme was allowed to incubate with TEVP for about an 
hour and a half at 28 °C. After, the enzyme was placed in a dialysis buffer containing 20 
mM HEPES, 150 mM NaCl, and 5% glycerol at 4 °C overnight. The following day the 
enzyme was removed and loaded back onto a Ni-NTA column equilibrated with the same 
binding buffer as before. Again the column was washed with 30 mM imidazole, at which 
point the enzyme eluted and fractions were collected in 2 mL aliquots. The fractions were 
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tested for purity on SDS-PAGE. The fractions were determined to be pure, pooled, and 
placed in dialysis of the pre-crystallization buffer containing 50 mM TRIS, 0.5 mM 
EDTA, 150 mM NaCl, 0.5 mM THP, and 5% glycerol at pH 7.5 at 4 °C overnight. 
 After removing from dialysis, protein concentration was checked using the BCA 
method. Centrifugal filters (Millipore) with a 30 kDa pore size membrane were used to 
increase the concentration to 8 mg/mL which was verified again using the BCA method. 
6.2.3 Protein Crystallization  
Crystallization of mutant BjPutAs occurred in similar conditions as described for 
BjPutA previously (21). Crystals were grown in sitting drops at room temperature in the 
presence of 1.7-2.1 M ammonium sulfate and Tris buffer at pH 7.5-9.0. Microseeding 
was performed with a seed stock made from crushing wild-type enzyme crystals, and 
vortexing the samples from there. All mutants used a 100-fold dilution of the seed stock 
to achieve maximum crystal growth(22). Subsequent optimizations utilized the crystals of 
the respective mutants grown at room temperature with a seed stock prepared in the same 
manner. Crystals were cryoprotected in 25-30% glycerol and then flash cooled by 
dunking in liquid nitrogen. 
 Wild-type BjPutA crystals were grown in the same conditions as described for the 
3HAZ structure (21). These crystals were cryoprotected with 2 M proline which was 
achieved through 0.5 M incremental steps at a starting concentration of 0.5 M 
proline(23). The cryoprotection in proline took approximately 10-15 minutes to reach the 
desired concentration of 2 M. These crystals were then looped and plunged and stored in 
liquid nitrogen. If many crystals were being pulled from the same drop, the cryobuffer 
being used was replaced with fresh solution after every 2-3 crystals. 
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6.2.4 Data Collection and Refinement  
The space group is C2 with a BjPutA dimer in the asymmetric unit. X-ray 
diffraction data sets were collected at beamline 4.2.2 of the Advanced Light Source 
(ALS) using a NOIR-1 detector. The data were integrated with MOSFLM (24) and scaled 
with SCALA (25). The E460A and E197A mutants were collected using the ALS 4.2.2 
beamline on their new CMOS-based Taurus-1 detector. XDS (26) was used for 
integration and SCALA was used for scaling. Refinements in PHENIX (27) were 
initiated from models derived from the structure of wild-type BjPutA (Protein Data Bank 
(PDB) entry 3HAZ). COOT (28) was used for model building. The structures were 
validated with MolProbity (29) and the PDB validation server. Data collection and 
refinement statistics are listed in Table 2.  
The changes in the internal cavity were monitored using VOIDOO (30) which 
characterizes cavities. Specifically, the probe-occupied (option O) calculation was used 
with a probe radius of 1.4 Å for water, which rolls a probe along the internal walls of the 
cavity and maps out all space that was occupied by the rolling of this probe. It was run 
with a grid spacing of 0.5 Å and a starting point in the middle of the internal cavity, near 
residue 779. MOLE(31), which finds tunnels that connect to the bulk solvent, was used to 
identify and characterize the tunnel system found inside this enzyme.  The Mole 2.0 
server(32) was used with a starting location of the sulfate ion in the PRODH active site. 
6.2.5 Steady-State Kinetics  
Steady-state kinetic assays were performed at room temperature. Kinetic 
parameters for the PRODH domain were determined for proline. The assay used is based 
on reduction of dichlorophenolindophenol (DCPIP) as described previously for PutA 
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proteins. One unit of activity is the quantity of enzyme that transfers electrons from 1 
µmol of substrate to DCPIP per minute at room temp (33). The enzyme concentration for 
E460A and E197A were 1.45 nM and 1.64 nM, respectively. Proline concentration was 
varied from as low as 1 mM all the way up to 1.2 M. All data were plotted and fitted 
using Origin 9.0. 
6.3. Results 
6.3.1 Proline Reduced BjPutA Structure  
The original BjPutA structure was crystallized in the presence of 2 M ammonium 
sulfate and the structure revealed a sulfate bound in the active sites of both PRODH and 
P5CDH. The 3HAZ structure illuminated arginine 456 (R456) interacting with both a 
sulfate in the active site and also glutamate 197 (E197). Any attempts to soak in 
inhibitors were met with failure as the high concentration of sulfate out competed with 
the much smaller concentrations of inhibitors used. However, proline is a known 
cryoprotectant and can be used in concentrations equal to and higher than that of the 
sulfate present. As a result crystals were soaked with 2 M proline for cryoprotection. 
BjPutA crystals have a distinct yellow color resulting from the FAD cofactor. As proline 
concentrations increased, the crystals visibly turned colorless from the edges inward, 
finally becoming completely colorless between 1 and 1.5 M proline.  
 . This color change points to reduction of the FAD which causes a butterfly bend 
in the isoalloxazine ring leading to the loss of color. This butterfly bend is widely 
associated with the reduced state of the cofactor. After hydride transfer to the N5 the 
aromaticity is disrupted and the isoalloxazine ring adopts a lower energy butterfly bend 
(Figure 1). This characteristic bend is seen in the proline reduced structure, as compared 
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to the planar ring seen in 3HAZ. The two ends point towards the re-face, away from the 
active site. The ribityl chain adopts the reduced conformation described previously for 
the N-propargylglycine (PPG) inactived PRODH domain of EcPutA. In fact, the only 
major difference between the flavins in these two structures is the isoalloxazine ring has a 
more severe bend in the PPG inactived structure. The proline reduced BjPutA flavins 
mimics very closely what the GsPutA PPG-inactivated and dithionite reduced structures 
show. The ribityl chain is oriented in the same way, but the bending is more severe in the 
GsPutA structures, at about 27° (14). 
 The reduced form of the enzyme has a proline occupying the P5CDH active site 
(Figure 2). The carboxyl group occupies a similar area as the sulfate that was seen in the 
3HAZ structure. One oxygen from the carboxyl group makes hydrogen bonds with the 
guanidinium group of arginine 791 (R791) and the back bone amino group of glycine 946 
(G946). The other oxygen of the carboxyl group interacts with the same amino group on 
G946 and the backbone amino group of alanine 947. This interaction is with amino acids 
on the binding loop as described previously (34). The proline ring points towards the 
catalytic cysteine and sits between two phenylalanines, F659 and F954. The aliphatic 
chain of glutamate is also known to sit here. 
In this proline reduced structure, there is no density for the sulfate in the PRODH 
active site. The guanidinium group of R456 now points away from the active site and 
makes a 3.1 Å hydrogen bond with the backbone carbonyl of alanine 344. The carboxyl 
group of E197 now points away from the active site, into the internal cavity and makes a 
3.2 Å hydrogen bond with arginine 200 as well as a water mediated hydrogen bond with 
163 
 
arginine 284 (Figure 3A). The original 2.8 Å hydrogen bond seen for this ion pair is 
broken and the side chains now sit about 6.8 Å away from each other. 
To analyze the possibility of this being a snapshot of an open conformation of the 
gate, Mole calculations were run on both the wild-type and proline reduced structures 
(Figure 3). Both could find their way into the cavity and back out, but how they entered 
the cavity was markedly different. The wild-type mole calculations found a narrow 
passage that passed by R456 and a hole at the C-terminal of Chain B, which is known as 
the flap. This route seems to briefly leave the channel of the enzyme, which would leave 
the intermediate solvent exposed and is inconsistent with the mechanism of substrate 
channeling. It finds many, probably water channels out of the PRODH domain, but when 
entering the internal cavity from the PRODH domain, it always enters through this 
“alternate” pathway. 
The mole calculations performed on the proline reduced structure never found this 
pathway (Figure 4). Instead, the PRODH domain connects to the main cavity through the 
now open gate. In fact, every pathway into the main channel from the PRODH active site 
enters through the open gate, the alternate pathway is never seen in these mole 
calculations. The 6.8 Å hole is just big enough for P5C to pass through, which is 
estimated to have a sphere diameter of approximately 5.8 Å. 
The VOIDOO calculations on both the wild-type and proline reduced structures 
show a very similar result as those seen from the Mole calculations (Figure 5). The wild-
type structure stops at the closed gate and does not enter the PRODH domain when the 
point of origin is within the internal cavity. Also, when the origin is moved to the 
PRODH domain, VOIDOO cannot map an escape route into the channel. This is not true 
164 
 
for the proline reduced structure, however. Instead the introduction of a 6.8 Å gap where 
the gate used to be allows VOIDOO to connect the PRODH active site and internal 
cavity. 
 The backbone amine group of glycine 196 (G196) flips about 180 degrees and 
forces a conformational change of the back bone carbonyl group of leucine 195 (Figure 
5). The amine group of G196 now faces in towards the active site, while the carbonyl of 
195 has flipped 180 degrees and faces away from the active site. Helix 8 looks very 
similar to that of the wild type structure, except the side chain of glutamate 460 (E460) is 
completely disordered. Arginine 457 (R457), an arginine implicated in substrate binding 
as well adopts the same conformation as that seen in the 3HAZ structure. 
6.3.2 E460A and E197A  
E197A mutant was made to disrupt the ion pair shown to be acting as a gate to the 
cavity. E197 typically makes a 2.8 Å bond with R456 to create this gate, however 
severing this side chain makes such interactions impossible. The R456 adopts a 
conformation that varies from the wild-type. The R456 guanidinium group in E197A 
does not point at the sulfate in the active site. Instead of one of the terminal nitrogens of 
the guanidinium group interacting with the sulfate, as seen in the wild-type, the nitrogen 
connecting the side chain (NE) makes a 2.2 Å hydrogen bond with the sulfate (Figure 6). 
The NH1 actually faces towards the now absent E197 side chain.  
 Starting at leucine 459, the backbone conformation completely changes and 
disrupts alpha helix formation. The E460 side chain actually moves about 5.4 Å and the 
back bone has a shift of about 3.6 Å (Figure 7). This glutamate appears to swing into the 
active site with one of the oxygens being only 2.7 Å away from the sulfate. Asparagine 
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461 (N461) moves into the space that E460 occupies in the wild-type structure. This 
constitutes about a 5.6 Å shift that leads to the side chain moving out of the proximity of 
glutamate 59 (E59). The side chain of E59 orders as opposed to the wild-type where it is 
completely disordered. Further, E59 seems to make a new pair with one of the dual 
conformations of R457 as described below (Figure 7). Glycine 462 shifts about 6.5 Å 
away from where the wild-type structure is resulting in the largest relocation in helix 8. 
Alanine 463 only has a shift of about 1.6 Å but the side chain in the mutant structure 
adopts a new conformation than that of the wild-type, which strangely sits outside of the 
Ramachandran allowed regions. It should be noted, though, that the electron density at 
the C-terminal of helix 8 is weak, and it is possible that A463 simply cannot be 
positioned correctly due to lack of data. Starting at asparagine 464, the mutant and wild-
type overlap again and the helix structure returns. 
 Arginine 457 in this case adopts a dual conformation. Confirmation A makes a 
2.7 Å hydrogen bond with tyrosine 453. It is similar to the conformation seen in the wild-
type; however it is shifted about 1.5 Å towards the active site. Conformation B faces 
away from the active site and points directly at the newly ordered E59. The two terminal 
nitrogens on the guanidinium ion make a 2.6 and 3.2 Å hydrogen bonds with the two 
oxygens from the carboxyl group of the glutamate. The two conformations are just about 
50/50 occupancy based off of PHENIX occupancy refinement. 
 The E460A mutant, however, the differences are harder to interpret. The active 
site only has one obvious change: the R456 guanidinium group is disordered. E197 looks 
the same as the wild-type but with the guanidinium of R456 disordered, no salt bridge is 
present.  There is a sulfate in the active site, like in the wild-type and FAD is in the 
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oxidized form. With this in mind it is probably that R456 adopts a very similar 
orientation as that of the wild type. Helix 8, surprisingly, is hard to analyze. Residues 
459-464, the C-terminal of the helix, are disordered with very little density. E460 has 
poor density in most BjPutA structures, including that of 3HAZ. This resulted in the 
exact position of this side chain to not be as concrete as even residues surrounding it. 
Also, there are no obvious interactions that would hold E460 in place. The presence of 
the side chain of E59 makes it seem as though the conformation that it is adopting is that 
seen in E197A. However, it is possible that the mutation has simply made this loop more 
mobile which, in turn, has allowed E59 to occupy space, previously taken by the helix. 
 Both of these glutamate mutants appear to severely reduce enzyme activity. 
Originally, the ubiquinone assay was attempted, as it is a more direct measurement of the 
enzyme activity. However, activity was so low using this assay, that it was not usable. 
Better success was seen using the DCPIP assay, but even in this case the activity was 
low. E460A appears to be the most severe as kinetic parameters were unable to be 
determined even when trying an upwards concentration of 1.2M proline. E197A had a Km 
of 798 mM, kcat of 0.080, with a kcat/Km of 0.0001.  
6.3.3 R456M  
R456M kills PRODH activity but leaves P5CDH active. R456 is important for 
substrate binding and in its absence the substrate can't be bound in the PRODH domain 
and activity is lost. Data for the structure for the non-proline soaked form was collected 
by Dhiraj and later refined by myself. I also collected data for the proline soaked 
structure. The methionine disrupts the ion pair seen in the wild-type and also substrate 
binding. E197 adopts the conformation seen in the proline reduced structure, hydrogen 
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bonding with R200. This is seen in both the proline and non-proline soaked R456M 
structures. Also the glycine 196 flip described for the proline reduced structure is seen in, 
again, both structures. The largest difference seen between the proline and non-proline 
soaked structures is the orientation of the M456. In the non-proline soaked structure the 
last carbon of the side chain points towards the active site. However, in the proline 
soaked structure, the side chain actually bends away from the active site, adopting a 
conformation similar to that in the proline soaked wild-type structure described above. It 
is worth noting that the FAD in both R456M structures is oxidized and that soaking of 
these crystals with proline did not yield colorless crystals. 
6.4. Discussion 
6.4.1 Proline Reduced wild-type BjPutA  
In the original structure paper for BjPutA, it was hypothesized that the R456-
E197 ion pair was a gate that moved and allowed the product of the PRODH domain 
access to the internal cavity. Mole calculations on the wild-type structure show that there 
is a path into the cavity that takes a narrow, circuitous route that moves towards the flap 
and briefly becomes solvent exposed. This route seems to defeat the purpose of a channel 
by increasing risk of losing the volatile product of the PRODH domain to bulk solvent. 
That coupled with a narrowing of the path as it passes by helix 8 to move around the 
R456, makes this path of travel possible but unlikely. 
 In the proline reduced structure, the R456-E197 pair breaks as the two side chains 
make large conformational changes to move away. Mole calculations only ever find its 
way into the internal cavity through the now open gate. The alternate pathway seen in the 
wild-type calculations never emerges during the mole calculations on the reduced 
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enzyme. The gap entrance to the cavity is a snug, but large enough opening of 6.8 Å. 
R456, that binds the substrate, actually swings inward into the cavity in what could be a 
way to further direct the substrate into the cavity. It is conceivable, that the substrate is 
not released by R456 until entering the internal cavity. It is known that the hydrolysis of 
P5C to GSA happens within the cavity; however the channel becomes quite narrow for 
such a reaction to occur. Perhaps being anchored in place upon entrance to a water filled 
cavity allows for the hydrolysis to happen, and allows release from the R456 to channel 
to the P5CDH domain. Further, if the released product travels through the ion pair instead 
of moving around, there is less risk of solvent exposure as the movement of the R456 is 
towards that of the flexible C-terminal flap. 
6.4.2 E197A  
Mutation of R456 is known to kill enzyme activity. However, it was unclear what 
the outcome would be if removing the glutamate from the ion pair. E197 does not directly 
interact with substrate; however, as part of the proposed gate, it had the potential to 
disrupt activity completely. E197A was made to test how the loss of the ion pair, but not 
the residue responsible for substrate binding would affect the overall activity. According 
to the kinetics, enzyme function is not lost but severely hampered by the removal of the 
glutamate side chain. Guess and inferences from the known structures of BjPutA can 
explain these kinetics as removing the interaction that stabilizes the needed arginine for 
substrate binding. It is possible that with the loss of the gate the substrate could more 
freely enter the cavity or leave the active site, making diffusion a larger obstacle to 
overcome during substrate binding. Thus, R456 becomes more flexible and the binding 
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affinity for proline becomes worse as substrate has to enter and interact at the right time 
for the arginine to be in position. 
 Interestingly, the structure of this mutant had large and unpredicted changes in it. 
R456 is actually interacting with a sulfate bound in the active site. This side chain 
occupies a similar space as the wild-type enzyme and would be well within hydrogen 
bonding distance of the glutamate 197 side chain if it were present. More intriguing is the 
effect that this mutation had on helix 8. Helix 8 is home to both of the important arginine 
residues, 456 and 457, which bind the substrate. It is also where glutamate 460 is located, 
which forms an ion pair with R457 when a ligand is bound. Arginine 457 in particular 
now adopts two different conformations, one that models the wild-type and another that 
creates a new ion pair with the previously disordered glutamate 59. 
 However, starting at leucine 458, the structure of the alpha helix is disrupted. 
E460 swings into the active site and makes a close contact with the sulfate bound, at 
about 2.8 Å. It is unclear why two negative charges of oxygen would want this close 
interaction. N461 moves into the space previously occupied by glutamate 460. It is the 
movement of this residue in particular that allows for E59 to order and form a salt bridge 
with R457. Glycine 461 makes the largest shift of 6.5 Å, and A463 while only shifting 
1.5 Å. The unstructuring of the loop with such large conformational changes was 
unexpected. Helix 8 is already known to be mobile and flexible, seen in GsPutA to make 
large shifts between the relaxed and substrate bound states. With the loss of E197, 
perhaps this flexibility allowed the enzyme to adopt a less favorable conformation to 
allow enzyme activity to continue. The E460 swinging into the active site might be a 
reflection of the need for the enzyme to adapt. 
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6.4.3 E460A  
After seeing the importance in this residue in pairing with R457 during substrate 
binding, it seemed worthwhile to compare the disruption of both ion pairs through the 
glutamate to alanine mutations. In this case, mutation of E460A severely hinders the 
activity of the enzyme. Kinetic parameters could not be established as activity was very 
low and hardly above noise levels below 1 M proline. Removal of this residue just about 
kills the enzyme. 
 The PRODH active site looks very similar to that of the wild-type structure with 
sulfate bound. There is density for the sulfate, R457 occupies the same orientation as the 
wild-type and E197 is in a similar orientation as the wild-type, well within range to ion 
pair with R456. The guanidinium group of R456, however, is disordered. It was 
unexpected to see this arginine disordered and a sulfate in the active site. This could be 
significant as the kinetics are clear in poor enzyme activity. The absence of only the 
guanidinium ion, however, most likely means that this is an artifact. 
 Helix 8 was a different story. After seeing the unstructuring effects that the 
E197A mutant had at the C-terminal of the helix, a similar effect was anticipated for the 
E460A mutant. However, instead of interrupting the helix formation the same residues, 
459-464 are completely disordered. Disordering of these residues indicates an increase in 
flexibility. The side chain of E460 was already known to be mobile as density is 
generally poor. The disordering of surrounding residues, however, shows that E460 not 
only plays an important role in substrate binding via a salt bridge, but also anchors helix 
8 into the right location. 
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 As compared with the E197A that has an unstructured but ordered C-terminal to 
the helix and lower but still measurable activity, it would seem to indicate that the helix 8 
being ordered is needed for enzyme activity. The glutamate half of the salt bridge, while 
important, is less important than an intact helix 8. It is unclear why the truncation of the 
side chain of E460 would cause such a severe disordering of the surrounding helix. Due 
to alanine's propensity for forming alpha helices(35), the complete disruption with the 
introduction of this mutation was surprising. With the wild-type E460 making no clear 
and important hydrogen bonds there seems to be a lack of explanation why the mutation 
caused such a sever change. 
6.4.4 R456M  
The two structures of R456M, glycerol cryoprotected and proline soaked yielded 
very similar results. The mutation of the arginine yields a dead enzyme. As a result the 
gate is already oriented in an open position. With the PRODH domain, the proline soak 
does not have the same effect as it does on the catalytically active wild-type. During the 
proline soak the FAD, in crystal, never reduces as visible by the lack of the crystal 
changing color and the lack of FADH density in the structure. 
 The VOIDOO calculations on these structures yield very similar results as the 
proline soaked wild-type structure. VOIDOO finds its way through the proposed gate 
from the internal cavity, which is completely absent in the oxidized structure. The Mole 
calculations mimic those of the proline soaked wild-type structure as well. Mole finds its 
way through the internal cavity via the open gate. Put simply, R456 is an important 
residue for substrate binding and controlling flow of product into the channel. Without an 
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arginine present, not only is there no activity, but there is now a large hole where the gate 
used to segregate the PRODH active site and internal cavity. 
6.5. Conclusion 
 In the PNAS paper describing the first full length structure of PutA, access to the 
internal cavity was hypothesized to happen via breaking the ion pair of R456 and E197A. 
Through mutation and ligand soaking the mechanism of this gate was probed. Indeed the 
ion pair is disrupted and the gate swings inward towards the cavity creating a gap of 
about 6.8 Å and connecting the internal cavity and the PRODH active site. Further the 
E197A and E460A mutations disrupting helix 8 points to the helix having an important 
role in catalytic activity and is likely sensitive to or involve in the gate opening. The 
movement of this gate allows for substrate to inter the channel without being exposed to 
bulk solvent, which is a key function for efficient channeling. 
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SCHEMES 
 
Scheme 6.1. The overall 4 step oxidation of proline catabolism to glutamate. Proline 
dehydrogenase catalyzes the oxidation of proline to Δ1-pyrroline-5-carboxylate (P5C) 
utilizing FAD as an electron acceptor. P5C goes through a nonenzymatic hydrolysis to 
glutamate γ-semialdehyde (GSA). The NAD-dependent P5C dehydrogenase (P5CDH) 
catalyzes the final oxidation of GSA to glutamate and NADH. 
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Table 6.1. Primers for Site-Directed Mutagenesis. 
 
 
 
 
  
Mutant Primers (5’-3’) 
E460A Fwd:     CGGCGACTGCTGGCGAACGGTGCCAAC 
Rev:      GTTGGCACCGTTCGCCAGCAGTCGCCG 
E197A Fwd:     CATGCTCGGCGCAGGCGCGCGCAC 
Rev:      GTGCGCGCGCCTGCGCCGAGCATG 
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Table 6.2. X-ray Diffraction Data Collection and Refinement. 
 BjPutA-
Proline 
BjPutA 
R456M 
BjPutA 
R456M-
proline 
BjPutA 
E197A 
BjPutA 
E460A 
Beamline ALS ALS ALS ALS ALS 
Space group C2 C2 C2 C2 C2 
Unit cell parameters 
(Å,°) 
a = 167.8 
b = 196.1 
c = 109.0 
β = 121.7 
a = 167.0 
b = 195.8 
c = 108.7 
β = 121.5 
a = 167.16 
b = 195.20 
c = 109.19 
β = 121.46 
a = 167.3 
b = 196.0 
c = 109.0 
β = 121.4 
a = 166.5 
b = 195.8 
c =108.7 
β = 121.4 
Wavelength 1.0000 1.0000 1.0000 1.0000 1.0000 
Resolution (Å) 37.84 – 2.20 
(2.32 – 2.20) 
29.89 – 2.30 
(2.42 -2 .30) 
29.96 – 2.03 
(2.14 -2.03) 
62.15 – 2.10 
(2.14 – 2.10) 
61.97 – 2.30 
(2.34 – 2.30) 
Observations 461836 500901 708040 642493 486982 
Unique reflections 138636 131581 190232 171782 130904 
Rmerge(I) 0.091 (0.480) 0.132 (0.495) 0.124 (0.589) 0.086 (0.611) 0.072 (0.509) 
Rmeas(I) 0.109 (0.648) 0.154 (0.577) 0.146 (0.723) 0.119 (0.839) 0.099 (0.698) 
Rpim(I) 0.058 (0.430) 0.079 (0.296) 0.076 (0.410) 0.082 (0.572) 0.068 (0.476) 
Mean I/σ 8.4 (2.0) 11.4 (2.4) 6.5 (2.5) 9.4 (1.8) 11.6 (2.1) 
Completeness (%) 91.7 (63.0) 100.0 (100.0) 99.1 (93.9) 98.8 (98.3) 99.7 (99.8) 
Multiplicity 3.3 (2.1) 3.8 (3.8) 3.7 (3.2) 3.7 (3.5) 3.7 (3.5) 
No. of protein chains 2 2 2 2 2 
No. of protein 
residues 
1938  1941   
No. of protein atoms 14631 14477 14681 14372 14285 
No. of FAD atoms 106 106 106 106 106 
No. of proline atoms 80 0 96 0 0 
No. of water 
molecules 
706 541 980 692  
Rcryst 0.2300 
(0.3559) 
0.2066 0.2217 
(0.3856) 
0.1926 0.2238 
Rfree
b
 0.2681 
(0.3693) 
0.2459 0.2634 
(0.4165) 
0.2239 0.2618 
Rmsd bond length, Åc 0.010 0.007 0.007 0.009 0.009 
Rmsd bond angles, ° 1.392 1.082 1.046 1.080 1.145 
Ramachandran plot
d
      
     Favored (no. 
residues) 
1883  1891   
     Allowed (no. 
residues) 
49  38   
     Outliers (no. 
residues) 
6  12   
Average B-factor 
(Å2) 
     
     Protein 28.14 31.21 26.72 35.15 43.315 
     FAD 23.92 21.90 18.65 26.47 37.017 
     Proline 42.09 - 45.71 - - 
     water 37.75 29.32 28.86 36.77  
Coordinate error (Å)e 0.35  0.33   
PDB code      
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Figure Legends 
Figure 6.1. Reduced FAD electron density from proline soaked BjPutA. A) In yellow is 
the reduced FAD seen in the proline reduced BjPutA structure. The mesh represents an 
Fo-Fc simulated annealing omit map. B) View of the butterfly bend of the isoalloxazine 
ring seen in the reduced structure. 
Figure 6.2. View of proline (pink) found in the P5CDH active site. NAD (cyan) sits 
above the dual conformation cysteine 792. Proline sits on the other side of the active site, 
with the pyrroline ring positioned between phenylalanine 659 and 954. The carboxyl 
group of proline occupies a similar location as sulfate found in 3HAZ, interacting with 
the backbone amino group of A947 and G946 and the guanidinium ion of R791. 
Figure 6.3. Movement of the R456-E197 ion pair gate. A) The blue surface represents 
the MOLE calculation starting at the sulfate for the proline reduced BjPutA structure. B) 
The pink surface represents the MOLE calculation starting at the sulfate for the BjPutA 
wild-type (3HAZ) structured. C) The superposition of the wild-type (gray) and proline-
reduced (green) ion pair, with the proline reduced MOLE tunnel (blue) present. 
Figure 6.4. VOIDOO calculation comparisons of the oxidized and reduced form of the 
wild-type enzyme. A) Shows the PRODH domain and the surface represents the 
VOIDOO calculation for the original 3HAZ structure. The side chains of the ion pair for 
the wild-type are colored cyan and FAD is colored yellow. B) The red mesh represents 
the extra space found during the VOIDOO calculation overlaid with that of the 3HAZ 
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VOIDOO calculation (surface). The gray side chains now represent the proline-reduced 
ion pair. C) View from the internal cavity into the PRODH domain, clearly showing the 
gate preventing VOIDOO from entering the active site. 
 
Figure 6.5. A) The oxidized gate (green) superimposed with the glycerol cryoprotected 
R456M structure (gray) and the proline soaked (pink) R456M structure. The surface 
represents the VOIDOO calculated for the proline-soaked wild-type enzyme. B) The 
proline soaked wild-type structure (cyan) superimposed with the glycerol cryoprotected 
R456M structure (gray) and the proline soaked R456M structure (pink). The surface 
represents the VOIDOO calculated for the proline soaked wild-type structure. 
Figure 6.6. View of the movement of glycine 196 and glutamate 197. The 3HAZ 
structure (green) superimposed with the proline soaked structure (gray). The dark blue 
mesh represents simulated annealing σA-weighted Fo - Fc omit maps contoured at 3.0 σ.    
Figure 6.7. A) Superposition of 3HAZ (gray) and the E197A (cyan) structures 
highlighting the unstructuring effect that the E197A mutant has on helix 8. B) The dark 
blue mesh represents simulated annealing σA-weighted Fo - Fc omit maps contoured at 
3.0 σ.    
Figure 6.8. Superposition of 3HAZ (gray) and the E197A mutant (cyan) structures 
highlighting residues involved in the unstructured of helix 8. A) All residues 
experiencing a significant movement in helix 8 in the E197A mutation. B) R457 dual 
conformation and ordering of the side chain of E59 in the mutant. Shift of the E460 
residue (C) and the N461 (D). 
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Figure 6.9.  The Michaelis-Menten curve for the E197A structure. The Y-axis represents 
the Vmax while the X-axis plots the proline concentration used. 
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Fig 6.1. 
 
 
 
 
184 
 
Fig 6.2. 
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Fig 6.3. 
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Fig 6.4. 
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Fig 6.5. 
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Fig 6.6. 
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Fig 6.7. 
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Fig 6.8. 
 
 
 
191 
 
Fig 6.9. 
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Chapter 7: 
Structure and Role of Mg
2+
 Binding of the  
Apoptosis-Linked Protein (ALG-2) 
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Abstract 
 Apoptosis-linked gene protein (ALG-2) is a penta-EF-hand calcium binding 
protein that induces apoptosis during high calcium concentrations in cells. Structures of 
this enzyme in the calcium bound, zinc bound, calcium free, and Alix bound ALG-2 have 
been solved previously. It was previously thought that these binding sites do not bind 
magnesium; however, recent studies show that this enzyme binds magnesium, albeit at a 
much lower affinity than calcium. This study aims to elucidate the structure of the 
magnesium bound ALG-2. However, it also highlights some of the problems not always 
seen in crystallography. Specifically, how do you distinguish between the electron 
density of different possible ions in the binding site? This question came about when 
close inspection of the “calcium-free” structure revealed that sodium ions were bound in 
all of the binding sites. This chapter outlines the methods used to try to answer this 
question and lays out further work that could be done to answer this question.  
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7.1. Introduction 
 Apoptosis-linked gene 2 (ALG-2) is a 22-kDa penta-EF-hand (PEF) protein, 
characterized by the presence of five EF-hands which are helix-loop-helix Ca
2+
 binding 
motifs(1). In ALG-2 only three of these sites are thought to be functional; EF1, EF3, and 
EF5. EF1 and 3 are considered high affinity sites, binding Ca
2+
 at micromolar levels(2, 
3). The fifth site, EF5, is located in the C-terminal and is the oligomerization domain, 
interacting with another EF5 to form a homodimer, and is considered a low affinity site. 
Dimer formation, however, happens in a Ca
2+
-independent manner(4). Canonical EF-
hands have a calcium ion with pentaganol bipyramidal coordination with five ligands on 
the yz plane and two ligands on the x axis. Five of the coordination spots are occupied 
with the oxygens of side chains (x, y, z and a bidentate –z). A sixth is from a peptide 
carbonyl at position –y and the seventh is from a water molecule located at –x(5). These 
enzymes interact Ca
2+
-dependently with a multitude of proteins with proline-rich areas. 
 In this family, ALG-2 and peflin belong to group 1 PEF proteins. These vary from 
group 2 PEF proteins, calpain and grancalcin, with variations within the EF1 and EF5 
binding sites. Group 2 enzymes have a one-residue deletion within the EF1 site and have 
a substitution of the x site with from asparagine to alanine, while group 1 does not have 
this. Group 2 also has an additional two residues present in the EF5 binding site. 
Additionally, these enzymes have an N-terminal proline/glycine rich region, with ALG-2 
having the shortest of these, about 22 residues. Removal of this N-terminal region has led 
to an increased crystallization chance, with many of the deposited structures having this 
region removed(5). 
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 Upon Ca
2+
 binding in EF3, conformation changes expose a hydrophobic region of 
ALG-2 allowing for the enzyme to interact with proline-rich regions of proteins. One 
protein in particular, Alix or AIP1, is a 95 kDa peptide that has three proline-rich regions 
at the N-terminal, middle, and C-terminal. The C-terminal region interacts with ALG-2 at 
a region containing four PxY repeating motifs. Mutation of either the proline or tyrosine 
to alanine results in a loss of binding of Alix to ALG-2(6-8). 
 Crystal structures of mouse and human ALG-2 have been solved(7, 9). The 
human structures, in particular, have a Ca
2+
-bound, Ca
2+
-unbound, Zn
2+
-bound, and an 
alix-ALG-2 complex structure. Comparisons between the bound and unbound structures 
provide important insights into the understanding of the binding. In short, binding of 
calcium to EF3 induces conformational changes in R125, exposing a hydrophobic pocket 
and allowing for the proline-rich, C-terminal area of the Alix peptide to bind(7). These 
comparisons between the calcium bound and the non-calcium bound structures, however, 
are not entirely accurate. Upon inspection of the Ca
2+
-free form of the enzyme, there is a 
Na
+
 bound in EF1, EF3, and EF5. In the Zn
2+
-bound structure, EF5 is occupied not by 
Zn
2+
 but Na
+
 as well. The issue of the presence of sodium in all of the binding pockets is 
not addressed, but could be an indication of why dimer formation is Ca
2+
-independent.  
 ALG-2 is only thought of as Ca
2+
-activated, which has low concentrations in vivo 
compared with another divalent cation, Mg
2+
. An increase in Ca
2+
 concentration in the 
cell inducing apoptosis regulated by ALG-2 works as long as Mg
2+
 doesn’t also bind and 
activate ALG-2. Binding studies done by Dr. Henzl have shown that ALG-2 does have an 
affinity for Mg2+, and while not as high as it is for Ca
2+
, it is not insignificant. This study 
aims to understand the differences in the structures of Ca
2+
-bound and Mg
2+
-bound ALG-
196 
 
2 and why only one of these cations leads to programmed cell death. This study focuses 
heavily on the crystallization of enzyme devoid of Ca
2+
, with only the presence of Mg
2+
. 
7.2. Materials and Methods 
7.2.1 Protein Preparation for Crystal Trays. 
Protein was given to me in a buffer containing 150 mM NaCl, 25 mM HEPES at pH 
7.8, 5 mM EGTA, and 1 mM MgCl2. The ALG-2 was already frozen and at a 
concentration of 10 mg/mL. The protein was thawed using two different methods. The 
first was holding the epitube under water at room temperature to unthaw it quickly. The 
second method, the one more commonly used, was to place the epitube containing the 
protein on ice, and let it thaw slowly overtime. 
The thawed ALG-2 at room temperature was clear, regardless of how it was 
unthawed. However, when storing the enzyme at 4°C, a white precipitate formed in the 
solution. When the enzyme was left at room temperature, after this this precipitate 
appeared, the precipitate disappeared, and reappeared again when stored at 4°C. 
7.2.2 Crystallization Trials 
Based off of previous crystallization of the Ca
2+ 
and the Ca
2+
-free form, two 
conditions were tested to attempt to reproduce crystals. First, a condition containing 14-
24% PEG 8,000, 0.2 M magnesium acetate (MgOAc), and 0.1 M cacodylate pH 5.5-7.0 
was attempted. The wells were set up in a 1:1 ratio with 10 and 5 mg/mL protein 
solutions being used. Trays were set up later after increasing the PEG 8,000 
concentration to 26-36%. The second condition tried was 6-16% isopropanol, 0.2 M 
MgOAc, and 0.1 M cacodylate at pH 5.5-7.0. The wells were again set up with a 1:1 µL 
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ratio using 10 and 5 mg/mL enzyme. A second set of trays was set up, increasing the 
isopropanol concentration range to 18-28%. None of these optimizations yielded crystals. 
Crystal screening using Index and Crystal Screen (CS) I and II was done in a 96 well 
plate. Reservoir size was 100 µL with a drop size of 1 µL of enzyme to 1 µL reservoir. 
Screens were set up at both 10 and 5 mg/mL at room temperature. Initial possible hits 
were seen in CS II 43, CS II 10, CS II 19, CS I 1, and CS I 14. These were promising as 3 
of the conditions contained MPD, a precipitant reported previously. However, none of 
these conditions were reproducible. Crystal screens were then set up using Index and CSI 
and II under Al’s Oil. These were set up by adding 1 µL of enzyme to the well followed 
by 8 µL of Al’s Oil, and finally 1 µL of the precipitant solution. These trays were 
wrapped with parafilm and incubated at room temperature. None of these screens yielded 
crystals. Screening took place again in 96 well plates only this time set up at 4°C. These 
trays were set up the exact same as the 96 well trays at room temperature except the trays 
were placed in the cold room ahead of time and allowed to cool down for about 10 
minutes before setting up the trays. This time there was a hit in 30% isopropanol and 0.1 
M Tris pH 7.5. 
Optimization of this hit was set up with a range of 22-32% isopropanol and 0.1 M 
Tris at pH 7.0-8.5. These trays yielded very large, very thin clear crystals that tended to 
cluster together, referred to as Form 1 (Figure 1). A second batch of these trays was set 
up using 22-32% isopropanol, 0.1 M Tris at pH 7.0-8.5, and 0.2 M MgCl2. These 
crystals, Form 2, were short, thick rod shaped crystals (Figure 2). Both crystal forms took 
about 2-3 days to grow to maximum size.  
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7.2.3 Cryoprotection 
Cryoprotecting these crystals proved difficult. The first crystals shot were 
cryoprotected in about 5% MPD, 30% isopropanol, 0.1 M Tris pH 7.5 and 0.2 M MgCl2 
(salt only for Form 2). Any concentration above 5% cracked and destroyed these crystals 
and ice ring diffraction was still present. 
Several problems presented themselves upon review of the cryoconditions. First, 
isopropanol has a tendency to evaporate quickly while cryoprotecting. Evaporation of the 
precipitant could lead to problems cracking of the crystals. Second, these crystals were 
very temperature sensitive, with crystals breaking down into just precipitate after being at 
room temperature for a few minutes. Finally, it could very well be the problem of the 
chosen cryoprotectant not being suitable for this condition. 
These first of these problems tested was that of simply changing the cryoprotectant. 
First, instead of adding a new molecule as a cryoprotectant, increasing the concentration 
of isopropanol might work. Loop tests were performed by dipping a loop in the prepared 
cryoprotectant and flash frozen in the X-stream of gaseous nitrogen. At 40% isopropanol, 
the appearance of ice seemed to be removed, leaving instead a waxy-looking drop on the 
pin. However, upon exposing the 40% isopropanol mixture to X-rays, ice ring diffraction 
was still present. Second, 2 M proline was tested with 30% isopropanol. This was indeed 
cryoprotective with no ice ring diffraction present. At low concentrations of proline, both 
forms of the crystals appeared to be stable. However, upon increasing the concentration 
of proline to 2 M, the crystals completely dissolved. Sadly, at 1 M proline, where the 
crystals were stable, the solution was not cryoprotective. Finally, the cryoprotectant that 
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worked was 25% glycerol with 30% isopropanol, 0.1 M Tris at pH 7.5, and either 1mM 
MgCl2 or 200mM MgCl2. 
This cryoprotectant was chilled on ice before use. Chilling was done to try to remove 
temperature-dependent degradation of the crystals. Then, 20 µL of the full 25% 
cryoprotectant was directly used in the well. The soak time was long enough to allow the 
Schlerian lines to settle and then crystals were looped, flash frozen, and stored in liquid 
nitrogen. 
7.2.4 Data Collection and Processing 
The first data set (Table 1) was collected at ALS beamline 4.2.2. 180 degrees was 
collected with an exposure time of 0.6 seconds, an oscillation width of 0.1 degrees, and a 
distance of 280 mm. The second data set was collected on the R-Axis IV++ home source 
and Rigaku detector. 170 degrees of data was collected with 20 minutes exposure times, 
0.5 degree oscillation width, and a detector distance of 100 mm. Finally, the last two data 
sets were also collected at ALS beamline 4.2.2. 180 degrees of data was collected with an 
exposure time of 0.6 seconds, 0.1 degrees of oscillation, and a detector distance of 290 
mm. 
Data integration was performed using XDS(10).  Aimless in the CCP4 package was 
used for space group determination and scaling(11). The spacegroup was determined to 
be P21221 with a unit cell of 75, 54, and 48 Å. However, convention is to have the unique 
axis in the terminal position. Using Reindex program, in the CCP4 suite, a matrix 
transformation was performed and moved the space group to P21212 and with the unit 
cell being 48, 75, and 54 Å. Molecular replacement was not needed because the Ca
2+
-free 
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model, previously published (2ZND), was in the same spacegroup and used for the Rfree 
flags. 
2ZND was used a model for refinement in PHENIX(12). Initial refinement was done 
with rigid body, TLS, NCS, and simulated annealing. The structures and electron density 
was viewed and adjusted in COOT(13). Significant density for something in all three of 
the Ca
2+
 binding sites (EF1, EF3, and EF5) was seen. Water was modelled into this 
density. A second refinement was performed without rigid body or simulated annealing. 
The newly refined structure was then plugged into the STAN server. According to 
WASP(14), on the STAN server, the three waters in the Ca
2+
 were determined to be 
either lithium or magnesium. In COOT, these waters were removed and replaced with 
Mg
2+
 and the occupancy was set to 0.5 and PHENIX refined the occupancy.  
7.3. Results 
7.3.1 Enzyme Precipitation 
 To begin, an interesting issue arises with the pure enzyme provided. After 
thawing the protein solution is clear at room temperature, but at 4°C a white precipitate 
forms. Since the crystals are grown at 4°C some trays were set up with the precipitate 
present and some where the precipitate had been spun off with a short spin in the 
centrifuge. Interestingly, the best crystals were grown from the enzyme that had the 
precipitate still present.  
7.3.2 Diffraction Quality and Cryoprotection 
Only Form 1 gave diffraction out to a reasonable resolution (Figure 3). Form 2 
diffraction (Figure 4) was very poor out to only about 4 Å. However, upon initial 
diffraction it was unclear why Form 2 was diffracting poorly. With substantial ice rings 
201 
 
and the knowledge that the cryoprotectant caused the crystals to crack at concentrations 
higher than 5% MPD, the poor diffraction could have been a direct result of these subpar 
conditions for the crystal. 
 Form 1, while it had substantial ice rings, diffracted beyond 2.1 Å. Initially XDS 
could not process the data. However, after excluding the ice rings XDS processed the 
data and find the correct space group with no issue. The result was P21221 space group 
with unit cell dimensions 48, 54, and 75 Å. However, convention is to put the unique axis 
at the terminal end. Reindex in the CCP4 suite can perform the transformation of (b,c,a) – 
(a,b,c), which puts the space group in the proper convention and the unit cell dimensions 
are now 75, 48, 54 Å. This is the same space group as was seen from the Ca
2+
-free form 
(2ZND), with the exception of the a dimension becoming 4 Å longer.  
 Data collection and refinement statistics are listed in Table 1. The low 
completeness would be troubling if ice rings had not been excluded. However, because of 
the substantial ice ring presence, a large piece of the data needed to be excluded and a 
reduction in the completeness was seen. One perplexing result was that of a low amount 
of unique reflections, especially in the inner shell. Usually, there are quite a few of 
unique reflections in this bin, but it was as low as 771 reflections in this group of data 
sets.  
 Perhaps equally surprising is the unusually high I/σ. There are many checks to 
deciphering good data quality, and one common method for evaluating if the correct 
resolution range has been picked is seen in the mean I/σ. It is a general rule of thumb that 
I/σ is cut off at a value of 2.0, though the view of this has changed to believe it is too 
conservative of an estimate(15). However, when attempting to push to higher resolution 
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to get to the cutoff, the diffraction statistics become poor with high Rmerge values and low 
completeness. It does not appear to be a result of twinning, as the tests for twinning came 
back fine and the structures looked great. It is worth noting that there was very intense 
diffraction, perhaps contributing to the observed high signal to noise ratio. 
7.3.3 Metal Binding Sites 
 The binding sites, EF1, EF3, and EF5, all originally had positive Fo – Fc map 
density. When comparing these binding sites with previously published structures, it was 
clear that any number of ions could be bound. The biggest concern was the presence of 
Na
+
 in the binding sites of the Ca
2+
- free form(7). With EGTA in the buffer, Ca
2+
 should 
not be a concern(16). However, Na
+
 and Mg
2+ 
are both present and with Na
+
 binding 
evident in what structure it will be difficult to tell if it is truly Mg
2+
 bound, or which of 
the three binding sites it is bound in.  
To help answer this question the STAN server was used. The STAN server 
specifically runs three different calculations, but the one of interest is called WASP. 
WASP will look at all the water molecules within a structure and give a list of waters that 
could possibly be either Li
+
, Na
+
, Mg
2+
, or Ca
2+
. Interestingly, the program does not seem 
to be able to distinguish between Li
+
 and Mg
2+
 or Na
+
 and Ca
2+
. However, when 
replacing the Ca
2+ 
and the Na
+
 with water, WASP will say that those particular waters 
should be either calcium or sodium. As a result these binding sites were modelled with 
water and then run through refinement. These refined structures were then used in the 
STAN server, and WASP gave an output that said the waters in the binding pockets 
should actually be either Li
+
 or Mg
2+
. With no lithium present, magnesium was modelled 
in. 
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Refinement in PHENIX left the Mg2+ modelled into all three active sites left 
occupancy of about 60% for all three sites. Another interesting question arose from this; 
is it possible that the sites have a dual occupancy of Na
+
 and Mg
2+
? Or perhaps even a 
triple occupancy with water as the third molecule? With no definitive suggestion that a 
triple occupancy would be occurring, Occam’s razor insists to throw this idea out. When 
modelling a dual occupancy, the answer does not become clear. Both ions go to an almost 
equal 50/50 split, with Mg
2+
 having a slightly higher occupancy, usually around 54-58%. 
However, with the B-factors being low for both the single occupancy and the dual 
occupancy structures, it is impossible to determine which the correct answer is. It is 
worth noting that when EF-3 was modelled as a dual occupancy of magnesium and 
sodium, the magnesium moves slightly out of the binding pocket making a very long (3.2 
Å) interaction. However, when using a single occupancy of just magnesium, the ion 
moves back into the binding pocket and makes interactions with expected distances. 
A summary of the coordination of the magnesium in comparison with that of 
sodium and calcium from previously solved structures is displayed in Table 2. 
Interestingly, the largest difference seen is that of glutamate 114 in EF3. In the case of the 
calcium bound structure, the glutamate coordinates with the ion at 2.3 and 2.5 Å. 
However, in the magnesium structure this glutamate is now much further away with a 
coordination of 4.3 and 4.8 Å, and this is seen in the sodium structure as well with the 
sodium being 3.7 and 4.3 Å from the two oxygens on the glutamate. 
7.4. Discussion 
 Calcium in EF1 has pentaganol bipyramidal coordination, with long bond lengths 
to E47 and S40. Actually moves completely away from S40 and makes a closer 
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interaction with OE1 from E47. Magnesium seems to make all the same coordinations as 
calcium. For calcium, a coordination number of 7 (needed for pentaganol bipyramidal) is 
fairly common, about 30%, in this resolution range. Magnesium, on the other hand, only 
has a 7 coordination number less than 5% of the time, much preferring coordination of 5 
and 6(17).  
 Calcium has a preferred coordination length of about 2.3-2.5 Å. Distances shorter 
than 2.2 Å are much less common and almost non-existent below 2.0 Å. Coordination 
bond lengths greater than 2.75 Å are uncommon. For EF1 this puts all of the coordination 
distances reported for the Ca
2+
 bound structure well within the expected ranges with only 
one unusual distance of 2.8 Å. Magnesium, however, has a preferred coordination bond 
length of 1.9-2.1 Å. The frequency of coordination lengths shorter than 1.8 Å is almost 
non-existent, and lengths greater than 2.5 Å become very rare. This gives the Mg
2+
 bound 
in the EF1 pocket 4 coordination bonds with lengths that fit perfectly in the expected 
range. However, two lengths 2.8 (OE2E47) and 3.0 Å (OS40) are rarely seen with 
magnesium coordination. The other interaction with E47 is at 2.3 Å, and while much 
more reasonable but still without the most common distances. 
 Further, bidentate coordination with either glutamate or aspartate for calcium with 
a coordination number of 7 is a common occurrence. In fact, bidentate coordination 
becomes increasingly more common with calcium as the metal binding with increasing 
coordination number. However, bidentate coordination is not as common with 
magnesium. With a coordination number of 7, which as stated earlier is rare for 
magnesium, bidentate coordination is less common then coordination with single amino 
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acid oxygens. However, with a smaller coordination number than 7, bidentate 
coordination becomes almost non-existent. 
 All of this points to Mg
2+
 not coordinating the active site in the same way as Ca
2+
. 
Instead, it is possible that only aspartate 36, aspartate 38, valine 42, and water make the 
inner-sphere coordination, bonding directly with the metal. The two oxygens from 
glutamate 47 and the oxygen from serine 40 are only loosely interacting with the metal 
ion and are in the Mg
2+
 outer-sphere. All 4 inner-sphere coordinations are within the 
same plane making the actual coordination square planar and giving the Mg
2+
 a 
coordination of 4, which is seen about 15% of the time in this resolution range. 
 The EF3 binding site geometry has an obvious and drastic change between Mg
2+
 
and Ca
2+
. Calcium has a coordination number of 6, with bidentate coordination with 
E114 and no interaction with a water present when magnesium is bound. Unlike in EF1, 
all of the distances (2.3-2.5 Å) are within the most commonly seen range for calcium. 
Magnesium, like with calcium, has a coordination number of 6 with bond lengths from 
1.9-2.1 Å, right in the most common range. However, with the short bond distances with 
residues 103, 105, 107, and 109, magnesium is too far away from glutamate 114 to 
interact directly with it. Instead, magnesium coordinates with a water molecule that 
hydrogen bonds with glutamate 114. Also, magnesium coordinates with an extra water 
molecule, not present in the calcium bound structure. Calcium not interacting with water 
is not hugely surprising in that coordination with water is a very small fraction of seen 
calcium coordination with a coordination number of both 6 and 7. However, at a 
coordination number of 6, magnesium has the lowest fraction seen coordinating with 
water. Interactions with water are clearly not unheard of, it is surprising that calcium does 
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not interact with that extra water to increase its coordination number from 6 to 7, which 
occupy almost equal observed percentages in the PDB. 
 In fact, magnesium models closely what is seen with the Na
+
-bound structure. 
Surprisingly, Na
+
 has similar bond lengths as Ca
2+
, however sodium has moved away 
from the bidentate coordinating E114. Also, the sodium does not appear to have a water 
mediated coordination with this glutamate as magnesium does. Based on sodium and 
magnesium occupying a similar location that is different from calcium, but sodium 
having equivalent bond lengths as calcium, it is not just magnesium having smaller 
coordination bond lengths and moving further into the pocket. Also, with calcium and 
sodium ions having a similar size, it seems unlikely that it is a conformational change in 
EF3 to accommodate the smaller magnesium ion. It is unclear why the movement away 
from glutamate happens. 
 Nothing overtly strange happens within binding pocket EF5. Both calcium and 
magnesium have the same coordination number, 6, interact with all of the same residues, 
and all have their respective expected bond lengths. EF5 is considered the low affinity 
binding site and is located within the oligomerization domain. This could explain why 
sodium is also seen in this binding site in not only the Ca
2+
-free form but also in the Zn
2+
-
bound enzyme. It could also explain why metal binding in this binding site is almost 
identical in all forms of the enzyme. 
 However, with sodium being able to interact in all of the same binding sites as 
those for the metals of interest, how at 2.0 Å resolution can magnesium and sodium be 
distinguished from one another? The STAN server uses an algorithm to determine if 
modelled water molecules are actually metal ions. This server gave the first indication as 
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to what was bound in the active site. For the Ca
2+
-free form the server found that there 
was either Na
+
 or Ca
2+
 in these binding pockets. However, when using the Mg
2+
 structure 
with water modelled into all of the active sites, the server finds either Mg
2+
 or Li
+
. With 
the absence of lithium in the crystallization solutions used, then it would be safe to 
assume that magnesium ions were those in the binding sites. With the divalent and 
monovalent ions having similar ionic radii, then it only follows that this algorithm would 
not be able to distinguish between the two. However, it does seem to be able to 
distinguish between sodium and magnesium. 
7.5. Future Work 
 To further prove that that it is magnesium bound over sodium a few experiments 
have been considered. The first and most direct method is to remove all traces of sodium 
from the protein buffer and crystallization condition. This, unfortunately, means no 
buffers used which changes the crystallization conditions and has the potential to not 
yield similar crystals to those crystallized with sodium. 
 Another experiment is to use lutetium, a lanthanide with a similar radius as 
magnesium, to replace magnesium in the binding pocket. Lanthanides will have a, 
roughly, 1000x higher binding affinity than magnesium. A simple soak should work, but 
adding lutetium to the crystallization condition may also be successful. Lutetium will be 
obvious within the anomalous scattering of X-rays. With lutetium being confirmed, then 
a comparison between modelling sodium and lutetium can be made with the current 
magnesium structure.  
The concern is lanthanides are notoriously insoluble, especially in the pH range 
that crystallization of these crystals takes place. A pH between 4-6 is where lutetium is 
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soluble, but not the pH range that these crystals exist. Further, with a 3+ ionic state, 
lutetium, if it binds, may cause unrelated conformational changes. With a distorted 
binding site, then a comparison between the two binding sites would be impossible. 
If lutetium fails, then manganese could be tried as well. Manganese is known to 
bind all the same binding pockets that magnesium does. Manganese would be obvious 
also based off of anomalous scattering within the crystal, and with a +2 charge, 
manganese should not cause the potential conformational changes that a +3 lutetium 
would. 
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 Table 7.1. Data collection and Refinement Statistics. 
 
  
 5% MPD Mg
2+
 Home Source 1mM Mg
2+
 
Spacegroup P21212 P21212 P21212 
Unit-cell 
parameters (Å) 
a = 75.8 
b = 48.6 
c = 53.9 
a = 75.7 
b = 48.5 
c = 54.0 
a = 76.1 
b = 48.6 
c = 54.3 
Wavelength 1.0000 1.541 1.0000 
Resolution 48.6 – 2.1 (2.2 – 
2.1) 
19.1 – 2.3 (2.4 – 
2.3) 
54.3 – 1.9 (2.0 -1.9) 
No. of observations 68495 (5798) 59829 (6010) 110235 (5557) 
Unique reflections 10352 (1081) 9286 (1020) 16134 (986) 
Rmerge (I) 0.028 (0.084) 0.053 (0.301) 0.025 (0.168) 
Rmeas (I) 0.033 (0.102) 0.063 (0.365) 0.029 (0.202) 
Rpim (I) 0.017 (0.058) 0.034 (0.204) 0.015 (0.110) 
Mean I/σ(I) 41.6 (14.2) 23.0 (5.6) 45.9 (9.5) 
Completeness (%) 85.1 (99.7) 99.8 (99.9) 98.3 (86.1) 
Multiplicity 6.6 (5.4) 6.4 (5.9) 6.8 (5.6) 
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Table 7.2. Comparison of the different coordination lengths between the Mg
2+
-bound 
structure, the Na
+
-bound structure (2ZND) and the Ca
2+
-bound structure (2ZN9). 
 
 
  
EF1 EF3 EF5 
 Distance  Distance  Distance 
 Mg
2
+
 
Na
+
 Ca
2+
  Mg
2+
 Na
+
 Ca
2+
  Mg
2
+
 
Na
+
 Ca
2+
 
OD1
D36
 2.0 2.3 2.3 OD1
D103
 2.1 2.4 2.3 OD1
D169
 2.0 2.4 2.5 
OD1
D38
 1.9 2.3 2.2 OD2
D105
 2.1 2.4 2.5 OD2
D171
 1.9 2.4 2.3 
OG
S40
 3.0 - 2.8 OG
S107
 2.1 2.5 2.5 OD1
D173
 1.9 2.3 2.2 
O
V42
 2.2 2.2 2.4 O
M109
 2.0 2.4 2.4 O
W175
 2.2 2.3 2.5 
H2O 1.9 2.6 2.3 H2O 2.0 2.3 ND H2O 1.9 2.5 2.3 
OE1
E47
 2.3 2.3 2.8 OE1
E114
 - 3.7 2.3 H2O 2.2 2.6 2.4 
OE2
E47
 2.8 2.8 2.6 OE2
E114
 - 4.3 2.5     
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Figure Legends 
Figure 7.1. Form 1 ALG-2 des23 crystals. Grown in sitting drop, vapor diffusion plates 
using 22-32% isopropanol and 0.1 M Tris pH 7.0-8.5.  
Figure 7.2. Form 2 ALG-2 des23 crystals. Grown in sitting drop, vapor diffusion plates 
using 22-32% isopropanol, 0.1 M Tris pH 7.0-8.5, and 0.2 M MgCl2. 
Figure 7.3. Diffraction pattern from Form 1 crystals of ALG2. 
Figure 7.4. Diffraction pattern from Form 2 crystals of ALG2. 
Figure 7.5. Overall structure of the symmetry-made dimeric ALG-2 enzyme. In red is the 
chain in the asymetric unit and blue is the chain made by symmetry. The orange spheres 
represent the magnesium modelled into EF1, EF3, and EF5. 
Figure 7.6. A) EF1 binding pocket with magnesium in orange. This pocket in particular 
appears to make a pentaganol bipyramidal coordination, which is unusual for Mg
2+
. B) 
EF3 binding pocket with magnesium (orange) making the expected octahedral 
coordination. C) EF5 binding pocket with magnesium (orange) making the expected 
octahedral coordination. 
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Fig 7.1. 
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Fig 7.2. 
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Fig 7.3. 
 
 
  
216 
 
Fig 7.4. 
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Fig 7.5. 
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Fig 7.6. 
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A1. 
EXPRESSION, PURIFICATION, CRYSTALLIZATION, AND 
SMALL ANGLE X-RAY SCATTERING (SAXS) OF THE Δ1-
986 BRADYRHIZOBIUM JAPONICUM PROLINE 
UTILIZATION A (BJFLAP) 
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A1.1. RATIONALE 
The original BjPutA structure was published in PNAS in 2010. The structure 
revealed an internal, water filled cavity that upon further investigation allowed for 
channeling of the product from the PRODH domain to the active site of the P5CDH 
domain without contact with bulk solvent. Further, it was discovered that the protomer of 
this enzyme had an elongated C-terminal domain that became disordered after residue 
989, 10 total disordered residues. Alone, the protomer had a large hole to the cavity, 
which would have made not only channeling difficult but contact with bulk solvent 
inevitable(1). 
Upon dimerization the C-terminal of one protomer covers the whole of another 
protomer. This means that for channeling to be possible dimerization has to occur, 
otherwise a large, gaping hole allows for leakage out of the channel. To test this idea, 
perhaps a large hole can be manufactured and then channeling can be tested to see if 
efficiency is reduced. It was decided that the very C-terminal of this enzyme would be 
removed. A truncation was made removing the last 13 residues. The truncation was 1-
986, removing residues 987-999, and it’s commonly referred to in the lab as BjFlap. 
Positive results in this hypothesis would confirm that dimerization is needed and would 
be further evidence that channeling is indeed occurring. 
A1.2. MATERIALS AND METHODS 
A1.2.1 Protein Expression and Purification  
This protein was expressed and purified as described previously for the wild-
type(2). The plasmid containing BjFlap was retransformed into BL21 DE3 pLysS cells. 
Colonies from these plates were placed in 10mL and 100 µg/mL ampicillin of LB Broth 
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and allowed to grow overnight. These starting cultures were used to inoculate 1L of LB 
Broth and 100 µg/mL ampicillin. Inoculated media was grown at 37 °C and 250 rpm until 
reaching an OD600 of 0.8. At this time, the media was induced using 500 µM IPTG and 
grown overnight at 25 °C and 200 rpm. 
The next day the cell cultures spun at 3500 rpm in an SLC-6000 rotor in a Sovall 
fixed-angle centrifuge. The pelleted cells were resuspended in 20 mM HEPES pH 8.2, 
150 mM NaCl, and 5% glycerol. The resuspended cells were flash frozen and stored at -
80 °C for later use. 
Frozen cells were thawed and broken using sonication with cycles of 30 seconds 
on and 2 minutes off to allow time to chill. Four of these were performed and the cell 
lysate was centrifuged in an SS-34 rotor at 16,500 rpm for 45 minutes. The cells were 
removed, the supernatant decanted into a fresh centrifugal tube and spun again for 45 
minutes at 16,500 rpm. This supernatant was decanted and then filtered through a 0.45 
µm syringe-driven filter. 
The filtered supernatant was then loaded onto a Ni-NTA column equilibrated with 
20 mM HEPES at pH 8.2, 150 mM NaCl, and 5% glycerol using an AKTA-prime FPLC. 
The loaded column was washed using the 30 mM imidazole to remove loosely binding 
contaminating enzymes. The enzyme was then eluted off the column using 300 mM 
imidazole. Fractions were collected in 2 mL aliquots. The fractions were pooled and 
about 1 mg/mL TEV protease was added. This mixture was allowed to incubate at 25 °C 
for 1 hour and then placed in a dialysis buffer containing 20 mM HEPES at pH 8.2, 150 
mM NaCl, and 5% glycerol and allowed to dialyze overnight. 
Following dialysis the enzyme was loaded, again, on a Ni-NTA column using the 
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afore mentioned binding buffer. However, this time during elution, only 30 mM 
imidazole was needed to remove the enzyme form the column. 2 mL fractions were 
collected and SDS-PAGE was run to check for purity. The enzyme was placed in a 
dialysis of 50 mM Tris pH 7.5, 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol in 4 °C 
overnight. The following day the enzyme was loaded onto a Hi-Trap anion exchange 
column with a binding buffer that was the same as the dialysis buffer. A gradient of 0-1 
M NaCl was run over 100 mL. The enzyme eluted around 300 mM NaCl and fractions 
were collected of about 500 µL. The fractions were tested for purity using SDS-PAGE 
and pure fractions were pooled. Pooled fractions were then dialyzed against the 
precrystallization buffer consisting of 50 mM Tris at pH 7.5, 50 mM NaCl, 0.5 mM 
EDTA, 0.5 mM THP, and 5% glycerol. 
A1.2.2 Crystallization  
Initial crystallography trials were attempted as previously reported for the wild-
type enzyme. Sitting drop trays containing 1.6-2.2 M ammonium sulfate and a pH range 
of 7.5-9.0 was attempted for crystallization. High concentrations of 8-10 mg/mL of 
BjFlap were tried, however, none of these worked. Another set of crystal trays were set 
up increasing the ammonium sulfate concentration with an upper limit of 2.8 M. 
However, these trays only had precipitate in them. 
Burning the end of a 0.1-10 µL pipet tip, and allowing it to cool created a nice 
pestle to crush wild-type BjPutA crystals. 10 µL of the crushed enzyme were placed into 
90 µL of mother liquor, to create a 10x dilution stock. This stock was vortexed for about 
30 seconds to break up any large crystal chunks that might be present. From the stock a 
100x and 1,000x dilution were made to further control nucleation. 
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Crystal trays in the original range were set up again, this time with varied 
concentrations of 4-8 mg/mL BjFlap. This time after mixing the enzyme and mother 
liquor in 1:1 ratio, a horse hair that had been dipped in a seed stock was swiped through 
each well, with a brief dip in ethanol at the end. Each stock solution of seed 10x, 100x, 
and 1000x was tried(3). Crystal trays were incubated at room temperature and after a 
couple days these trays had yellow, plate crystals present. They took about a week to 
grow to maximum dimensions. Subsequent optimizations utilized the crystals of the 
respective mutants grown at room temperature with a seed stock prepared in the same 
manner. Crystals were cryoprotected in 25-30% glycerol and then flash cooled by 
dunking in liquid nitrogen. 
A1.2.3 Data Collection and Refinement  
The space group is C2 with a BjPutA dimer in the asymmetric unit. X-ray 
diffraction data sets were collected at beamline 4.2.2 of the Advanced Light Source using 
a NOIR-1 detector. The data were integrated with MOSFLM(4) and scaled with 
SCALA(5). Refinements in PHENIX(6) were initiated from models derived from the 
structure of wild-type BjPutA (Protein Data Bank (PDB) entry 3HAZ). COOT(7) was 
used for model building. The structures were validated with MolProbity(8) and the PDB 
validation server. Data collection and refinement statistics are listed in Table 1. 
A1.2.4 SAXS  
Enzyme for SAXS was purified in the same way as that for purification with one 
extra step added; running the enzyme was run through size exclusion chromatography. 
Any aggregate was discarded and homogenous enzyme was collected. Collected fractions 
were pooled and concentration was estimated using the BCA method(9). Enzyme was 
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concentrated up to about 8 mg/mL and again verified using BCA. This concentrated 
sample was used for SAXS and the flow through from concentration was used as a 
reference buffer. 
SAXS experiments were performed at SIBYLS beamline 12.3.1 of the Advanced 
Light Source through the mail-in program(10, 11). For each sample, scattering intensities 
were measured at three nominal protein concentrations.  Data were collected for each 
protein concentration at exposure times of 0.5 s, 1.0 s. 3.0 s, and 6.0 s. The scattering 
curves collected from the protein samples were corrected for background scattering using 
intensity data collected from the reference buffer.   
The SAXS data were analyzed as follows.  Composite scattering curves were 
generated with PRIMUS(12) by scaling and merging the background-corrected low q 
region data from the 0.5 s exposure  with the high q region data from the 3.0 s exposure.  
PRIMUS was also used to perform Guinier analysis. FoXS(13) was used to calculate 
theoretical scattering profiles from atomic models.  GNOM was used to calculate pair 
distribution functions. The SASTBX “Shape Up!” server was used for shape 
reconstruction calculations.  
A1.2.5 PISA 
 To analyze the interfaces for oligomerization, the PISA server was used. The 
3HAZ structure was plugged directly into the server from a search of the PDB. The 
different interfaces were examined for potential mutation sites using COOT. The same 
thing was done, again, by loading the BjFlap structure and analyzing the proposed 
interfaces. 
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A1.3. RESULTS 
A1.3.1 Crystallography  
The structure looks very similar to that of the wild-type enzyme. The PRODH 
domain has a sulfate bound and the ion-pair gate is in the closed state. The flavin is in the 
oxidized form as well. The P5CDH domain also, looks as if it was the wild-type enzyme 
as well. The most distinct difference is that reisudes 987 and 988 and 989 are missing. 
The structure ends 986, which was expected. Further when running mole calculations the 
escape routes run out near the C-terminal residues, 986. VOIDOO(14) calculations also 
show a widening of this hole near the C-terminal just on the large cavity side of the ion 
pair gate.  
A1.3.2 SAXS  
The oligomeric state of BjFlap was investigated using SAXS. Guinier plots of 
data from four samples having different protein concentrations yield a radius of gyration 
(Rg) in the range 44.5-47.5 angstroms. The least noisy data was consistently 46-47 Å. The 
Rg of the BjPutA dimer in the asymmetric unit is about 45 Å, which suggests that the 
BjFlap actually looks most like the dimer. For comparison, the tetramer of the wild-type 
BjPutA has an Rg value of 51.1, which is much larger than the experimental Rg values 
found. 
More to the point, when investigating the scattering profile, BjFlap loses two 
important characteristics of the wild-type tetramer. First, the characteristic dip at about 
.075 q is completely gone. Second, and possible more importantly, the low q range 
approaching zero no longer aligns well with the tetramer scattering profile. 
SASTBX shape reconstructions no longer find any trace of the donut shaped 
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tetramer from the wild-type. Shape reconstructions fit well with the U-shaped dimer seen 
for many PutA dimers. The FoXS server picks the dimer as the best fit with a χ value of 
3.00. The protomer (unexpected) had a χ value of 8.30 and the tetramer had a χ value of 
20.36. However, when using the servers minimal ensemble search (MES) which can take 
multiple structures and find a combination of them to give the best result, reduces the χ 
value to 1.74 when combining 89% dimer and 11% tetramer. 
A1.4. DISCUSSION 
A1.4.1 Structure Analysis of the Flap Mutant  
The structure of this mutant does not offer much information. The mutation was 
removed the last 13 residues of the enzyme, making BjFlap a truncation mutant with 
identical sequence as wild-type from residues 1-986. The problem is that the wild-type 
structure becomes disordered after 989. The last 10 residues of the wild-type structure 
have no density present. The only observable difference in the structure comparison 
between these two is missing the absence of 987-989 in the BjFlap. All other residues 
look similar. 
VOIDOO and CAVER(15) calculations were done to determine if there is any 
difference in the internal cavity. VOIDOO performed on the wild-type structure 
frequently finds an exit from the cavity to the bulk solvent near the C-terminal of one 
protomer and the PRODH of the complementing protomer. As expected, VOIDOO 
calculations for the BjFlap find this same exit, however, the exit it finds appears to be a 
substantially larger opening. This leads credit to the hypothesis of the removal of this C-
terminal makes a substantial hole, exposing the internal cavity to bulk solvent, 
CAVER starts at designated coordinates within the structure and then finds the 
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fastest way out of the enzyme for a water molecule. Using this calculation for the wild-
type structure there is an escape route out to the bulk solvent, but only finds this route 
once. The same calculations performed on BjFlap show upwards of 3 different escape 
routes near the C-terminal of the enzyme. This clearly indicated an enlarging of this hole 
to the cavity. 
What is unclear is how much larger this hole is as compared to the wild-type. 
With the final 10 residues missing in the wild-type structure it is hard to tell if the access 
to the bulk solvent found by VOIDOO and CAVER is simply an artifact of the structure. 
A different space group with an ordered C-terminal might stop VOIDOO and CAVER 
from finding this hole. Unfortunately, another space group for this enzyme never gave 
usable data for structure determination. It is likely this hole is real based on the wild-type 
structure having approximately 70% efficiency. Substrate leakage is highly likely. 
What is clear, though, is that the hole and CAVER escape routes found in the 
BjFlap structure are real. This gives some indication that the C-terminal is important to 
covering the cavity. Without the C-terminal the cavity is still covered but a large hole 
decreases efficiency of the channel and increases the likelihood of the substrate escaping 
to bulk solvent. 
A1.4.2 C-Terminal Deletion Disruption of Tetrameric Oligomerization  
Perhaps the most surprising of results of the oligomeric state. The wild-type 
enzyme is a tetramer in solution. When plugged into the FoXS server using the multiple 
ensemble search (MES) yields a mixture of 85% tetramer and 15% dimer. The dominant 
species, by far, is the tetramer, shown in the scattering profile with a characteristic dip 
and bump. The dimer, however, lacks that specific characteristic. Further when doing 
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shape reconstruction a donut shape appears which fits well with the dimer of dimer 
ensemble found through crystallographic symmetry. 
However, the scattering profile of the BjFlap mutant is devoid of the dip and 
bump expected for a tetramer. Rather, when using the FoXS server the experimental 
scattering profile fits well with the dimer found in the asymmetric unit. When using MES 
the scattering profile fits best with a mixture of 11% tetramer and 89% dimer. Compared 
to the wild-type at the same concentration the ratios have been virtually reversed, with 
the mutant now favoring dimer. Further when using the SASTBX server for shape 
reconstruction, the envelope resembles that of the dimer found in the asymmetric unit, 
fitting with a 0.94 correlation coefficient. Tetramer formation is almost non-existent and 
does not play a dominant role in the overall shape of the enzyme. 
As mentioned previously, the C-terminal domain is completely disordered in the 
crystal structure and there is no direct evidence to what it is doing. However, recently 
there have been two more structures of PutAs solved that of GsPutA(16) and that of 
SmPutA (unpublished), that both have a complete C-terminal. In the wild-type  BjPutA 
structure the last visible residue, 989, is about 18-20 angstroms away from the 
tetramerization oligomerization domain. It is conceivable that the full length of the C-
terminal could reach there. To get a better picture of what is happening the two new 
structures of homologous PutAs were superimposed on the BjPutA. However, the C-
terminal of both enzymes pointed away from the oligomerization domain, and instead 
coiled up over the hole over the PRODH domain found in the BjPutA structure. 
These may be a poor substitute for modeling the BjPutA C-terminal, however, 
because GsPutA is a dimer in solution and SmPutA is a monomer. In fact, to date the 
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only PutA that has been discovered to be a tetramer is BjPutA. It is entirely possible, 
considering it is a unique case, that the C-terminal plays a special role in this enzyme to 
stabilize tetramer formation.   
A1.4.3. Possible Mutations for Disruption of the Tetramer 
 PISA indicates that a tetramer assembly is stable in solution. The tetramer is a 
dimer of dimers. Each dimer is a domain swap where the C-terminal of one protomer 
covers the internal cavity of the other protomer. The tetrameric assembly, however, 
appears to be largely loose stacking interactions near the PRODH domain. The two 
dimers interact at three separate domains all near the same area. Residues 46-66, 144-
154, and 474-479 are the major oligomeric domains. However, even in these domains, 
there are virtually no direct hydrogen bonding interactions between dimers. Rather, the 
domains appear to just come into fairly close contact and sit near eachother. Without 
PISA indicating this as a stable interaction and the SAXS data backing up the claim, this 
could have easily been dismissed as a crystal packing artifact. 
 Mutations to disrupt oligomer formation in the yeast and thermus thermophiles 
P5CDHs were relatively straight forward as there were clear interactions of side chains 
reaching out and interacting with areas on other protomers. Removing these interacting 
side chains disrupted oligomerization almost completely for these enzymes. However, the 
approach here is to take a small side chain and make it a large, obtrusive one to disrupt 
the tetramerization domain on these enzymes. Specifically, Ala66, Gly148, Pro150, and 
Val478 to tryptophan. The tryptophan introduces a very large and space filling side chain 
that may impede the somewhat loose interactions seen between these two dimers. 
 However, it might also be worthwhile investigating mutations similar to those 
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used before. Such as taking a larger, polar side chain and replacing it with a large, 
nonpolar side chain. There are a few interactions that, while not making a direct 
interaction between dimers, may be important for the interface to come together 
correctly. Glu46, Arg49, and Glu64 to tryptophan mutations may be able to interrupt 
tetramer formation as well by disrupting the interface. 
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Table A1.1. Data Collection and Refinement Statistics 
 
 
  
 BjFlap 
Spacegroup  C2 
Unit-cell Parameters (Å) a = 167.1 
b = 196.1 
c = 108.8 
β = 121.4 
Wavelength 1.0000 
Resolution 38.69 – 2.75 (2.90-
2.75) 
No. of Observations 284897 (38961) 
Unique Reflections 77333 (11219) 
Rmerge (I) 0.146 (0.469) 
Rmeas (I) 0.171 (0.553) 
Rpim (I) 0.088 (0.291) 
Mean I/σ(I) 6.3 (2.1) 
Completeness (%) 99.9 (99.7) 
Multiplicity 3.7 (3.5) 
No. of Proteins Atoms 14470 
Rcryst 0.2136 
Rfree 0.2667 
R.m.s. Deviations  
   Bond Lengths (Å) 0.008 
   Bond Angles (°) 1.128 
Ramachandran Plot (%)  
    Favored 94.6 
    Allowed 4.6 
    Outliers 0.8 
Average B (Å
2
)  
    Protein 39.640 
    Water 24.14 
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Figure Legends 
 
Figure A1.1.  Summary of BjPutA C-terminal truncation SAXS data. A) The 
experimental scattering curve of BjFlap overlaid with the calculated scattering profile of 
the BjPutA dimer (Solid Blue), BjPutA tetramer (Solid Red), and an MES combination of 
89% dimer and 11% tetramer (Dashed Yellow). The inset represents the Guinier Analysis 
plotted for all three concentrations as indicated. B) The shape reconstructions from the 
SASTBX Shape Up web server of BjFlap superimposed with the structure of the dimer of 
the structure of BjFlap. 
 
Figure A1.2. The structure of Chain A of the BjPutA structure is shown. FAD is in 
yellow, NAD is in cyan, and the cavity calculated for the wild type is represented as the 
pink surface. A) The C-terminal flap motif of Chain B that covers the cavity hole of 
Chain A is shown for the wild-type in red and blue. B) The C-terminal flap motif of the 
truncated Flap mutant highlighting the enlarging of the hole seen in the cavity. 
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Fig A1.1. 
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Fig A1.2. 
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A2. 
 
PROTEIN EXPRESSION, PURIFICATION, 
CRYSTALLIZATION AND SAXS ANALYSIS OF 
LEGIONELLA PNEUMOPHILA PUTA (LPPUTA) 
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A2.1. RATIONALE 
BjPutA was the first full length PutA that was crystallized. Homologous screening 
shows that many organisms have similar PutA enzymes. Legionella pneuomophila PutA 
(LpPutA) was a minimalist PutA much like BjPutA, but was only about 30% identical in 
sequence. This gives the possibility of further characterizing questions that remained 
about BjPutA, such as characterization of the channel, how the C-terminal of the enzyme 
is ordered (10 residues were completely disordered), and how important the high order 
oligomeric state was. 
Usable crystals of BjPutA were only ever seen and obtained in 2 M ammonium 
sulfate. Unfortunately, density for sulfate was seen in both the active site of PRODH and 
P5CDH. The high concentration of sulfate made it hard to displace with inhibitors and 
ligands that would help characterize the active sites and explain enzyme function. 
Homologs open up the possibility of crystallizing an enzyme in either the absence of salts 
that bind the active site, or at low enough concentrations that ligand soaking is possible. 
The quality of diffraction data of BjPutA was another concern for homologous 
screening. BjPutA had severe anisotropic diffraction, which was evident by the 'smearing' 
of diffraction spots. This led to many crystals needed to obtain one usable data set, as 
data reduction of many data sets was impossible. This made obtaining structures of 
mutants a more arduous task. However, if a homolog could provide more reliable 
diffraction void of these issues, than characterization would be much easier. 
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A2.2. MATERIALS AND METHODS 
A2.2.1 Protein Expression and Purification  
LpPutA was expressed as described previously for BjPutA with a few 
exceptions(2). First, instead of BL21 DE3 (pLysS) cells for expression, BL21 DE3 Star 
cells were used. After induction the temperature was reduced to 25C and rpm reduced to 
220. After pelleting and resuspending cells in the binding buffer for Ni-NTA, the cells 
were flash frozen and stored at -80 °C. Frozen cells were thawed in the presence of 5 
protease inhibitors: 0.1 mM TPCK, 0.5 mM AEBSF, 0.005 mM E-64, 0.001 mM 
pepstain, and 0.01 mM leupeptin. Cells were disrupted in a French pressure cell at 110 
MPa. The cell debris and insoluble material were removed by centrifugation in an SS-34 
rotor at 16,500 rpm for 60 minutes and the supernatant decanted off. Purification of the 
enzyme is the same as that described for BjPutA previously(2). 
A2.2.2 Crystallography  
Screening attempts using Crystal Screen I and II, Index, and Wizard I-III were set 
up both in sitting drop, vapor diffusion trays and under Al’soil. Vapor diffusion trays 
were set up at 10 and 5 mg/mL in a ratio of 1 µL protein to 1 µL mother liquor. Under oil 
was set up in the same way with 8 µL of Al’s oil added to conceal the 2 µL mixture. All 
trays were incubated at room temperature. 
 Wizard II - 42 with a solution of 30% PEG 400, 0.1 M HEPES (pH 7.5), and 0.2 
M NaCl had a hit that was optimized. Optimizations of this hit were grown with a range 
of PEG 400 of 21%-36%, 0.1 M HEPES (pH 6.5 – 8.0) and either with or without NaCl. 
Crystals took about 2 weeks to appear and grow to a maximum dimension. Crystals were 
cryoprotected in 36% PEG 400 and 0.1 M HEPES (pH 7.5), mounted on a copper base 
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pin, flash cooled by plunging into liquid nitrogen, and stored in liquid nitrogen.  
A2.2.3 SAXS  
SAXS data were collected on Advanced Light Source beamline 12.3.1 through 
the mail-in program(10, 11). Before SAXS analysis, LpPutA was subjected to size-
exclusion chromatography using a Superdex-200 column equilibrated with 0.05 M Tris 
(pH 8.0), 0.5 M NaCl, and 1 mM THP. The enzyme was then concentrated after SEC 
using a centrifugal filter. SAXS analysis was performed at three different concentrations 
(8 mg/mL, 5.3 mg/mL, and 2.7 mg/mL). Scattering intensities were measured with 
exposure times of 0.5, 1.0, and 3.0 s for each concentration. Scattering curves collected 
from the protein samples were corrected for background scattering using intensity from 
effluent of the centrifugal filter and concentration procedure. PRIMUS(12) was used to 
create a composite scattering curve for each protein concentration. Scaling and merging 
of the background corrected data with the high q region of the 3.0 s exposure and the low 
q region of the 1.0 s exposure. PRIMUS was also used to perform Guinier analysis.  
FoXS(13) was used to calculate theoretical scattering profiles from atomic models.  
A2.3. RESULTS 
A2.3.1 Expression and Crystallography  
Many hits were seen for this enzyme, almost all of them were microcrystals and 
micro-needles. One crystal obtained was a needle, very long and thin, but was large 
enough to mount and shoot. This crystal grown in 36% PEG 400 and 0.1 M HEPES (pH 
8.0) diffracted to 3.8 Å. Data collection statistics are listed in Table 1. Molecular 
replacement of the crystal was successful using the dimeric search model of the BjPutA 
3HAZ structure. A dimer in the asymmetric unit was seen much like that of BjPutA. 
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However, instead of a dimer of dimers related by symmetry, a tetramer of dimers was 
seen related by crystallographic symmetry. 
 Unfortunately, pursuing higher resolution was cut short. After obtaining this 
crystal structure the protein became insoluble on subsequent expression attempts. 
Originally expression was high and very little was insoluble. The plasmid was 
retransformed into BL21 (DE3), pLysS, Rosetta, and Star cells. Star gave the best 
expression, but yields were still poor. Further auto induction was tried as plasmid was 
retransformed into AI cells. However, autoinduction was also unsuccessful. 
The enzyme was housed in pET151 vector, which uses a topoisomerase to insert 
the gene into the plasmid. Attempts were made to remove the gene from this plasmid by 
placing BAMH1 and Ned1 cleavage cites on each end. However, these attempts were 
unsuccessful. Instead, protein obtained from expression in BL21 (DE3) Star cells was 
used to recreate the crystals seen previously. However, the crystal hits were not seen even 
after rescreening with both His-tag present and removed. Further attempts to pursue this 
crystal form were dropped. 
A2.3.2 Molecular Replacement and PISA 
 To solve the phasing issue molecular replacement was done using MolRep. 
Pointless had already determined the Laue symmetry to be in I4, however the question 
remained if I41 was the real space group. However, at 3.8 Å resolution finding systematic 
absences will be difficult. Instead MolRep was used to determine which of these 
symmetries gave a better score (Table 1). A BjPutA monomer using chainsaw was used 
as the search model. The score and contrast from MolRep indicates that I4 is most likely 
the correct solution. The Matthews coefficient suggests that in I4 that the most likely two 
241 
 
or three monomers in the assymetric unit. Two was used based off of knowledge of 
dimerization seen broadly in PutAs. 
 The results of the MolRep model show an octomer, or a tetramer of dimers, 
related by 4 fold symmetry. However, PISA analysis suggests that a dimer is what is 
stable in solution, implying that the presence of the octomer is a result of crystal packing. 
In contrast, the BjPutA tetramer was found to be stable in solution. Indeed, when the 
octomer scattering profile is calculated using the FoXS server, it does not much the 
experimental profile found for LpPutA. 
A2.3.3 SAXS  
The oligomeric state of LpPutA was investigated using SAXS. Guinier plots of 
three different protein concentrations gave Rg values of 46-48 Å. P(r) distributions gave 
an even narrower range for Rg at 46-47 Å and gave a maximum particle dimension of 
150-160. When compared to the Rg values of BjPutA (30% identical), LpPutA more 
closely resembles the U-shaped dimer, as opposed to the tetramer.  The BjPutA scattering 
curve has a characteristic dip and peak around a q range of 0.05 which was absent from 
the LpPutA scattering profile.  
Without a structure of LpPutA the only full length structure up to that point, 
BjPutA, was used as a model for comparison. The FoXS server indicates that the best fit 
is the BjPutA dimer with a chi value of 6.31. The protomer had a chi value of 24.67 and 
the tetramer had a chi value of 66.45. The MES only improves this chi to 5.16 when 
splitting between 13% protomer and 87% dimer. Shape reconstructions run with 
DAMMIN(17) and the SASTBX server both give good correlation with the dimer found 
in the asymmetric unit of BjPutA. 
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A2.4. DISCUSSION 
BjPutA had been a tetramer, more specifically a dimer of dimers, in solution after 
the discovery of the existence of the tetramer by crystallographic symmetry in the 
structure. The low resolution structure obtained from LpPutA, assuming molecular 
replacement was correct, indicated that this enzyme was an octomer, or tetramer of 
dimers, related by crystallographic symmetry. This was a surprising find as such a high 
order oligomer is unusual. SAXS analysis was done and the results indicated a dimer in 
solution, meaning that the octomer seen was most likely a crystal artifact or an indication 
that molecular replacement did not work. 
However, being a minimalist PutA the expectation was that LpPutA would mimic 
what was seen in BjPutA previously. However, as indicated by the SAXS data the 
presence of a tetramer was not seen. Even in the MES calculation there was no presence 
of a tetramer, rather a presence of dimer and protomer. The protomer seems unlikely as 
dimerization is needed to cover the cavity. However, the absence of a tetramer in solution 
led to question which of these enzymes the outlier was. As it turns out, BjPutA ended up 
being a unique case as tetramerization was not seen in any other PutAs studied, but rather 
most of the minimalist PutAs formed dimers in solution much like LpPutA.  
Further, the tetramerization domain is almost completely disrupted by removing 
the C-terminal domain of BjPutA. The cause of this cannot be easily investigated as the 
C-terminal domain is disordered in the BjPutA structure. A comparison to a minimalist 
homolog such as LpPutA would have been perfect for modelling the C-terminal and 
perhaps shedding light on this question. It is unfortunate that the crystallization of 
LpPutA was not reproducible and had to be stopped.  
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Table A2.1. MolRep Space Group Determination Results. 
 SG # Space Group Score Contrast 
1 79 I4 0.252 9.676 
2 80 I41 0.195 3.899 
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Table A2.2. Data Collection Statistics 
 
 LpPutA 
Spacegroup I4 
Unit-cell Parameters (Å) a,b = 199.80 
c = 134.23 
Wavelength 1.0000 
Resolution 74.38 – 3.80 (4.01-3.08) 
No. of Observations 103636 (15345) 
Unique Reflections 26021 (3785) 
Rmerge (I) 0.189 (0.465) 
Rmeas (I) 0.255 (0.628) 
Rpim (I) 0.170 (0.420) 
Mean I/σ(I) 5.9 (3.0) 
Completeness (%) 99.7 (99.9) 
Mulitplicity 4.0 (4.1) 
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Figure Legends 
Figure A2.1. A) The scattering profile collected from SAXS represented by the black 
circles. The curves represent the calculated scattering curve for the dimer (blue) and the 
tetramer (green) superimposed by the FoXS server. The inset represents the Guinier plots 
for all three concentrations used. Their calculated Rg values are shown above the Guinier 
plots. B) The DAMMIN reconstructions superimposed with the BjPutA model. The two 
figures are rotated 90° along the x axis from eachother. 
 
Figure A2.2 The stable oligomeric dimer as determined by PISA. 
 
Figure A2.3 The octomer formed by four-fold symmetry in the crystal lattice. 
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Fig A2.1. 
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Fig. A2.2 
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Fig. A2.3 
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A3. 
EXPRESSION, PURIFICATION, CRYSTALLIZATION AND 
SAXS ANALYSIS OF DESULFOVIBRIO VULGARIS PUTA 
(DVPUTA) 
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A3.1. RATIONALE 
 Proline catabolic enzymes have been classified into three separate branches. 
Branch 3 houses the monofuncational enzymes, PRODH and P5CDH. The fused 
enzymes are divided into two separate branches, branches 1 and 2. Branch 1 is primarily 
PutAs from alpha-, beta-, and gamma- proteobacteria. This branch has PutAs ranging in 
size from 999-1400 residues with sequence identities greater than 38%. Branch 2 consists 
mostly of epsilon-proteobactera and cyanobacteria PutAs. These range in size from 980-
1300 residues and have a sequence identity greater than 23%. The sequence identities 
between the two branches are generally less than 30%. However, the active sites for 
PRODH and P5CDH are highly conserved, but with the large gap in identity it is clear 
these two branches have variations. Further branch 1 contains not only bifunctional 
enzymes, but have a subset of trifunctional PutAs as well, such as that for EcPutA. 
Trifunctional PutA has the additional function of repressing its own gene. Branch 2 does 
not have these larger trifunctional enzymes. 
 Up until recently, the only full length PutA structure solved was that of BjPutA, 
which is a minimalist, branch 1 PutA. EcPutA has some individual domain structures, but 
a full length trifunctional PutA has yet to be fully realized. Additionally, there are no 
branch 2 PutAs that have been fully sequence. Considering that branch 2 appears to be a 
much more diverse grouping, structural data on this group of enzymes would be 
beneficial. Branch 2 houses the Helicobacter pylori and hepaticus PutAs(18), which have 
been shown to be more reactive with oxygen than other PutAs. This activity with oxygen 
is structurally unclear because BjPutA does not have such reactivity. Desulfovibrio 
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vulgaris PutA (DvPutA) is a branch 2 PutA and crystallization of this enzyme could lead 
to a better understanding of this diverse family of enzymes(19, 20). 
 Further, as with the BjPutA homolog, LpPutA, a new crystal form of a PutA that 
lacks a high concentration of sulfate would be beneficial. Ligand soaking and structural 
mutant studies have been challenging with the BjPutA because of its anisotropic 
diffraction and presence of sulfate in both active sites. A new crystal form could solve the 
poor diffraction problem and a smaller concentration of salt has the potential to yield 
better data and a deeper understanding of the mechanistic functions of this enzyme. 
A3.2. MATERIALS AND METHODS 
A3.2.1 Protein Expression and Purification  
Protein was grown in LB Broth with 100 µg/mL kanamycin. The cultures were 
allowed to grow at 37 °C and an rpm of 250 to an OD600 of 0.5 and then induced with 50 
µM IPTG. After induction the temperature was dropped to 18 °C and rpm reduced to 200. 
Cells were left overnight and pelleted the following morning in an SLC-6000 rotor at 
3500 rpm. The pelleted cells were resuspended with the binding buffer for Ni-NDA 
containing 20 mM HEPES pH 8.2, 50 mM NaCl, and 5% glycerol. The cells were flash 
frozen in liquid nitrogen and stored at -80 °C. 
 Frozen cells were thawed and broken with 4 rounds of sonication. Each round 
involved 30 seconds on and 2 minutes of cooldown time for the sample. Debris and 
insoluble material was removed through centrifugation using an SS-34 rotor at 16,500 
rpm. The supernatant was decanted and filtered through a 0.45 µm, syringe-driven filter.  
 This filtered supernatant was loaded onto a Ni-NTA column with the binding 
buffer described above. Much of the impurities were removed from sample while loading 
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as nothing bound. The column was then washed with 30 mM imidazole to remove extra 
impurities. After removing all impurities at 30 mM, the concentration was increased to 
300 mM imidazole at which point DvPutA eluted off the column. Eluted enzyme was 
collected in 2 mL aliquots and then pooled. The His tag was not cleaved and the pooled 
fractions were put into a dialysis buffer containing 50 mM Tris, 0.5 mM EDTA, 0.5 mM 
THP and 5% glycerol at pH 7.5. The protein was allowed to dialyze for over 12 hours. 
 The dialyzed enzyme was loaded onto a Hi-trap anion exchange column with a 
binding buffer that is the same as the dialysis buffer. After the enzyme was loaded a 
gradient of 0-1 M NaCl was run over 100 mL. The protein eluted at approximately 300 
mM NaCl and the eluted protein was collected in 500 µL samples. These samples were 
checked for purity on SDS-PAGE. Pure samples were pooled and put into a pre-
crystallization dialysis buffer consisting of 50 mM Tris (pH 7.5), 50 mM NaCl, 0.5 mM 
EDTA, and 0.5 mM THP. The enzyme was allowed to dialyze overnight and after 
removal enzyme concentration was checked using the BCA method. The enzyme was 
then concentrated up to about 13 mg/mL using a centrifugal concentrator and verified 
through another round of the BCA method(9). 
A3.2.2 Crystallography  
This enzyme was screen using Crystal Screen I and II, Index, and Wizard I-III in 
sitting drop, vapor diffusion trays. Wells consisted of 1 µL of 10 mg/mL DvPutA mixed 
with 1 µL of mother liquor. Crystal trays were incubated at room temperature and another 
set were incubated at 4°C. Microbatch trays under Al’s oil were set up with the same 1:1 
ratio of protein and mother liquor and incubated at room temperature. 
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A3.2.3 SAXS  
SAXS data were collected on Advanced Light Source beamline 12.3.1 through 
the mail-in program. Before SAXS analysis, LpPutA was subjected to size-exclusion 
chromatography using a Superdex-200 column equilibrated with 0.05 M Tris (pH 8.0), 
0.5 M NaCl, and 1 mM THP. The enzyme was then concentrated after SEC using a 
centrifugal filter. SAXS analysis was performed at three different concentrations (8 
mg/mL, 5.3 mg/mL, and 2.7 mg/mL). Scattering intensities were measured with exposure 
times of 0.5, 1.0, and 3.0 s for each concentration. Scattering curves collected from the 
protein samples were corrected for background scattering using intensity from effluent of 
the centrifugal filter and concentration procedure. PRIMUS(12) was used to to create a 
composite scattering curve for each protein concentration. Scaling and merging of the 
background corrected data with the high q region of the 3.0 s exposure and the low q 
region of the 1.0 s exposure. PRIMUS was also used to perform Guinier analysis.  
FoXS(13) was used to calculate theoretical scattering profiles from atomic models.   
A3.3. RESULTS 
A3.3.1 Crystallography  
Several hits were obtained as a result of the many crystal screens set up and many 
of them were investigated. However, the most widely reproducible and largest crystals 
came from 6-16% PEG 8,000, 8% ethylene glycol, and 0.1 M HEPES pH 7.0 – 8.5. 
These were very large, hollow, and hexagonal-looking crystals. Hollow crystal types had 
been reported before, in fact hollow crystals were the only Put2 crystals that gave usable 
data(21). There were originally determined to be of the space group P3 and have unit cell 
parameters of a,b = 163.6, c = 214.5, and γ = 120. Unfortunately, these crystals had 
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pseudotranslational symmetry, a serious pathology in crystallography that makes the 
diffraction data unusable. 
 The other crystal forms never diffracted to a reasonable resolution and could 
never be grown much larger. This, in conjunction with GsPutA, another branch 2 PutA 
with 67% sequence identity with DvPutA, already having a high resolution structure 
made DvPutA undesirable and ultimately was dropped. 
A3.3.2 Molecular Replacement and PISA 
 The 3.5 Å structure of DvPutA was determined using molecular replacement as 
implemented in MOLREP using the GsPutA dimer as a search model. MOLREP was first 
used to search all Laue group members, using a GsPutA monomer as a search model 
(Table 1). The scores indicate that the correct space group is likely P6122. The matthew’s 
coefficient suggests a dimer or monomer in the asymmetric unit. MOLREP was run again 
using the monomer of GsPutA as the search model. MOLREP determined that only a 
monomer exists in the asymmetric unit. Analysis using PISA indicated that a dimer was 
stable in solution, however it was not the expected dimer found in the SAXS data and 
seen in other PutAs. Instead of a domain swap of the C-terminals there is a loose 
association near the PRODH domains. 
A3.3.3 SAXS  
The oligomeric state was investigated using SAXS. The scattering profiles of 
DvPutA resembled those of GsPutA. Guinier analysis of the profile yields a radius of 
gyration (Rg) value of 43.6-43.9 Å. Without a structure of DvPutA to compare to, the 
closest homolog was used as a comparison, which is GsPutA with a sequence identity of 
67%. The calculated Rg value for the dimer in the asymmetric unit of GsPutA is 44.6 Å.  
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The overlapping of the scattering curves reveals that the calculated GsPutA dimer 
scattering is a close fit with that of DvPutA, however the calculated BjPutA tetramer is a 
poor lap. 
 It is not that surprising to find DvPutA present as a dimer in solution. The initial 
discovery of GsPutA being dimeric in solution, was surprising since previously the full 
length PutA was seen as a tetramer. However, as more data has been collected on the 
oligomeric state of this family of enzymes, it is becoming apparent that BjPutA was the 
exception. With DvPutA being more identical to GsPutA and being a branch 2 PutA as 
opposed to the branch 1 BjPutA, the expected outcome was DvPutA being a dimer.  
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Table A3.1 MolRep Space Group Determination 
 SG # Space Group Score Contrast 
1 178 P6122 0.247 14.421 
2 177 P622 0.079 2.548 
3 179 P6522 0.153 4.209 
4 180 P6222 0.076 1.661 
5 181 P6422 0.080 1.719 
6 182 P6322 0.150 4.726 
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Table A3.2. Data Collection Statistics. 
 DvPutA 
Spacegroup P6122 
Unit-cell Parameters (Å) a,b = 163.6 
c =214.9 
γ = 120.0 
Wavelength 1.541 
Resolution 19.71 – 3.50 (3.69-3.50) 
No. of Observations 181740 (26918) 
Unique Reflections 20902 (3060) 
Rmerge (I) 0.406 (0.589) 
Rmeas (I) 0.430 (0.625) 
Rpim (I) 0.140 (0.205) 
Mean I/σ(I) 7.1 (3.8) 
Completeness (%) 95.9 (3.8) 
Multiplicity 8.7 (8.8) 
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Figure Legends 
 
Figure A3.1. Diffraction pattern of DvPutA collected on the Rigaku IV++ home source 
detector.  
 
Figure A3.2. A) The scattering profile collected from SAXS represented by the black 
circles. The curves represent the calculated scattering curve for the dimer (blue) and the 
tetramer (green) superimposed by the FoXS server. The inset represents the Guinier plots 
for all three concentrations used. Their calculated Rg values are shown above the Guinier 
plots. B) The SASTBX reconstructions superimposed with the BjPutA model. The two 
figures are rotated 90° along the x axis from each other. 
 
Figure A3.3. The oligomeric ensemble predicted by PISA to be stable in solution. 
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Fig A3.1. 
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Fig A3.2. 
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Fig. A3.3. 
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